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Abstract 
A balance between inhibitory and excitatory neurons is essential for the 
establishment of a functional vertebrate nervous system. A key factor in 
regulating this balance is the bHLH transcription factor Ptf1a, which promotes a 
GABAergic inhibitory neuronal identity at the expense of a glutamatergic 
excitatory neuronal identity in the vertebrate retina, hindbrain and spinal cord. In 
this context, the activity of Ptf1a requires formation of a trimeric complex, in 
which Ptf1a binds to a commonly expressed bHLH E-protein and to a member 
of the Su(H) family. Ptf1a has also been shown to promote general neuronal 
differentiation in X. laevis embryos and explants, suggesting that Ptf1a has 
proneural activity.  
 
In this thesis work, the role of Ptf1a in the context of both general 
neurogenesis (early function) and neuronal subtype specification (late function) 
was investigated. Through the temporal expression analysis of known genes, 
Ptf1a was shown to drive neurogenesis in animal caps (naïve ectoderm) at 
early time points through the activation of downstream target genes similar to 
the proneural transcription factor Ngn2. However, at later stages, Ptf1a 
activated marker gene expression indicative of GABAergic neurons, while 
glutamatergic neuronal markers were induced by Ngn2. A mutant version of 
Ptf1a (Ptf1aW224A/W242A), that is unable to interact with the cofactor Su(H), 
maintained the ability to drive general neurogenesis, but was unable to activate 
GABAergic marker genes. These findings suggest that Ptf1a forms context 
specific transcription complexes during the development of the nervous system: 
a Su(H)-independent complex to drive general neurogenesis and Su(H)-
dependent complex to specify GABAergic neurons.  
As target genes of Ptf1a during the development of the nervous system are not 
well defined, two independent whole transcriptome analyses were conducted to 
elucidate the genetic network downstream of Ptf1a. In these assays, a temporal 
analysis of genes induced by wild-type Ptf1a, Ptf1aW224A/W242A and Ngn2 in X. 
laevis animal caps was performed; direct targets for Ptf1a and Ptf1a/Su(H) were 
determined by activation of these transcription factors in the presence of an 
inhibitor of protein synthesis (CHX). Through this approach, many putative 
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novel early and late Ptf1a target genes were identified. Further analysis of these 
downstream targets will give insight into how Ptf1a regulates general 
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 A primary aim in the field of neurobiology is the development of 
therapeutic treatments for neurodegenerative and other neurological diseases. 
Many promising strategies are based on the manipulation of cells in vitro and in 
vivo. It is therefore essential to understand the molecular mechanisms by which 
a progenitor cell acquires a neuronal fate and subsequently obtains a specific 
neuronal subtype identity. 
 The African clawed frog Xenopus laevis (X. laevis) is an ideal vertebrate 
model organism to study the development of the vertebrate nervous system. 
The first primary neurons are born in the open neural plate in a relative 
simplistic pattern (Hartenstein, 1989; Chitnis et al., 1995). Moreover, owing to 
the external development, the earliest stages of embryogenesis are easily 
accessible for manipulations, such as microinjection of DNA, mRNA or 
antisense morpholino oligonucleotides. In addition, explant and transplantation 
experiments are easy to perform. The animal caps are pluripotent embryonic 
cells derived from the ectoderm of blastula stage embryos and are an attractive 
system to study in vitro differentiation (Borchers and Pieler, 2010). As the X. 
laevis genome is partially tetraploid, the closely related species Xenopus 
tropicalis (X. tropicalis) is increasingly being used as it has a sequenced diploid 
genome (Amaya, 2005; Hellsten et al., 2010; Harland and Grainger, 2011). 
However, routine use of X. tropicalis as a model system is hindered by the 
faster development of early cleavage stages and the more difficult cultivation of 
the embryos.  
1.2 Neural induction 
 The development of the nervous system begins with the process of 
neural induction, during which ectodermal cells become committed to a neural 
cell fate (Rogers et al., 2009b). X. laevis explant experiments demonstrated that 
the neural fate of ectodermal cells is specified during gastrulation. While 
ectodermal explants (animal caps) of blastula stage embryos develop into 
epidermal tissue, those from gastrula stage embryos give rise to neural tissue 
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(Hamburger, 1969; Sanes, Reh and Harris, 2006). However, upon dissociation 
of X. laevis blastula ectodermal explants, cells obtain a neural instead of an 
epidermal fate, implicating that in the absence of cell-to-cell signalling a neural 
fate is specified (Godsave and Slack, 1989; Grunz and Tacke, 1989; Sato and 
Sargent, 1989; Wilson and Hemmati-Brivanlou, 1995) (Fig. 1.1). This is further 
supported by the rescue of an epidermal cell fate in dissociated cells when 
cultivated in the presence of BMP-4 (Wilson and Hemmati-Brivanlou, 1995) 
(Fig. 1.1). Similarly, upon overexpression of a dominant-negative activin 
receptor, animal caps also acquire a neural fate, further indicating that inhibition 
of the TGF-beta signalling-pathway is required for neural cell fate determination 
(Hemmati-Brivanlou and Melton, 1994) (Fig. 1.1). These initial experiments led 
to the so called 'default model', suggesting that the neural identity of dorsal 
ectodermal cells is the 'default' state and that BMP-signalling must actively be 
inhibited.   
 
Figure 1.1 Schematic representation of experiments supporting the 'default 
model' of neural induction.  
Ectodermal explants (animal caps) excised from the animal pole of X. laevis blastula 
stage embryos, develop into atypical epidermis. However, upon overexpression of a 
dominant-negative activin receptor or dissociation of the animal caps, the cells acquire 
a neural cell fate. An epidermal cell fate can be restored, if dissociated animal caps are 
cultivated in the presence of BMPs. (Muñoz-Sanjuán and Brivanlou, 2002, modified) 
 Several BMP-antagonists including Chordin (Piccolo et al., 1996; Sasai 
et al., 1994), Noggin (Zimmerman et al., 1996; Lamb et al., 1993) and Cerberus 
(Bouwmeester et al., 1996; Piccolo et al., 1999) have been identified. These 
factors all have neural inducing activity and are expressed in the Spemann 
Organizer, which during gastrulation involutes and underlies the prospective 
neuroectoderm. Moreover, they are all secreted factors that inhibit BMP-
signalling by binding BMP-molecules in the extracellular space and prevent 
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receptor activation (Fig. 1.2). BMP activity is further attenuated by FGF-
signalling (Furthauer et al., 1997; Wilson et al., 2000), which inactivates Smad1 
(Fig. 1.2), an intracellular effector of the BMP-pathway (Pera et al., 2003).  
 The 'default model' of neural induction remains controversial as several 
experimental findings, particularly in higher vertebrates, are inconsistent with 
this hypothesis. In this regard, individual knock-out mice of the neural inducer 
molecules Noggin, Chordin or Follistatin show no defect in neural induction 
(Bachiller et al., 2000; Bachiller et al., 2003; Matzuk et al., 1995; McMahon et 
al., 1998). However, functional redundancy of the multiple neural inducer 
molecules cannot be excluded. Furthermore in chick, the BMP-inhibitors are not 
sufficient to induce neural cells in epidermal or extra-embryonic ectodermal 
tissue and their temporal expression pattern does not coincide with the ability of 
the chick organizer to induce neural cells (Wilson and Edlund, 2001; Wilson et 
al., 2000; Streit et al., 1998; Storey et al., 1992; Levin, 1998). In summary, 
these data indicate that an inhibition of BMP-signalling alone is not sufficient to 
induce neural fate.  
 Several experiments implicate a role for FGF-signalling in neural 
induction, independently from its function to attenuate BMP-signalling. In X. 
laevis, experiments demonstrated that the induction of neural cell fate in non-
neural ectoderm requires both, inhibition of BMP-signalling and active FGF-
signalling (Wawersik et al., 2005; Delaune et al., 2005; Linker and Stern, 2004). 
This notion is further supported by the fact that in X. laevis and chick, blockage 
of FGF-signalling disturbs neural development (Streit et al., 2000; Hongo et al., 
1999) and that overexpression of a dominant-negative FGF-receptor renders 
Noggin and Chordin unable to induce neural cell fate (Launay et al., 1996; 
Sasai et al., 1996). FGF alone is also able to induce ectopic expression of 
neural markers in X. laevis ectodermal cells as well as in chick epiblast cells 
(Lamb and Harland, 1995; Kengaku and Okamoto, 1995; Storey et al., 1998; 
Alvarez et al., 1998). 
 In addition to FGF-signalling and inhibition of the BMP-pathway, Ca2+-
signalling has been implicated in neural induction (Leclerc et al., 2012). 
Spontaneous elevations of intracellular Ca2+ occur in dorsal ectodermal cells at 
blastula stage and Ca2+-levels increase during gastrulation (Leclerc et al., 2000; 
Leclerc et al., 1997). Furthermore, blocking Ca2+-signalling abolishes neural 
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induction (Leclerc et al., 2012), whereas an increase in Ca2+ is sufficient to 
induce neural cells (Moreau et al., 1994) . 
 Several transcription factors are expressed in the neuroectoderm during 
neural induction and are involved in neural fate stabilization (Rogers et al., 
2009b) (Fig. 1.2). One important group is the Zic family of zinc-finger 
transcription factors. Both Zic1 and Zic3 are activated in the ectoderm through 
inhibition of the BMP-pathway (Nakata et al., 1997; Mizuseki et al., 1998a; 
Marchal et al., 2009) and Zic3 is additionally a target of Ca2+-signalling (Leclerc 
et al., 2003). Overexpression of both members of the Zic family, as well as any 
of the three Iroquois genes, Iro1, Iro2 and Iro3, not only expands the neural 
plate, but also promotes the onset of neural differentiation factors (Bellefroid et 
al., 1998; Gomez-Skarmeta et al., 1998). Overexpression of Zic2, another 
member of the Zic family, also expands the neural plate, however, it represses 
the expression of neural differentiation genes (Brewster et al., 1998). This 
suggests that Zic2 expression maintains neural cells in an undifferentiated cell 
state. Additionally, three members of the Sry-related HMG-box family, Sox2, 
Sox3 and SoxD are involved in neural fate stabilization. Sox2 and Sox3 are 
thought to be important for neural progenitor maintenance (Hardcastle and 
Papalopulu, 2000; Ellis et al., 2004; Pevny and Placzek, 2005; Rogers et al., 
2009a), whereas SoxD was shown to activate the expression of the neural 
determination gene Neurogenin 2 (Ngn2) and to promote delayed neural 
differentiation (Mizuseki et al., 1998b). Further pan-neural genes involved in 
progenitor maintenance are the forkhead transcription factor FoxD5 and the 
coiled-coil protein Geminin (Seo and Kroll, 2006; Kroll, 2007; Kroll et al., 1998; 
Pitulescu et al., 2005; Sullivan et al., 2001). Several studies indicate a cross-talk 
between these genes, which thereby regulates the balance between neural fate 
stabilization and neural differentiation (Rogers et al., 2009b).  
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Figure 1.2 Scheme of the molecular mechanism of neural induction in X. laevis. 
Upon BMP binding to the receptors, the BMP-receptors dimerize and undergo 
autophosphorylation. Through the activation of target genes such as Gata2, Msx1, 
Vent1 and Vent2, BMP-signalling induces an epidermal cell fate. However, BMP-
signalling can be intracellular inhibited through the FGF/MAPK pathway, as well as 
extracellular through the secreted molecules Noggin, Cerberus and Chordin. Through 
the inhibition of BMP-signalling, multiple genes are activated, including Zic1, Zic3 and 
SoxD, which lead to neural differentiation of ectodermal cells. Progenitor pools are 
maintained by the induction of genes like Sox3 and Geminin. (after Rogers et al., 
2009b) 
1.3 Neuronal differentiation 
 In vertebrates, the progenitor cells within the neural plate are highly 
mitotic (Hartenstein, 1989) and become differentiated due to the expression of 
proneural genes. The first proneural basic-helix-loop-helix (bHLH) genes 
discovered were the genes of the Achaete-scute complex in Drosophila (Murre 
et al., 1989). These genes, as well as the gene Atonal (Jarman et al., 1993), 
induce neural commitment of ectodermal cells and were therefore termed 
proneural genes (Ghysen and Dambly-Chaudiere, 1989; Jan and Jan, 1994). 
Several vertebrate homologues have been identified, including in X. laevis, and 
can be classified into Atonal and Achaete-scute related genes (Fig. 1.3) (Lee, 
1997; Guillemot, 1999). Through the conserved bHLH domain, these factors 
form dimers, either homo- or heterodimeric complexes with an ubiquitously 
expressed class A bHLH transcription factor. These complexes bind a 
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characteristic sequence known as the E-box motif (CANNTG) within regulatory 
elements of target genes (Murre et al., 1989).  
 In vertebrates, proneural genes induce neuronal cell fates of neural cells 
and are key regulators of the neurogenic differentiation program. However, not 
all members of the Achaete-scute and Atonal gene family have an endogenous 
proneural function, as NeuroD1, NeuroD6/Ath2 and NeuroD4/Ath3 are only 
expressed in post-mitotic neurons. 
 
 
Figure 1.3 X. laevis homologues of the proneural Achaete-scute and Atonal 
genes of Drosophila.  
Due to conserved sequences in the bHLH domain, X. laevis proneural bHLH 
transcription factors can be classified into the Achaete-scute and the Atonal gene 
family. The table summarizes the onset of gene expression as well as the expression 
domains of the identified proneural bHLH transcription factors on each side of the 
midline in X. laevis at st. 14 (open neural plate). tp, trigeminal placode 
 The vertebrate proneural genes include the members of Neurogenin 
family (Sommer et al., 1996; Nieber et al., 2009), Ascl1/Ash1 (Ferreiro et al., 
1993; Talikka et al., 2002) and Ascl3/Ash3 (Turner and Weintraub, 1994; 
Chitnis and Kintner, 1996) as well as Atoh1/Ath1 (Kim et al., 1997) and 
Atoh7/Ath5 (Kanekar et al., 1997). During neuronal differentiation, the proneural 
genes have multiple functions, which induce the process of neuronal 
differentiation and maturation (Fig. 1.4 A) (Bertrand et al., 2002; Guillemot, 
1999; Castro and Guillemot, 2011). To promote neuronal commitment of a cell, 
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proneural genes activate a cascade of neuronal differentiation factors 
(Guillemot, 1999; Bertrand, 2002), regulate cell migration (Ge et al., 2006) and 
cell-cycle withdrawal (Castro et al., 2011; Klisch et al., 2011) (Fig. 1.4 A). In 
addition, the Notch-signalling pathway is also activated by the proneural bHLH 
factors, which regulates the balance between neural progenitors and neuronal 
differentiated cells (see chapter 1.4).  
 
 
Figure 1.4 Scheme of neuronal differentiation regulated by proneural genes.  
(A) Vertebrate proneural genes such as Ngn2 confer distinct activities to induce 
neuronal commitment of a cell, including activation of Notch-signalling, promotion of 
cell migration and neuronal differentiation as well as regulation of the cell cylce. 
Furthermore, proneural genes are also involved in neuronal subtype specification. (B) 
Due to the onset of proneural gene expression as e.g. Ngn2, a neural cell obtains 
neuronal cell identity. Ngn2 is known to induce a cascade of differentiation factors in X. 
laevis, such as Myt1, Ebf2, NeuroD4, Ebf3 and NeuroD1, which lead to the induction of 
N-tubulin. In addition, Ngn2 activates the cell cycle inhibitors Pak3 and Gadd45g. 
 In X. laevis, the primary nervous system is essential for the movements 
and responses of the larvae (Roberts, 2000). Prior to morphogenesis, a second 
round of neurogenesis starts in X. laevis and replaces the majority of primary 
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neurons. Several studies indicate that many factors involved in primary 
neurogenesis are also expressed during secondary neurogenesis, suggesting 
that the molecular mechanism between the two processes is conserved 
(Schlosser et al., 2002; Wullimann et al., 2005).  
 In X. laevis, the first primary neurons differentiate at the open neural 
plate stage in three longitudinal stripes on each side of the midline, as well as in 
the trigeminal ganglia (Fig. 1.7 A) (Chitnis et al., 1995). Post-mitotic neurons 
can be visualized by the expression of class II beta-tubulin (N-tubulin) 
(Oschwald et al., 1991). Neuronal differentiation in the anterior neural plate, with 
exception of the trigeminal ganglia, is delayed until tadpole stages (Papalopulu 
and Kintner, 1996).  
 The best-characterised proneural gene during X. laevis primary 
neurogenesis is the Atonal ortholog and neuronal determination factor 
Neurogenin 2 (Ngn2, also known as Ngnr-1) (Ma et al., 1996). Ngn2 is 
expressed already during early gastrula stage (stage 10.5/11) in the prospective 
neural ectoderm (Ma et al., 1996; Nieber et al., 2009). In the open neural plate, 
it prefigures the characteristic three longitudinal stripes of primary neurons on 
each side of the midline (Bellefroid et al., 1996). Ngn2 confers all the above-
described activities to be classified as a proneural bHLH transcription factor 
(Fig. 1.4 A). It induces a cascade of differentiation factors (Fig. 1.4 B.), including 
the bHLH proteins NeuroD1 (Ma et al., 1996), NeuroD4 (Ath3) (Perron et al., 
1999), the zinc finger HLH transcription factors Ebf2 (Dubois et al., 1998) and 
Ebf3 (Pozzoli et al., 2001) as well as the proneural RNA binding protein Seb4R 
(Boy et al., 2004). In addition, Ngn2 activates the zinc finger transcription factor 
Myt1, which allows the cells fated to become a neuron to escape lateral 
inhibition (Bellefroid et al., 1996). All these genes downstream of Ngn2 are also 
expressed in the characteristic stripe-like pattern at the open neural plate and 
form a synexpression group (Niehrs and Pollet, 1999). Furthermore, genes that 
regulate cytoskeleton or migratory events in the context of the nervous system 
development are targets of Ngn2 (Seo et al., 2007) as well as genes that 
promote cell-cycle withdrawal such as the growth arrest and DNA-damage-
inducible gamma (Gadd45g) gene and Pak3 (Souopgui et al., 2002; de la Calle-
Mustienes et al., 2002) (Fig. 1.4 B). Additional proneural bHLH transcription 
factors are also expressed in the open neural plate, but show expression in 
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divergent domains (Fig. 1.3). Following neural tube closure, the individual 
proneural bHLH transcription factors are expressed in discrete domains, 
suggesting that they are essential for generation of post-mitotic neurons and 
neuronal subtype identities in distinct domains of the CNS. Indeed several 
proneural factors such as Ngn2 (Perron et al., 1999) and Ath5 (Kanekar et al., 
1997) have been also shown to play a role in neuronal subtype specification. 
1.4 Notch-signalling  
 The Notch-signalling pathway regulates the balance between progenitor 
maintenance and differentiation (Lewis, 1996). During X. laevis primary 
neurogenesis, the process of lateral inhibition is mediated by the Notch-
signalling and generates a salt and pepper like pattern of the neurons at the 
open neural plate stage (Fig. 1.5 A). The Notch pathway acts through cell-to-cell 
signalling with cells being defined as either signal-sending or signal-receiving. 
Proneural genes such as Ngn2 and Ascl1 activate the expression of the 
transmembrane Notch-ligands in the signal-sending cell (Fig. 1.4 B) (Chitnis et 
al., 1995; Chitnis and Kintner, 1996; Ma et al., 1996; Henke et al., 2009a). In 
vertebrates, several such ligands are known (Bray, 2006), including Dll1, 2, and 
4 as well as Jag1 and 2 in X. laevis. The ligands bind one of the four 
transmembrane Notch-receptors (Bray, 2006) on the neighbouring cell, which 
induces a series of proteolytic cleavages in the Notch-receptor. As a result, the 
intracellular domain of the Notch-receptor (Notch-ICD) is released and 
translocates to the nucleus (Schroeter et al., 1998; Chan and Jan, 1999; Selkoe 
and Kopan, 2003). In the nucleus, Notch-ICD binds a DNA-binding protein of 
the CSL family (Su(H)) in X. laevis and Drosophila, Rbp-j in mouse, Lag-1 in C. 
elegans) (Honjo, 1996), which acts in a complex as a transcriptional repressor. 
However, after binding of Notch-ICD, the repressor is converted into an 
activator and together with co-factors activates the transcription of the Notch-








Figure 1.5 Notch-signalling during development.  
(A, B) Lateral inhibition. At the open neural plate stage, the primary neurons arise in 
a salt-and-pepper like pattern, which is mediated by the Notch-signalling pathway. This 
process allows neuronal differentiation of a cell, whereas its neighboring cells stay in 
an undifferentiated cell state. Proneural genes such as Ngn2 activate neuronal 
differentiation factors as well as the Notch-ligand Dll1, which binds to the Notch-
receptor at the neighboring cell. Upon binding, the Notch-receptor is proteolytic cleaved 
and the intracellular domain of the Notch-receptor is released into the nucleus. Notch-
ICD binds Su(H) to form an activator complex to induce the transcription of the direct 
target genes. These transcription factors, in a negative-feedback loop, inhibit the 
expression of proneural genes. Thus the sending cell differentiates into a neuron, 
whereas the receiving cell stays in an undifferentiated cell state. (after Louvi and 
Artavanis-Tsakonas, 2006; Beres et al., 2006, modified) (C, D) Maintenance of neural 
progenitor cells. When the neural tube is closed, Notch-signaling is still essential as it 
is highly active in the ventricular zone of the neural tube and maintains the pool of 
progenitor cells. When cells start to differentiate into neurons, they migrate outwards 
through the subventricular zone into the marginal zone, where the differentiated and 
post-mitotic neurons are located. rp, roof plate; fp, floor plate 
 The direct targets of the Notch-signalling include members of the bHLH 
family that are related to the Drosophila Hairy and enhancer of split genes 
(E(spl)) (Sasai et al., 1992; Ohtsuka et al., 1999; Davis and Turner, 2001). In a 
negative-feedback-loop, the Notch target genes act as repressors and inhibit 
the expression of the proneural genes (Takke et al., 1999; Schneider et al., 
2001; Ishibashi et al., 1995; Cau et al., 2000) in the neighbouring cell (Fig. 1.5 
B). Due to this mechanism, the ligand-expressing cell differentiates into a 
neuron, whereas the neighbouring cells stay in an undifferentiated cell state and 
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later differentiate into glia-cells (Louvi and Artavanis-Tsakonas, 2006; Wang 
and Barres, 2000). In this context, overexpression of Notch-ICD in X. laevis 
decreases the number of primary neurons, while inhibition of the Notch-pathway 
by microinjection of a dominant-negative Dll1 (Deltastu) increases the density of 
primary neurons (Chitnis et al., 1995). After neural tube closure, Notch-
signalling is highly active in the ventricular zone of the neural tube and 
preserves the pool of neural progenitors (Lindsell et al., 1996; Imayoshi and 
Kageyama, 2011) (Fig. 1.5 C, D).  
1.5 Neurulation and Neuronal subtype specification 
 During neurulation, the neural folds rise and fuse to form the closed 
neural tube. During this process, neural precursors cells migrate laterally 
inwards and reside in the ventricular zone (Fig. 1.5 D). After cell cycle exit, 
these precursor cells migrate outwards through the intermediate zone into the 
outer marginal zone (Fig. 1.5 D) (Bellefroid et al., 1996) and differentiate into 
distinct neuronal cell types. Neuronal subtype specification in vertebrates is 
best-characterised in the chick and mouse neural tube, in which the first 
neurons are born within the closed neural tube. Dorso-ventral patterning of the 
neural tube gives rise to specific neuronal subtypes within the neural tube. This 
is primarily generated through two signalling centers, BMP in the dorsal and 
Sonic Hedgehog (SHH) in the ventral part of the neural tube (Fig. 1.6) (Dreau 
and Marti, 2012). These signals act as morphogens, generating gradients along 
the dorso-ventral axis of the embryo. Thus, the progenitor cells within the neural 
tube are exposed to different concentrations of these signals. Due to the partly 
opposing gradients, progenitors domains are generated in the inner ventricular 
zone of the neural tube. Each progenitor domain expresses distinct transcription 
factors, including bHLH and homeodomain (HD) transcription factors (Fig. 1.6) 
(Alaynick et al., 2011). From these progenitor domains, distinct neuronal 
subtypes arise that express a specific combinatorial code of HD transcription 
factors (Fig. 1.6) (Alaynick et al., 2011).  
 The roof plate and the dorsal ectoderm express several members of the 
TGF-beta-signalling pathway, including BMP-4, BMP-7, BMP-5 and Dsl1 (Liem 
et al., 1995; Liem et al., 1997). The importance and a concentration-dependent 
mechanism of the BMP-signals in generating dorsal interneuronal subtypes 
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could be demonstrated by in vitro studies using neural plate explants as well as 
in vivo (Liem et al., 1997; Liem et al., 1995; Timmer et al., 2002; Barth et al., 
1999; Nguyen et al., 2000). Furthermore, the in vitro experiments suggested 
that the different BMPs have qualitative distinct functions in generating the 
dorsal interneuron populations (Liem et al., 1997), which is further supported by 
in ovo electroporations in the chick neural tube (Le Dreau et al., 2012; Dreau 
and Marti, 2012)  
 In addition to BMP-signalling, the Wnt-pathway has been implicated in 
the dorsal patterning of the neural tube (Muroyama et al., 2002; Yu et al., 2008; 
Alvarez-Medina et al., 2008), which is supported by the expression of multiple 
Wnts in the roof plate and in the dorsal ectoderm (Parr et al., 1993; Hollyday et 
al., 1995; Megason and McMahon, 2002). Due to the dorsal extrinsic signalling 
events, six early (dI1-dI6) and two late (dILA and dILB) interneuron populations 
are generated (Fig. 1.6) (Helms and Johnson, 2003).  
 In the ventral neural tube, the morphogen SHH is expressed by the 
mesodermal derived notochord as well as by the floor plate induced by it 
(Echelard et al., 1993; Marti et al., 1995b; Placzek et al., 1991; Yamada et al., 
1991). In vitro experiments showed a concentration-dependent induction of the 
ventral neuronal subtypes by SHH (Ericson et al., 1996; Ericson et al., 1997; 
Marti et al., 1995a; Roelink et al., 1995). However, of the five neuronal subtypes 
generated (V0-V3, MN) (Ericson et al., 1997; Briscoe et al., 2000), SHH is not 
sufficient for the specification of V0 and V1 interneurons as in SHH knock-out 
mice, these neuron types are still present (Litingtung and Chiang, 2000).  
 The transcription factors in the neural tube can be divided into distinct 
subgroups. In the dorsal neural tube, genes can be divided into BMP-dependent 
(Class A) or -independent  (Class B). Similarly in the ventral neural tube, Class I 
transcription factors are independent and in fact repressed by SHH-signalling, 
whereas class II transcription factors are SHH-dependent (Briscoe and Ericson, 
2001; Alaynick et al., 2011; Jessell, 2000). Furthermore, cross-repressive 
interactions between the distinct classes establish the borders of gene 
expression and thereby of the progenitor domains (Briscoe et al., 2000; 
Vallstedt et al., 2001). 
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Figure 1.6 Dorso-ventral patterning of the mouse neural tube.  
The patterning of the neural tube along the dorso-ventral axis is based on extrinsic 
signals. In the dorsal part, a gradient of BMP- and Wnt-signalling is generated by the 
roof plate and is responsible for the formation of the six early (dI1-dI6) and two late 
(dILA and dILB) dorsal interneuronal subtypes. In the ventral part, the morphogen SHH 
is expressed from the notochord and the floor plate and is involved in the generation of 
the five ventral (V0-V3 and motor neurons (MN)) neuronal subtypes. The two ventral 
neuron populations V0 and V2 can be subdivided into two distinct neuron types 
(indicated by arrows). Due to the opposing gradients, specific bHLH (left) and HD 
(right) transcription factors become expressed in the ventricular zone along the dorso-
ventral axis, forming distinct neuronal progenitor domains. From these, different 
neuronal subtypes arise, which express a specific code of HD transcription factors. The 
neurotransmitter expression of the distinct post-mitotic neuron populations is indicated 
by red (glutamatergic) and blue (GABAergic) circles. (Hori and Hoshino, 2012, 
modified)  
 In X. laevis, the first neurons differentiate not within the closed neural 
tube, but already at the open neural plate stage in the three characteristic 
stripes on each side of the midline (Fig. 1.7 A). The region of the ectoderm that 
gives rise to the neural plate is excluded from BMP expression and can be 
visualized by the expression of Sox3, an early marker for neural progenitor cells 
(Fig. 1.7 A). However, the lateral stripe of primary neurons is located outside the 
Sox3 expression domain (Fig. 1.7 A) (Hardcastle and Papalopulu, 2000) and 
requires intermediate levels of BMP-signalling (Rossi et al., 2008). Furthermore, 
SHH is expressed in a longitudinal stripe along the dorsal midline (Brewster et 
Introduction 14
al., 1998). Therefore, neuronal subtype specification in X. laevis may already be 
initiated at the open neural plate stage.  
 Dependant on their position within the open neural plate and the closed 
neural tube, the primary neurons obtain a specific neuronal subtype (Fig. 1.7 B). 
The lateral stripe of the primary neurons will give rise to the dorsal Rohon-Beard 
sensory neurons, while the intermediate and medial stripe will develop into 
interneurons and ventral motor neurons, respectively (Fig. 1.7 A and B) (Chitnis 
and Kintner, 1995; Hartenstein, 1989). The first differentiating neurons in the X. 
laevis spinal cord are the dorsal Rohon-Beard sensory neurons (Hartenstein, 
1993) followed with a slight delay by the ventrally located neurons (Hartenstein, 
1993), which include motor neurons and Kolmer-Agduhr cells. Interneurons are 
the last to differentiate and do so in the lateral part of the spinal cord 
(Hartenstein, 1993). A more detailed analysis considering soma location, axon 
projection and neurotransmitter expression defined in total ten different types of 
neurons in the X. laevis spinal cord (Roberts et al., 2012). These include the 
dorsal Rohon-Beard sensory neurons, the ventral motor neurons and Kolmer-
Agduhr cells, but also seven distinct interneuronal subtypes (Roberts et al., 
2012). In contrast to mouse, the molecular transcription factor codes to 
discriminate between distinct neuronal subpopulations are not well established. 
However, there is evidence indicating that these codes actually might be 
conserved in vertebrates.   
 
Figure 1.7 Neuronal subtype specification in the X. laevis spinal cord.  
(A) Scheme of primary neurogenesis domains in X. laevis. At the open neural plate 
stage, primary neurons are born in three longitudinal stripes on each side of the midline 
(white) and in the trigeminal ganglia. Grey indicates Sox3 expressing areas, which 
reflect low BMP-signalling. (B) Scheme of neuronal subtype identity in the X. laevis 
spinal cord. When the neural tube is closed, the primary neurons obtain a specific 
neuronal subtype identity depending on their previous position within the neural plate. 
The outer stripe of primary neurons will give rise to the sensory Rohon-Beard neurons, 
while the medial and intermediate stripe will give rise to interneurons and motor 
neurons, respectively. rp, roof plate, fp, floor plate, m, mediate, i, intermediate, l, lateral, 
tp, trigeminal placodes  
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1.6 Ptf1a 
The nervous system consists of many different cell types, including distinct 
neuronal subtypes, astrocytes and oligodendrocytes. Among the different 
neuronal cell types, most can be classified as excitatory or inhibitory neurons. 
An imbalance between the two distinct neuronal subtypes impairs functional 
neural networks, which underlies a number of neurological disorders 
(McCormick and Contreras, 2001; Rossignol, 2011). GABA and glutamate are 
the primary neurotransmitters of the inhibitory and excitatory neurons, 
respectively. The pancreatic transcription factor 1a (Ptf1a), which encodes for a 
bHLH transcription factor, has a central role in promoting GABAergic inhibitory 
neurons at the expense of glutamatergic excitatory neurons in the vertebrate 
CNS (Hori and Hoshino, 2012).  
1.6.1 Ptf1a function during development of the pancreas  
The importance of Ptf1a during embryogenesis is demonstrated by the 
pancreatic and cerebellar agenesis, as well as diabetes mellitus that occur in 
individuals with mutations in the Ptf1a gene (Sellick et al., 2004; Hoveyda et al., 
1999; Tutak et al., 2009; Al-Shammari et al., 2011). A similar phenotype is 
observed upon loss of Ptf1a in the mouse (Kawaguchi et al., 2002; Sellick et al., 
2004). 
 Ptf1a was first identified and characterised in the pancreas and was 
shown to be essential for the specification of pancreatic precursor cells 
including both, progenitors for endocrine and exocrine cells (Cockell et al., 
1989; Burlison et al., 2008; Kawaguchi et al., 2002). Later in development, Ptf1a 
plays a central role in exocrine cell differentiation and in the adult exocrine 
pancreas, Ptf1a activates the transcription of the acinar digestive enzymes 
(Krapp et al., 1998; Krapp et al., 1996;  Kawaguchi et al., 2002; Zecchin et al., 
2004; Lin et al., 2004). Microinjection of Ptf1a mRNA in X. laevis is sufficient to 
induce ectopic formation of pancreatic tissue within the expression domains of 
the Pancreatic and duodenal homeobox 1 (Pdx1) gene in the foregut (Afelik et 
al., 2006). Moreover, a combination of Pdx1 and Ptf1a allows conversion of 
non-pancreatic endodermal cells into both, endocrine and exocrine pancreatic 
cell lineages (Afelik et al., 2006).  
 Pdx1 was shown to be a direct target of Ptf1a in the mouse (Wiebe et al., 
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2007; Miyatsuka et al., 2007) and additional Ptf1a downstream targets, 
including direct targets in early pancreatic progenitors (Thompson et al., 2012), 
in exocrine cell differentiation (Cockell et al., 1989; Masui et al., 2010) and in X. 
laevis have been identified (Bilogan and Horb, 2012). Additionally, Ptf1a itself 
has been reported to be a direct target through positive autoregulation (Masui et 
al., 2008). Experiments in zebrafish and mouse could show that the distinct 
Ptf1a activities during pancreas development are dosage-dependent. Low 
levels of Ptf1a expression promote pancreatic endocrine cell fates, whereas 
high levels specify exocrine cell differentiation (Fukuda et al., 2008; Dong et al., 
2008). In addition, recent studies in the mouse showed that Ptf1a molecularly 
forms context-dependent transcription factor complexes. Ptf1a was originally 
identified as a subunit of the heterotrimeric pancreas transcription factor 
complex 1 (PTF1) (Cockell et al., 1989; Roux et al., 1989). In this complex, 
Ptf1a forms a heterodimer with an ubiquitously expressed class A bHLH factor 
(E-protein, E2A/p75/HEB/TCF12), which binds to the E-box sequence 
(CANNTG) at the DNA (Beres et al., 2006; Murre et al., 1989). Additionally, 
Ptf1a interacts with a member of the CSL family of DNA binding proteins 
(Su(H), CBF1, Lag-1, Rbp-j and -l) through two conserved C-motifs (C1:HSLSW 
and C2:WTPEDPR) located in the C-domain of Ptf1a (Beres et al., 2006). The 
CSL-binding protein binds DNA via a TC-box motif (TTTCCCA) (Beres et al., 
2006). Thus, the heterotrimeric PTF1 complex binds a specific bipartite binding 
site, in which the TC-box must be separated by one or two helix turns from the 
E-box motif (Cockell et al., 1989). In pancreatic progenitor cells, Ptf1a interacts 
with Rbp-j, which at the onset of acinar cell development is gradually replaced 
by its paralogue Rbp-l (Masui et al., 2007). Strong expression of Rbp-l is 
restricted to adult pancreatic tissue and is so far unknown in X. laevis (Beres et 
al., 2006).  
 In the mouse, the interaction between Ptf1a and Rbp-j/-l, but not with the 
class A bHLH protein can be abolished by introducing mutations in the C1 and 
C2 domain of Ptf1a (Beres et al., 2006). Rbp-j, but not Rbp-l is also involved in 
Notch-signalling, where it forms a transcriptional complex with Notch-ICD. It 
could be demonstrated that the binding of Rbp-j to Notch-ICD and Ptf1a is 
mutually exclusive (Beres et al., 2006). Thus, Ptf1a and Notch-ICD activity 
could potentially antagonize each other. Furthermore, Notch target genes can 
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directly bind to Ptf1a (Ghosh and Leach, 2006) and downregulate Ptf1a 
transcriptional activation and DNA-binding (Esni et al., 2004). 
1.6.2 Ptf1a function during development of the nervous system 
 In the vertebrate nervous system, Ptf1a is expressed in the retina, the 
hindbrain and in the dorsal horn of the spinal cord in precursor cells of 
GABAergic inhibitory interneurons (Glasgow et al., 2005; Hoshino et al., 2005; 
Nakhai et al., 2007; Fujitani et al., 2006). Ptf1a was shown to act as a selector 
gene for GABAergic inhibitory interneurons at the expense of glutamatergic 
excitatory neurons in the vertebrate retina, hindbrain and spinal cord (Glasgow 
et al., 2005; Hori et al., 2008; Hoshino et al., 2005; Fujitani et al., 2006; Nakhai 
et al., 2007; Pascual et al., 2007; Dullin et al., 2007). Consistent with the 
molecular mechanism of gene activation in the pancreas, Ptf1a in neural tissue 
forms a heterotrimeric PTF1 complex through interaction with Rbp-j and the 
ubiquitous expressed class A bHLH transcription factor. For its function as a 
GABAergic selector gene, Ptf1a requires the interaction with Rbp-j (Hori et al., 
2008; Lelievre et al., 2011) and Rbp-j function in this context is Notch-
independent (Hori et al., 2008).  
 In contrast to the pancreas, only a few direct downstream targets of Ptf1a 
in the nervous system have been identified. Similar to the pancreas, Ptf1a 
regulates its own expression via positive autoregulation (Meredith et al., 2009). 
In the mouse neural tube and cerebellum, the bHLH transcription factor Ngn2 is 
a direct downstream target of the heterotrimeric PTF1 complex (Henke et al., 
2009b). Furthermore, the expression of two members of the immunoglobulin 
superfamily, Nephrin and Neph3 (Kirrel2 in X. laevis) is directly controlled by 
binding of Ptf1a within the promoter region of these genes (Nishida et al., 2010). 
Neph3 is expressed in progenitors of the GABAergic Purkinje cells, suggesting 
that its activation by Ptf1a plays a role in GABAergic neuronal subtype 
specification (Mizuhara et al., 2010). In combination with the oligodendrocyte 
transcription factor 3 (Olig3), Ptf1a induces the expression of the forkhead box 
D3 (FoxD3) gene to generate the glutamatergic climbing fiber neurons (Yamada 
et al., 2007; Storm et al., 2009).  
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1.6.3 Ptf1a also forms context-dependent transcription 
complexes in the nervous system 
 In X. laevis, Ptf1a not only functions as a selector gene for GABAergic 
inhibitory neuronal cell fates, but also promotes general neurogenesis in naïve 
ectodermal explants and in the non-neural ectoderm of embryos (Dullin et al., 
2007; Hedderich, 2008). Analysis of a limited set of marker genes demonstrated 
that Ptf1a drives neuronal differentiation similar to the neuronal determination 
gene Ngn2 (Hedderich, 2008). However, Ptf1a and Ngn2 have distinct neuronal 
subtype specificities (Dullin et al., 2007; Hedderich, 2008). Ptf1a activates the 
expression of Glutamate decarboxylase 1 (Gad1), a marker for GABAergic 
inhibitory neurons (Li et al., 2006). In contrast, Ngn2 induces the expression of 
Hox11L2, which marks sensory neurons (Patterson and Krieg, 1999; Perron et 
al., 1999). The murine homolog of Hox11L2, Txl3 functions as a selector gene 
for glutamatergic excitatory neurons (Cheng et al., 2004; Cheng et al., 2005). 
Mutations in the X. laevis Ptf1a C1- and C2-domain (Ptf1aW224A/W242A) reveal 
that the interaction of Ptf1a with Su(H) is essential for the GABAergic specificity 
of Ptf1a (Hedderich, 2008), a result congruent to the situation in the murine 
nervous system (Hori et al., 2008). Surprisingly, the proneural activity of Ptf1a 
was not impaired by the mutations, as Ptf1aW224A/W242A could still activate 
neuronal differentiation genes (Hedderich, 2008). Taken together, the data 
suggest that Ptf1a also forms context-dependent transcription complexes in the 
nervous system: A Su(H)-independent complex to drive general neurogenesis 
and a Su(H)-dependent complex to specify GABAergic inhibitory neurons 





Figure 1.8 Ptf1a forms context-dependend transcription complexes  
(A) In the context of general neurogenesis, the dimeric complex, consisting of Ptf1a 
and the class A bHLH transcription factor is sufficient to drive neuronal differentiation 
and to induce the formation of glutamatergic/sensory neurons. Thus, this complex 
activates Su(H)-independent Ptf1a target genes. (B) In contrast, the genes involved in 
GABAergic interneuron formation are Su(H)-dependent as the Su(H)-interaction of 
Ptf1a is essential for their activation. (Beres et al., 2006, modified) 
1.7 Aims 
The bHLH transcription factor Ptf1a was identified as an important selector 
gene for generation of GABAergic inhibitory neurons in the vertebrate CNS. 
However, previous experiments in X. laevis indicated that Ptf1a also functions 
as a proneural gene and forms context-dependent transcription complexes to 
drive neuronal differentiation and to promote GABAergic inhibitory interneurons. 
The goal of the thesis was to further analyse the two distinct Ptf1a specificities, 
including identification of the genetic network downstream of Ptf1a and 
providing insight into the regulation of the distinct transcription complexes.
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2. Materials and Methods 
2.1 Material 
2.1.1 Model organism 
The African clawed frog Xenopus laevis (X. laevis) was used as a model 
organism during this study. Albinos and pigmented frogs were obtained from 
Nasco (Ft. Atkinosn, USA). The embryos were staged according to Nieuwkoop 
and Faber (1967). 
2.1.2 Bacteria 
For molecular biology standard methods, the chemical competent 
Escherichia coli strain XL1-Blue was used. 
XL1-Blue: recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac[F’proAB, 
laclqZDM15, Tn10(Tetr)]c (Stratagene). 
2.1.3 Antiobiotics and Media 
Antibiotics 
Ampicillin 
stock: 100 mg/ml in dH2O, working: 100 µg/ml. Stored at -20 °C. 
 
Media 
32 g LB medium (GIBCO) dissolved in 1000 ml dH2O 
The LB Media was autoclaved for 20 min and cooled down to 50 °C. Afterwards 
the selective antibiotic was added. The agar plates were poured under a steril 
bench and stored at 4 °C.  
2.1.4 Oligonucleotides 
Oligonucleotides were purchased from Sigma-Aldrich and dissolved in 
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Sequencing oligonucleotides  





Table 2.2 Summary of RT-PCR oligonucleotides and working conditions 
 
2.1.5 Overexpression constructs 
Ptf1a-GRpCS2+ (Afelik et al., 2006), Ptf1a-VP16-GRpCS2+ (Dullin et al., 
2007), GR-Ngn2-p3' (Perron et al., 1999), ß-Gal-pCS2+ (Chitnis et al., 1995). 
 
Ptf1aW224A/W242A-GRpCS2+ (Hedderich, 2008). This construct harbors the open 
reading frame of Ptf1a (DQ007931.1) with two point mutations at position 224 
and 242. The point muations were introduced using the "QuickChange XL Site 
directed Mutagenesis" kit (Stratagene) and the following primers p48C1mut_up 
GGA CAT TCT CTC TCA GCG ACT GAT GAG AAG CAA CTG AG and 
p48C1mut_down CTC AGT TGC TTC TCA TCA GTC GCT GAG AGA GAA 
TGT CC as well as p48C2mut_up GTT GTC AGA ACG GCC AAA GTG GCG 
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ACT CCT GAG GAT CC and p48C2mut_down GGA TCC TCA GGA GTC GCC 
ACT TTG GCC GTT CTG AC AAC, thereby exchanging a tryptophan to an 
alanine (mutations are red). Ptf1a-GRpCS2+ (Afelik et al., 2006) served as DNA 
template for the PCR. For preparation of sense mRNA, the construct was 
linearized with NotI and transcribed with SP6 polymerase.  
 
Chimeric Ptf1a-GRpCS2+ (Hedderich, 2008). To synthesize the chimric Ptf1a-
GR, the bHLH domain of Ngn2 was PCR amplified using GR-Ngn2p3' (Perron 
et al., 1999) as template. The primers contained the surrounding sequences of 
the bHLH domain of Ptf1a (in italics): Ptf1a/bHLH-Ngnr1_for CTG AGG TCG 
GAC GCG GAG ATG CAG CAG CGG CGC GTT AAA GCT AAC AAC and 
Ptf1a/bHLH-Ngnr1_rev GCG GCA GAT CGG ACT GTA CCA TCT CGC TAA 
GAG CCC AGA TGT AGT TGT AG. The so called megaprimer was used 
together with the "QuickChange XL Site Directed Mutagenesis" kit (Stratagene) 
in a PCR using Ptf1a-GRpCS2+ (Afelik et al., 2006) as template. For 
preparation of sense mRNA, the construct was linearized with NotI and 
transcribed with SP6 polymerase.  
 
Su(H)-HApCS2+ (Hedderich, 2008). This construct harbors the open reading 
frame of Su(H) (U60093.1), which was PCR amplified using Su(H)pCS2+ 
(Wettstein et al., 1997) as a template as well as the following primers: 
3’HASu(H)_BamHI_for: CTG GAT CCA TGC AAC CTG GC and 
3’HASu(H)_XhoI_rev: CAA CTC GAG GGA CAC TAC TGC TGC. Su(H) was 
subcloned into HA-pCS2+ (Damianitsch, 2008) using the BamHI und XhoI 
restriction sites. For preparation of sense mRNA, the construct was linearized 
with NotI and transcribed with SP6 polymerase.  
 
Su(H)-GRpCS2+. The open reading frame of Su(H) (U60093.1) was PCR 
amplified with the following primers: Su(H)_BamHI_for: CGG GAT CCA TGC 
AAC CTG GCA TTC and Su(H)_BamHI_rev: CGG GAT CCG GGG ACA CTA 
CTG CTG and using Su(H)-HApCS2+ as template. Su(H) was subcloned into 
GRpCS2+ (D. Turner and R. Rupp derivate) using the BamHI restriction sites. 
For preparation of sense mRNA, the construct was linearized with NotI and 
transcribed with SP6 polymerase.  
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MT-Ptf1a-GRpCS2+. The open reading frame of Ptf1a (DQ007931.1) was PCR 
amplified using the primers: Ptf1a_EcoRI_for: CGG AAT TCC ATG GAA ACG 
GTC C and Ptf1a_StuI_rev: GAA GGC CTC ATA TCA AGG CAC AAA GT. 
Ptf1a-GRpCS2+ was used as template in the PCR. The amplified Ptf1a was 
subcloned into MT-GRpCS2+ (D. Turner and R. Rupp derivate) uisng the EcoRI 
and StuI restrictions sites. For preparation of sense mRNA, the construct was 
linearized with NotI and transcribed with SP6 polymerase.  
 
MT-Ptf1aW224A/W242A-GRpCS2+. The open reading frame of Ptf1aW224A/W242A was 
PCR amplified with the following primers: Ptf1a_EcoRI_for: CGG AAT TCC 
ATG GAA ACG GTC C and Ptf1a_StuI_rev: GAA GGC CTC ATA TCA AGG 
CAC AAA GT. Ptf1aW224A/W242A-GRpCS2+ served as template in the PCR. The 
amplified Ptf1aW224A/W242A was subcloned into MT-pCS2+GR (D. Turner and R. 
Rupp derivate) uisng the EcoRI and StuI restrictions sites. For preparation of 
sense mRNA, the construct was linearized with NotI and transcribed with SP6 
polymerase.  
2.1.6 Constructs for real-time RT-PCR standard curves 
To perform standard curves in the real-time RT-PCR, the amplified RT-PCR 
products were subcloned into the pGEM-T easy vector (Promega). The 
amplified region is given with respect to the ATG.  
 
Gad1pGEMT easy (U38225, 1126 to 1289); ODCpGEMT easy (X56316, 222 
to 441); N-tubulinpGEMT easy (X15798, 80 to 329); Hox11L2/Tlx3pGEMT 
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2.1.7 antisense RNA Constructs 
Table 2.3 Summary of antisense RNA constructs 
 
2.2 Methods 
2.2.1 DNA standard methods 
2.2.1.1 DNA restriction digestion 
Restriction digests were performed according to the manufacturer’s 
instruction using restriction enzymes purchased from Fermentas Life Sciences.  
2.2.1.2 Agarose gel electrophoresis 
TAE (Tris/Acetate/EDTA): 40 mM Tris-Acetate, pH 8.5, 2 mM EDTA 
 
Analytical and preparative restrictions or PCR products were analysed by 
agarose gel electrophoresis (Sharp et al., 1973). Depending on the size of the 
DNA fragments, different percentages of agarose gels were used (0.7% to 2%). 
The gels were made out of agarose and 1x TAE buffer, which was also used as 
running buffer. To analyse the size of the DNA fragments, Standard DNA 
ladders (FastRuler DNA Ladder, Fermentas) were used. For visualization of the 
DNA, ethidium bromide (0.5 µg/ml) was added and for documentation the 
ChemiDoc video documentation system (EASY view) was used. 
2.2.1.3 Purification of DNA fragments and linearized templates 
Purification of DNA fragments from agarose gels or restriction digestions 
were performed with the "Invisorb Fragment Cleanup" kit (Invitek) or the "GFX 
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PCR DNA und Gel Band Purification" kit (GE Healthcare) according to the 
manufacturer's instructions. 
2.2.1.4 Polymerase chain reaction (PCR) 
A standard PCR reaction (Mullis et al., 1986) contained 1x Polymerase 
buffer, 0.2 mM of each dNTP (Thermo Scientific), 1.15 mM of each 
oligonucleotide and 0.5-1 U Pfu Polymerase (Stratagene GmbH) as well as 100 
ng template DNA. The cycle numbers of the PCR reaction were adapted to the 
product size and the temperature adapted to the melting temperature of the 
oligonucleotides. The PCR reaction was performed in thermocyclers (Biometra) 
with the following program: 95 °C 2 min., 95 °C 45 sec., Tm-2 °C 45 sec., 72 °C 
60 sec per 1 kb product, 72 °C 600 sec, 8 °C Pause.  
2.2.1.5 DNA ligation  
Standard ligation reactions were carried out using the T4 DNA Ligase (10 
U/µl) (Fermentas Life Sciences) according to the manufacturer's instructions. 
The ligation was incubated overnight at room temperature (RT). To prevent self-
religation, the linearised vector was treated with 1 U CIAP before ligation.  
2.2.1.6 Chemical transformtaion of bacteria cells 
For chemical transformation of the ligation reaction, the chemical 
competent cells XL1-Blue were used. 100 µl to 200 µl thawed cells were added 
to the ligation and incubated on ice for 30 min. After incubation, a heat shock at 
42 °C for 90 sec was performed followed by a further incubation on ice for 3 
min. 800 µl LB medium was added and the reaction was incubated for 45 min at 
37 °C with mild shaking at 300 rpm. After centrifugation for 30 sec at 10,000 
rpm, 800 µl supernatant was discarded and the bacteria pellett was 
resuspended in the remaining media. The bacteria solution was seeded on LB 
agar plates supplemented with the appropriate antibiotic for the selection of the 
transformed cells. Colonies were grown over night at 37 °C (Mandel and Higa 
1970).  
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2.2.1.7 Plasmid DNA preparation 
The bacteria were grown in 4 ml LB media together with the selective 
antibiotic overnight at 37 °C with shaking at 250 rpm. For the plasmid 
preparation, 3 ml of the bacteria culture was centrifuged for 2 min at 13,000 
rpm. Isolation of DNA in analytical amounts was performed using the 
"GeneJET™ Plasmid Miniprep" kit (Fermentas) according to the manufacturer's 
protocol. Isolation of DNA in preparative amounts was carried out with the 
"NucleoBond®Xtra Midi" kit (Macherey-Nagel) following the manufacturer's 
protocol. The DNA concentration was measured with the NanoDrop-2000c 
spectrophotometer (Thermo Scientific) using 1 µl of the DNA sample. 
2.2.1.8 DNA-sequencing 
Sequencing of plasmid DNA (Sanger et al., 1977) was performed with 
the  "Big Dye Terminator Cycle Sequencing" kit (Applied Biosystems) according 
to the manufacturer's protocol. The reaction was performed in a thermocycler 
with the following PCR program: 95 °C 2 min, 95 °C 30 sec., 55 °C 30 sec., 60 
°C 4 min, 12 °C pause. In total, 26 cycles from step two to four were performed.  
To purify the sequencing reaction, 1 µl EDTA (125 mM), 1 µl NaAc (3 M) 
and 50 µl 100% Ethanol were added and incubated for 5 min at RT. After 
centrifugation for 20 min at 13,000 rpm, the pellet was washed with 70% 
ethanol and centrifuged for 5 min with 13,000 rpm. The pellet was air-dried and 
resuspended in 15 µl HiDi. To sequence the reaction, the ABI 3100 xl Genetic 
Analyzer (Applied Biosystems) was used.  
2.2.2 RNA techniques 
2.2.2.1 In vitro synthesis of capped sense mRNA 
In vitro capped sense mRNA was synthesized using the "SP6/T3 
mMESSAGE mMACHINE" kit (Ambion Inc.) according to the manufacturer's 
protocol. For a 20 µl reaction, 1 µg of linearised plasmid was used. The 
purification of the synthesized mRNA was performed using the "Illustra 
RNASpin Mini" kit (GE Healthcare) according to the manufacturer's instructions. 
The RNA was eluted in 30 µl RNase-free water at 80 °C. The RNA 
concentration was measured using the NanoDrop 2000c spectrophotometer 
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(Thermo Scientific). The quality of the mRNA was analysed on a 1% agarose 
gel. The RNA was aliquoted in 2 µl and stored at -80 °C. 
2.2.2.2 In vitro synthesis of antisense RNA 
Antisense RNA was used in the whole mount in situ hybridization as 
probe to detect in vivo transcripts. To synthesize antisense RNA, 1 µg of the 
linearised plasmid was used in a 25 µl reaction. A standard reaction contained:  
 
5x transcription buffer (Fermentas)      5 µl 
ATP, GTP, CTP, UTP, Dig or Flu-UTP (10 mM each)    4 µl 
DTT (0.75 M)         1 µl 
Ribolock RNase inhibitor (40 U/µl) (Thermo Scientific)   1 µl 
RNA polymerase  (20 U/µl) (Fermentas)     1,5 µl 
 
The reaction was incubated for two hours at 37 °C. Afterwards, the DNA 
template was digested by the addition of TURBO DNase™ (2 U/µl, Ambion) for 
30 min at 37 °C. The purification of the antisense RNA was performed using the 
"RNeasy® Mini" kit (Qiagen GmbH) according to the manufacturer's protocol. 
The RNA was eluted in 100 µl RNase-free water at 80 °C. The quality of the 
antisense RNA was analysed on a 1% agarose gel. 1 ml of hybridization mix 
was immediately added to the antisense RNA and stored at -20 °C.   
2.2.2.3 RNA isolation from ectodermal explants ("animal caps")  
For total RNA isolation, 50 to 100 ectodermal explants were cut, frozen in 
liquid nitrogen and stored at -80 °C. 
Total RNA isolation was performed using the "RNAqueous®-Micro" kit (Ambion) 
or trizol as described below. After RNA isolation according to both protocols, the 
RNA quality was evaluated with the 2100 Bioanalyzer (Agilent). To check for 
genomic DNA contamination, a control PCR with histone H4 (H4) was 
performed and analysed on a 2% agarose gel.  
2.2.2.3.1 Isolation of total RNA with the "RNAqueous®-Micro" kit (Ambion)  
The animal caps were lysated in 100 µl lysis buffer by a 29-Gauge 
syringe and centrifuged for 5 min at 4 °C. Afterwards, total RNA was isolated 
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according to the manufacturer's protocol. The RNA was eluted in 30 µl elution 
buffer at 75 °C. For genomic DNA digestion, the RNA was incubated with 
DNaseI provided within the kit for 1.5 h at 37 °C. The DNAseI activity was 
inhibited by incubation for 10 min at 70 °C followed by the use of the DNaseI 
inactivation reagent according to the manufacturer's protocol.  
2.2.2.3.2 Isolation of total RNA with trizol  
The animal caps were lysated in 400 µl trizol with a 29-Gauge syringe 
and vortexed for 30 sec. 80 µl chloroform was added, vortexed and centrifuged 
for 10 min at 4 °C and 13,000 rpm. After centrifugation, the upper phase, 
containing the total RNA (approximately 200 µl), was transferred to a new 
eppendorf tube. 200 µl chlorofom was added, vortexed for 30 sec and again 
centrifuged for 10 min at 4 °C. The supernatant was recovered and transferred 
into a new eppendorf tube and 500 µl isopropanol was added, mixed well and 
incubated at -20 °C for at least 2 h. After centrifugation at 4 °C and 13,000 rpm 
for 30 min, the precipitate was washed with 400 µl of 70% ethanol and 
centrifuged for 2 min at 4 °C. The pellet was air-dried and resolved in 30 µl 
RNase-free water. For genomic DNA digestion, the RNA was incubated with 
DNaseI (1U/µl) (Thermo Scientific) at 37 °C for 1.5 h. The DNAseI activity was 
inhibited by incubation for 10 min at 70 °C.  
2.2.2.4 Reverse transcription and PCR (semi-quantitative and 
quantitative RT-PCR) 
2.2.2.4.1 Reverse transcription 
For cDNA sysnthesis, 50 ng to 100 ng total RNA was used per 10 µl 
reaction mix. A standard reaction mix contained 5 mM MgCl2, 2.5 ng random 
hexamer, 5 mM dNTP mix, 8 U Ribolock RNase inhibitor (Thermo Scientific) 
and 20 U MuLV reverse transcriptase (Roche) in 1x Go Taq flexi buffer 
(Promega). The synthesis was performed in cycler using the following 
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2.2.2.4.2 Semi-quantitative RT-PCR 
For semi-quantitative RT-PCR analysis, 2.5 µl cDNA was added to a 12.5 
µl total reaction volume. The standard reaction mix contained: 1x Go Taq 
reaction buffer (Promega), 0.2 mM of RT-primer each as well as 0.5 U Go-Taq 
DNA-Polymerase (Promega). The reaction was performed in a thermocycler 
with the following program: 2 min at 95 °C, 45 sec at 95 °C, 45 sec at 
annealingtemperature of the oligonucleotides, 45 sec at 72 °C, 5 min at 72 °C. 
The cycle number from step 2 to 5 of the PCR was adapted to the 
oligonucleotides. The RT-PCR was analysed on a 2% agarose gel.  
2.2.2.4.3 Quantitative real-time RT-PCR 
For quantitative real-time RT-PCR analysis, 5 µl cDNA was added to a 
25 µl reaction volume. The standard reaction mix contained: 1x 
iQTMSYBRGreen Supermix (Biorad) and 0.2 mM RT-primers each. The real-
time RT-PCR was performed with the IQ5 Biorad machine. All measurements 
were performed in triplicates and normalized to the values of ornithine 
decarboxylase (ODC). Two independent biological replicates were performed. 
The copy numbers were based on a standard dilution series.  
2.2.2.5 Quantitative Nanostring 
In addition for quantitative measurements, the digital multiplexed gene 
expression analysis system Nanostring was used according to the 
manufacturer's instructions using 500 ng of total RNA. The genes analysed by 
Nanostring as well as the target region and sequences of the reporter probes 
are shown in Appendix 6.3. To process the data, the counts were first 
normalized with respect to the geometric mean of the positive control counts 
using the nSolver software program provided by Nanostring. In a second step, 
the counts were normalized with respect to the geometric mean of ornithine 
decarboxylase (ODC). Even though additional housekeeping genes were 
present in the Nanostring set, only ODC was chosen for normalization as the 
other genes show developmental regulatory effects. Finally, a stringent 
background correction was performed by subtracting the mean and two 
standard deviations of the eight negative control counts for each lane. Negative 
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values were set to 1 as background level. Two independent experiments were 
performed. 
2.2.2.6 RNA-sequencing 
2.2.2.6.1 RNA isolation 
For RNA-sequencing, total RNA was isolated with trizol as described 
above with the following modifications: 
The ectodermal explants were lysated in 360 µl trizol with a 29-Gauge syringe 
and incubated for 10 min at RT. 72 µl chloroform was added, mixed and 
incubated for further 5 min at RT. After centrifugation for 20 min at 4 °C, the 
upper phase, containing the total RNA, was transferred to a new eppendorf 
tube. 180 µl isopropanol was added, mixed well and incubated at -20 °C for at 
least 2 h. After centrifugation at 4 °C for 30 min, the precipitate was washed 
with 500 µl of 75% ethanol. The pellet was air-dried and dissolved in 20 µl of 
RNase-free water. For genomic DNA digestion, the RNA was incubated for 1 h 
at 37 °C in a 50 µl reaction containing 1x DNaseI reaction buffer (Thermo 
Scientific), 1 µl DNaseI (Thermo Scientific) and 0.5 µl RNAse inhibitor (Thermo 
Scientific). The DNaseI digest was stopped by the addition of 150 µl RNase-free 
water and 200 µl Phenol-Chloroform-Isoamylalcohol. After mixing well, the 
solution was centrifuged for 10 min at 4 °C and the upper phase transferred to a 
new eppendorf tube. To the upper phase, 1/10 vol. of 5 M ammonium acetate 
and 1 vol of isopropanol was added and incubated for at least 2 h at -20 °C. 
After centrifugation for 30 min at 4 °C, the pellet was washed twice with 75% 
ethanol and air-dried. The pellet was resolved in 25 µl RNase-free water.  
To evaluate the RNA quality, an analysis with the 2100 Bioanalyzer (Agilent) 
was performed. To check for genomic DNA contamination a control PCR with 
histone H4 was performed and analysed on a 2% agarose gel. 
2.2.2.6.2 Sample preparation and sequencing 
For sequencing, the RNA-samples were prepared with the "TruSeq RNA 
Sample Prep Kit v2" according to the manufacturer (Illumina). The sequencing 
was performed using the HiSeq 2000 (Illumina). Two independent biological 
replicates were performed. 
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2.2.2.6.3 Sequencing alignment 
After quality control using FastQC 
(http://h.bioinformatics.babraham.ac.uk/projects/fastqc/), the sequence reads 
consisting of 2 x 95 base pairs from the paired-end mode were first aligned to 
the Xenopus tropicalis (X. tropicalis) using JGI v72b (kindly provided by Michael 
J. Gilchrist). Additionally, the reads were also aligned to selected sequences of 
the X. laevis transcriptome (UniGene Build #91 X. laevis) representing genes 
which were not found in the X. tropicalis transcriptome to get more information 
and to avoid redundancies. 
The mapping was performed using the software Bowtie2 (version 2.0.0-beta5) 
in local alignment mode allowing 3 mismatches (Langmead and Salzberg, 
2012). Reads aligned greater than 2 times were removed to facilitate the 
analysis.  
2.2.2.6.4 Statistical analysis 
First, the reads were counted on transcript level and the gene level 
expression was calculated as the sum of counts from all associated transcripts. 
After normalization between library samples, gene models with less than 50 
read counts were subtracted from the data set. For the detection of differentially 
expressed genes, the DESeq package (Anders and Huber, 2010) (version 
1.4.1) of bioconductor (http://h.bioconductor.org) was used.  
2.2.3 Xenopus laevis embryo culture and microinjections 
2.2.3.1 Stimulation of eggs  
X. laevis female frogs were induced to lay eggs by the injection of 1000 
units human chorionic gonadotropin (HCG, Sigma Aldrich) into the dorsal lymph 
sac the evening before the supposed egg-laying. The frogs were kept at 16 °C 
overnight. To induce the egg-laying later in the afternoon, the female X. laevis 
frogs were injected with 500 units of HCG into the dorsal lymph sac the evening 
before and kept at RT over night. The next morning the frogs were injected with 
1000 units of HCG.  
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2.2.3.2 Preparation of Xenopus laevis testis 
10x MBS: 880 mM NaCl, 10 mM KCl, 10 mM MgSO4, 25 mM NaHCO3, 50 mM 
HEPES, pH 7.8 
1x MBS: 1x MBS, 0.7 mM CaCl2 
 
For in vitro fertilization of the eggs, the male X. laevis frog was sacrificed 
and the testis was removed, washed in 1x MBS and stored at 4 °C. For the 
fertilization, around one third of the testis was cut and diluted in 1x MBS and 
stored on ice.  
2.2.3.3 Fertilization 
Cysteine: 2% L-cysteine hydrochloride in 0.1x MBS, pH 8.0  
10x MBS: 880 mM NaCl, 10 mM KCl, 10 mM MgSO4, 25 mM NaHCO3, 50 mM 
HEPES, pH 7.8 
Nile Blue: 0.01% (w/v) Nile blue in 0.1x MBS 
 
The layed eggs were in vitro fertilized using 50 µl of the testis diluted with 
450 µl water. To remove the jelly coat, the eggs were treated with 2% cysteine 
hydrochloride, pH 8.0 and washed three times with 0.1x MBS. Albino embryos 
were additionally stained with Nile Blue vital dye for 5 min and washed three 
times with 0.1x MBS.  
2.2.3.4 Microinjections 
Injection buffer: 2% Ficoll in 1x MBS 
 
Microinjections were performed on a cooling plate at 12.5 °C. For 
microinjections, the mRNA was loaded into glass needles, which were prepared 
on a needle puller (PN-30, Science Products GmbH, Hofheim). The 
microinjector PV 820 (H. Sauer, Reutlingen) was used. During and after the 
injections, the embryos were kept in injection buffer. 4 nl of the mRNA were 
injected either in one or in both blastomeres of two-cell stage embryos. After 1 h 
incubation in injection buffer, the embryos were transferred into 0.1x MBS and 
cultured in incubators until the desired developmental stage was reached. The 
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developmental stage of the embryos was defined according to Nieuwkoop and 
Faber.  
2.2.3.5 Xenopus laevis ectodermal explants ("animal caps") 
5xMBS AC: 880 mM NaCl, 10 mM KCl, 10 mM MgSO4, 25 mM NaHCO3, 2.05 
mM CaCl2, 1.65 mM Ca(NO3)2, pH 7.8 
 
Animal caps were cut at blastula stage (stage 8 to 9) on a 1% agarose-
coated Petri-dish in 0.8x MBS on a cooling plate set at 12.5 °C (Wallingford and 
Harland 2001). First, the vitelline membrane was carefully removed with 
foreceps and then the animal caps were excised from the animal hemisphere of 
the embryo using the gastromaster system (Xenotek Engineering, Bellville, 
USA). The ectodermal explants were cultivated in 0.8x MBS until control whole 
embryos reached the desired developmental stage.  
2.2.3.6 Treatment of whole embryos and animal caps   
2.2.3.6.1 Dexamethasone (Dex) treatment  
Dexamethasone 
stock: 4 mg/ml in 100% ethanol, working: 10 µM 
 
To control the time point of protein activity, hormone-inducible constructs 
were used for microinjections. Therefore, the coding regions were fused to the 
ligand-binding domain of the glucocorticoid receptor (Gammill and Sive, 1997). 
To induce protein activity, injected embryos or animal caps were cultivated in 
the dark in the presence of 10 µM dexamethasone in 0.8x MBS until the desired 
stage was reached (Perron et al., 1999). For the 3 and 6 h time point, the 
animal caps were incubated at 14 °C. For the 9 h and the 25 h as well as for the 
32 h time point, the animal caps were incubated at 16 °C and 18 °C, 
respectively. 
2.2.3.6.2 Cycloheximide (CHX) treatment  
Cycloheximide 
stock: 100 mg/µl in DMSO (Sigma-Aldrich), working: 10 µg/ml 
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To block protein synthesis, animal caps were treated with 10 µg/ml CHX in 0.8x 
MBS (Perron et al., 1999) and incubated at 16 °C. 
2.2.4 Whole mount in situ hybridization 
Whole mount in situ hybridization was performed to visualize the spatial 
and temporally expression of endogenous RNA transcripts. For detection, a 
Digoxigenin or Fluorescin labeled antisense RNA probe was used, which was 
visualized using an alkaline phosphatase-coupled anti-Dig antibody or FastRed 
(Roche) (Harland, 1991; Hollemann and Pieler, 1999; Nieber et al., 2009). 
2.2.4.1 Fixation and β-Gal staining 
10x MEM: 1 M Mops, 20 mM EGTA, 10 mM MgSO4, pH 7.4, sterile filtered and 
stored in dark 
10x PBS: 1.75 M NaCl, 1 M KCl, 65 mM Na2HPO4, 18 mM KH2PO4, pH 7.4 
K3FE(CN)6: 0.5 M in H2O, stored in dark 
K4FE(CN)6: 0.5 M in H2O stored in dark 
MEMFA: 4% (v/v) formaldehyde (37%) in 1x MEM 
X-Gal: 40 mg/ml 5-Bromo-4-chloro-3-indolyl-b-D-galactopyranoside in 
formamide, stored -20 °C in the dark 
X-Gal staining solution: 1 mg/ml X-Gal, 5 mM K3FE(CN)6, 5 mM K4FE(CN)6, 2 
mM MgCl2 in 1x PBS 
 
Embryos were collected in glas vials and fixed in MEMFA at RT. 
Uninjected-embryos were fixed for 1 h and washed three times with 100% 
ethanol for 5 min. Injected embryos were fixed for 25 min and washed three 
times with 1x PBS for 10 min.  
LacZ (β-gal) mRNA was co-injected as a lineage tracer to discriminate the 
injected from the uninjected side of the embryo and to analyse the distribution of 
the injected mRNA. To visualize the β-gal injected side of the embryos, X-Gal 
staining was performed (Hardcastle et al., 2000). Therefore, the embryos were 
incubated in the dark in X-gal solution for at least 20 min until the desired level 
of staining was achieved. Afterwards, the embryos were washed three times for 
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10 min in 1x PBS and refixed for 25 min in 1x MEMFA. Finally, the embryos 
were washed three times for 5 min in 100% ethanol and stored at -20 °C.  
2.2.4.2 Rehydration 
PTW: 0.1% Tween-20 in 1x PBS 
 
The following steps were performed at RT in 4 ml solution with mild 
agitation. The embryos were rehydrated using an ethanol series (75%, 50%, 
25%) and finally incubated 4 times for 5 min in 100% PTW.  
2.2.4.3 Proteinase K treatment 
Proteinase K: 10 µg/ml proteinase K in 0.1x PBS 
PTW: 0.1% Tween-20 in 1x PBS 
 
To make the embryos accesible to the Dioxigenin labeled antisense RNA 
probe, the embryos were treated with proteinase K (Merck). Therefore, the 
embryos were incubated in a 2 ml PTW/proteinase K-solution (10 µg/ml PTW) 
for a defined time depending on the developmental stage. Embryos of 
developmental stage 28/29 were treated for 17 min in proteinase K solution.  
2.2.4.4 Acetylation and refixation 
PTW: 0.1% Tween-20 in 1x PBS 
0.1 M Triethanolamine: 0.93 g Triethanolamine in H2O, pH 7.5 
 
To stop the proteinase K treatment, the embryos were washed two times 
for 5 min in triethanolamine. To avoid unspecific reaction of the Dioxigenin 
labeled antisense RNA probe, free amino-acid ends were blocked by treating 
the embryos with 25 µl acetic anhydride in triethanolamine. Afterwards the 
embryos were washed two times for 5 min with PTW and refixed in 4% 
formaldehyde (v/v) in PTW for 20 min. Before hybridization, the embryos were 
washed again 5 times for 5 min in PTW. 
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2.2.4.5 Hybridization 
Hybridization Mix: 50% formamide, 1 mg/ml Torula RNA, 10 µg/ml Heparin, 1x 
Denhardt's, 0.1% Tween-20, 0.1% CHAPS, 10 mM EDTA in 5x SSC 
20X SSC: 3 M NaCl, 0.3 M NaCitrate, pH 7.2-7.4 
100x Denhardts solution: 1 g BSA, 1 g Polyvinylpyrollidone (PVP), 1 g Ficoll, 
 
For pre-hybridization, the embryos were first incubated in 1 ml fresh 
hybridization mix and then after exchanging the hybridization mix, for at least 5 
h at 65 °C. Afterwards, the embryos were incubated in 1 ml hybridization mix 
containing the Dioxigenin labeled antisense RNA probe overnight at 65 °C.  
2.2.4.6 Washing 
20X SSC: 3 M NaCl, 0.3 M NaCitrate, pH 7.2-7.4 
MAB: 100 mM maleic acid, 150 mM NaCl, pH 7.5 
 
The next morning, the hybridization mix conatining the antisense RNA 
probe was exchanged for fresh hybridization mix for 10 min at 65 °C. 
Afterwards, the embryos were washed three times with 2x SSC for 15 min at 65 
°C. To remove unspecific and unbound RNA probes, the embryos were washed 
and treated for 1 h at 37 °C with RNAse A (10 µg/ml, Fermentas) and RNAse 
T1 (10 U/ml, Fermentas) in 2x SSC. After a short washing step with 2x SCC for 
5 min, the embryos were incubated two times in 0.2x SSC at 65 °C. Finally, the 
embryos were transferred into MAB and incubated two times for 15 min.  
2.2.4.7 Blocking and antibody reaction 
MAB: 100 mM maleic acid, 150 mM NaCl, pH 7.5 
MAB/BMB: 2% BMB in 1x MAB 
MAB/BMB/HS: 2% BMB, 20% heat-treated horse serum in 1x MAB 
 
To avoid additionally unspecific binding, the embryos were treated with 
blocking buffer containing MAB and the Boehringer Mannheim Blocking reagent 
(BMB) as well as horse serum (Gibco). First, the embryos were washed 15 min 
in MAB/BMB, which was exchanged for MAB/BMB/HS for 40 min. For detection, 
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the Sheep alkaline phosphatase-coupled anti-Dig antibody (1:5000, Sigma) was 
used and the embryos were incubated for 4 h at RT. Afterwards, the embryos 
were washed 3 times for 10 min and then overnight at 4 °C with MAB. 
2.2.4.8 Staining reaction 
APB: 100 mM Tris-HCl, pH 9.0, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween-20, 
pH 9.0 
NBT: 100 mg/ml in 70% Dimethylformamide, stored in dark 
BCIP: 50 mg/ml in 100% Dimethylformamide, stored in dark 
 
The next day, the embryos were washed 5 times for 5 min with MAB, 
followed by two times for 5 min with ABP at 4 °C. The staining reaction was 
performed in the dark until the desired staining was reached using a mixture of 
BCIP/NBT, a substrate of the alkaline phosphatase.  
2.2.4.9 Destaining and refixation 
To remove background staining, the embryos were treated stepwise with 
methanol of different perncentage (100%, 75%, 50%, 25%). Finally, the 
embryos were refixed with MEMFA for 15 min at RT. The MEMFA was replaced 
by fresh MEMFA for long storage of the embryos at 4 °C.  
2.2.4.10 Bleaching 
20X SSC: 3 M NaCl, 0.3 M NaCitrate, pH 7.2-7.4 
MEMFA: 4% (v/v) formaldehyde (37%) in 1x MEM 
 
Pigmented embryos were bleached using one of two different methods 
and afterwards fixed with MEMFA for long storage.  
To reduce the background, the embryos were first destained with 100% 
methanol. For a more sensitive bleaching, the embryos were incubated in a 
mixture of 75% methanol/H2O2 for up to three days, followed by treatments with 
50% and 25% methanol. More time efficient, the embryos were incubated for 1 
to 2 h in the following solution at RT: 5x SSC, 50% formamide and 1-2% H2O2. 
Finally, two washing steps with 5x SSC for 5 min were performed before 
fixation. 
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2.2.5 Vibratome sectioning 
Gelatin/Albumin: 4.88 mg/ml gelatin was dissolved in PBS. Afterwards, 0.3 
g/ml bovine serum albumin and 0.2 mg/ml sucrose were added and dissolved. 
The solution was sterile filtered and stored at -20 °C. 
Mowiol: 5 g Mowiol was dissolved in 20 ml PBS by stirring for more than 16 h. 
Afterwards, 10 ml glycerol was added and stirred for 16 h. The supernatant was 
recovered and a pH of 7.0 was adjusted. The solution was stored at -20 °C. 
 
For vibratome sectioning, the whole embryos were embedded in a 
mixture of gelatin and albumin by adding gluturylaldehyde. The embryos were 
vibratome sectioned at 30 μM using a vibratome (Leica VT1000M). The 
sections were collected on glass slides and covered with a cover slip using 
mowiol.  
2.2.6 Protein standard techniques 
2.2.6.1 Protein-protein interaction in vivo (Co-
immunoprecipitation) 
Table 2.4. Summary of antibodies and working dilutions 
 
 
Co-IP buffer: 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM EDTA, 1 mM 
EGTA, 0.5 % (v/v) NP-40, 10 % (v/v) glycerol, 1mM Sodium-Orthovanadate, 
1mM b-Glycerolphosphate, 1mM NaF, protease inhibitor cocktail (1 tablet per 
50 ml Co-IP buffer, Roche) 
6x SDS sample buffer: 125 mM Tris pH 6.8, 30% glycerol, 10% SDS, 0.6 M 
DTT, 0.012% Bromphenol blue 
 
For a Co-immunoprecipitation assay, 25 injected embryos were 
harvested at gastrula stage. The embryos were lysated with a 27-gauge-syringe 
in 500 µl Co-IP buffer. The lysates were centrifuged for 15 min at 4 °C and the 
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supernatant was transferred to a new eppendorf tube. 50 µl of the lysates were 
transferred to a new eppendorf tube and served later as input control (10%). To 
the input samples, 10 µl 6x SDS loading buffer was added and heated for 3 min 
at 95 °C before storing at -20 °C. The Co-IP samples were adjusted to 500 µl 
with the Co-IP buffer. For pre-clearing, 30 µl of Υ-bind sepharose immunopellets 
(GE Healthcare) were added. The Co-IP samples were incubated for 30 min at 
4 °C on a rotating wheel and then centrifuged for 20 sec at 2,000 rpm. 
Afterwards, the supernatants were transferred to a new eppendorf tube and split 
in 250 µl each. To the Co-IP samples the specific antibodies were added. The 
samples were incubated for 2 h at 4 °C on a rotating wheel. Afterwards 20 µl of 
the Υ-bind sepharose immunopellets was added. The Co-IP samples were 
incubated for another 2 h at 4 °C on a rotating wheel. Finally, the samples were 
centrifuged for 30 sec at 2,000 rpm and the pellets were washed 5 times with 1 
ml Co-IP buffer. The supernatant was removed and 10 µl of 6x loading buffer 
were added. The Co-IP samples were incubated for 3 min at 95 °C and stored 
at -20 °C.  
2.2.6.2 SDS-Polyacrylamide gel electrophoresis  
10x Laemmli buffer: 250 mM Tris-base, 2.5 M Glycine, 0.1% SDS  
 
To separate denatured proteins according to their molecular weight in an 
electric field, SDS-polyacrylamide gel electrophoresis was performed (Laemmli, 
1970). To denaturate the proteins, the samples were diluted with 6x SDS 
loading buffer and boiled for 3 min at 95 °C in a water bath. For separation of 
the denatured proteins, a 12% SDS gel was used and prepared according to 
standard protocols (Sambrook and Russel, 2001). To visualize the size of the 
proteins molecular weight, a standard protein marker was used (Page RulerTM 
prestained protein ladder, Thermo Scientific). The gel electrophoresis was 
performed using 1x Laemmli buffer as running buffer. First, a voltage of 100 V 
was applied and when the bromphenol-blue front reached the separating gel, 
the voltage was raised to 250 V.  
2.2.6.3 Western blot 
Blocking Buffer: 5% (w/v) dry, non fat-milk powder in PBS-T 
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PBS-T: 1x PBS, 0.5% (v/v) Tween 20 
Anode blotting buffer 1: 0.3 M Tris, 10% methanol, pH 10.4 
Anode blotting buffer 2: 25 mM Tris, 10% methanol, pH 10.4 
Cathode blotting buffer: 25 mM Tris, 40 mM glycine, 10% methanol, pH 9.4 
 
After separation, the proteins were transferred from the polyacrylamide 
gel to a nitrocellulose membrane using the semi-dried blotting method for 1 h 
(Sambrook and Russel, 2001; Towbin et al., 1979). To minimize unspecific 
binding, the nitrocellulose membrane was blocked for 1 h at RT using 5% (w/v) 
milk powder in PBS-T buffer. Afterwards, the nitrocellulose membrane was 
incubated overnight at 4 °C in milk buffer containing the first antibody. The 
following morning, the membrane was washed with 1x PBS-T for 30 min at RT 
thereby exchanging the buffer every ten minutes. Afterwards, the second 
antibody in milk buffer was added. After 1 h incubation at RT, the nitrocellulose 
membrane was again washed for 30 min with 1x PBS-T. For detection, the 
membrane was incubated with the chemiluminescent substrate "Super Signal 
West Dura" (Thermo Scientific) according to the manufacturer's protocol and 




 3. Results 
3.1 Ptf1a promotes general neurogenesis and specifies 
GABAergic inhibitory interneurons at the expense of other 
neuronal cell types  
The bHLH transcription factor Ptf1a functions in the nervous system to 
promote generation of GABAergic inhibitory interneurons at the expense of 
glutamatergic excitatory neurons in the spinal cord, cerebellum and retina 
(Glasgow et al., 2005; Hoshino et al., 2005; Fujitani et al., 2006; Nakhai et al., 
2007; Pascual et al., 2007; Dullin et al., 2007). Microinjection of Ptf1a-GR 
mRNA is sufficient to induce ectopic neurons in animal caps and in the non-
neural ectoderm of X. laevis embryos and these neurons have a GABAergic 
identity (Dullin et al., 2007; Hedderich, 2008). Thus, Ptf1a not only acts as a 
GABAergic selector gene in the post-mitotic neurons, but also drives neuronal 
cell commitment of progenitor cells.  
 In the mouse, Ptf1a is expressed in the dorsal horn of the spinal cord in 
the progenitor domain of the dI4 and later dILA neurons, which give rise to 
GABAergic inhibitory interneurons (Glasgow et al., 2005); the dI4 and dILA 
neurons can be molecularly identified by a specific code of HD transcription 
factors consisting of Pax2, Lbx1, Lhx1 and Lhx5 (Glasgow et al., 2005; Helms 
and Johnson, 2003). In X. laevis, the domains and combinatorial codes of 
transcription factors that characterise distinct neuronal subtype domains are not 
well defined. Therefore, to evaluate Ptf1a activity during the development of the 
X. laevis nervous system, gain-of-function experiments analysing marker genes 
indicative of specific neuronal subtype identities in embryos were performed. To 
control the onset of protein activity, the ligand-binding domain of the 
glucocorticoid receptor was fused to the C-terminus of Ptf1a (Ptf1a-GR) (Afelik 
et al., 2006). In the absence of the ligand dexamethasone (Dex), the fusion 
proteins are bound by heat shock proteins and remain transcriptionally inactive 
in the cytoplasm. Upon addition of dexamethasone, the fusion proteins 
translocate into the nucleus and regulate transcription of target genes (Gammill 
and Sive, 1997). 
 Ptf1a-GR mRNA was injected into one blastomere of two-cell stage 
embryos together with LacZ mRNA, in order to localize the distribution of the 
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injected mRNA. At early gastrula stage (stage 10), the injected embryos were 
treated with dexamethasone to induce Ptf1a-GR protein activity. In agreement 
with previous reports (Dullin et al., 2007; Hedderich, 2008), overexpression of 
Ptf1a-GR mRNA in the X. laevis hindbrain and spinal cord promoted a dramatic 
increase in expression of the post-mitotic neuronal marker N-tubulin and of 
Glutamic acid decarboxylase (Gad1), an enzyme that catalyses the synthesis of 
GABA and is indicative of GABAergic inhibitory neurons (Li et al., 2006) (Fig. 
3.1 B, B’ and C, C'). In line with studies in the murine nervous system (Glasgow 
et al., 2005), overexpression of Ptf1a-GR mRNA also promoted the activation of 
Pax2 and Lhx1, which mark dorsal interneuron populations (Fig. 3.1 E, E' and F, 
F'). Additionally, Lbx1 expression was induced, which also encodes for a 
transcription factor required in the post-mitotic neurons to specify a GABAergic 
interneuronal subtype (Fig. 3.1 D, D’) (Cheng et al., 2005). In contrast, 
transcription factors expressed in neuronal domains more ventral to the 
endogenous Ptf1a progenitor domain, such as Hox11L2 or Lmx1b (Fig. 3.1 G, 
G' and H, H) were inhibited by Ptf1a. Similar results were reported for Ptf1a in 
the murine spinal cord (Glasgow et al., 2005). 
 While Ptf1a is thought to function as a transcriptional activator (Cockell et 
al., 1989; Krapp et al., 1996), many transcription factors have been shown to 
act both as transcriptional activators or repressors in a context-dependent 
fashion (Iype et al., 2004; Yu et al., 2005; Sakabe et al., 2012). The expression 
of the above marker genes was therefore evaluated upon microinjection of a 
hormone-inducible version of Ptf1a that was fused to a heterologous strong 
activator domain derived from VP16 (Ptf1a-VP16-GR) (Sadowski et al., 1988; 
Dullin et al., 2007). Similar to Ptf1a-GR, overexpression of Ptf1a-VP16-GR 
mRNA induced strong expression of the GABAergic interneuronal markers 
Gad1, Pax2, Lhx1 and Lbx1 (Fig. 3.1 J, J’; K, K’; L, L’ and M, M') as well as of 
the general neuronal marker N-tubulin (Fig. 3.1 I, I’). Moreover, the expression 
of Hox11L2 and Lmx1b was still inhibited (Fig. 3.1 N, N’ and O, O'), suggesting 
that the repression by Ptf1a is indirect. 
 The ability of Ptf1a to induce general neurogenesis in the non-neural 
ectoderm of X. laevis embryos and in animal caps is similar to that of the 
proneural bHLH transcription factor Neurogenin 2 (Ngn2, also known as X-ngnr-
1) (Ma et al., 1996). However, while Ptf1a induces Gad1, a GABAergic marker 
Results 43
in such assays (Dullin et al., 2007; Hedderich, 2008), Ngn2 promotes the 
expression of Hox11L2, a marker for cranial sensory ganglia and Rohon-Beard 
sensory neurons (Perron et al., 1999; Dullin et al., 2007; Hedderich, 2008). 
Hox11L2 is the X. laevis ortholog of Tlx3, which has been shown in mouse to 
act as a selector gene promoting a glutamatergic excitatory at the expense of a 
GABAergic inhibitory cell fate (Cheng et al., 2004; Cheng et al., 2005). In the X. 
laevis neural tube, overexpression of Ngn2-GR mRNA strongly activated the 
expression of N-tubulin (Fig. 3.1 P, P'), similar to Ptf1a-GR and Ptf1a-VP16-GR 
mRNA. In contrast, Ngn2-GR mRNA did not influence Gad1, Pax2, Lbx1 or 
Lhx1 expression (Fig. 3.1 Q, Q’; R, R’; S, S’; T, T'), but instead led to ectopic 
activation of Hox11L2/Tlx3 (Fig. 3.1 V, V’). Moreover, Ngn2-GR mRNA had no 
effect on the expression of Lmx1b (Fig. 3.1 U, U’), which was repressed by 
injection of Ptf1a-GR and Ptf1a-VP16-GR mRNA.  
 Interestingly, overexpression of Ptf1a-GR and Ptf1a-VP16-GR mRNA not 
only led to an induction or suppression of the described marker genes, but 
additionally resulted in a strong increase in tissue formation on the injected side 
of the embryo (Fig. 3.1 B, B' - O, O'). It can be excluded that the extra tissue 
formation is a general consequence of mRNA overexpression, as the effect was 
not upon microinjection of Ngn2-GR mRNA (Fig. 3.1 P, P' - V, V'). However, the 
identity of the extra tissue promoted by Ptf1a-GR and Ptf1a-VP16-GR mRNA 
overexpression could not be elucidated so far. 
 Taken together, these findings demonstrate that Ptf1a like Ngn2 
promotes general neurogenesis and that Ptf1a confers GABAergic interneuron 
subtype specification at the expense of other neuronal subtypes. In contrast, 
Ngn2 induces a glutamatergic excitatory cell fate. 
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Figure 3.1 Ptf1a promotes general neurogenesis and specifies GABAergic 
inhibitory interneurons at the expense of other neuronal cell types.  
(A) The mRNAs indicated above (20 pg each) were co-injected with LacZ mRNA (75 
pg) into one blastomere at the two-cell stage. Protein activity was induced by 
dexamethasone (Dex) at the equivalent of stage 10. (B-V) Gene expression was 
analysed by whole mount in situ hybridization (wmish) using markers indicated on the 
left side. (B-V) Dorsal view of the head region and (B'-V') the corresponding transversal 
section through the hindbrain at the level of the otic vesicle of stage 28 X. laevis 
embryos. The injected side is always at the bottom of the whole head view and to the 
right on the sections. nc, notochord, is, injected side. 
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3.2 Ptf1a and Ngn2 promote general neurogenesis via activation 
of the same gene network 
The ability of Ptf1a to induce general neuronal differentiation in X. laevis 
embryos is similar to the activity of the bHLH transcription factor Ngn2. 
However, both transcription factors confer distinct neuronal subtype identities 
(Fig. 3.1). This raises the question, if Ptf1a and Ngn2 activate the same or a 
different gene network, to achieve general neurogenesis. Previous results in 
whole embryos analysing only a limited set of marker genes suggested that 
Ptf1a and Ngn2 drive general neurogenesis in progenitors through the same 
cascade of neuronal differentiation factors (Hedderich, 2008). To obtain a 
higher resolution comparison, a temporal expression analysis of genes induced 
by Ptf1a-GR and Ngn2-GR mRNA overexpression was performed utilizing the 
animal cap assay. Animal caps are embryonic pluripotent cells excised from the 
animal pole of X. laevis embryos of the blastula stage. Untreated animal caps 
will give rise to atypical epidermal tissue. However upon treatment or injection 
of various factors, the animal caps can obtain cell fates of all three germ layers 
(Borchers and Pieler, 2010).  
 Ptf1a-GR or Ngn2-GR mRNA were injected into both blastomeres of two-
cell stage X. laevis embryos, animal caps were excised at blastula stage and 
treated with dexamethasone to induce protein activity (Fig. 3.2 A). The animal 
caps were collected 3, 6 and 25 h after addition of dexamethasone. Total RNA 
was isolated and the levels of specific mRNAs digitally quantified without 
amplification using Nanostring nCounter multiplex analysis, which employs 
target-specific fluorescent barcodes and single molecule imaging (Geiss et al., 
2008; Kulkarni, 2011) (Fig. 3.2 and Appendix 6.1.1). The analysis of a selected 
set of genes is represented in Figure 3.2. Animal caps that were injected, but 
not treated with dexamethasone served as a negative control and did not 
significantly express any of the analysed marker genes (Fig. 3.2 B-M). Both 
Ptf1a-GR and Ngn2-GR mRNA overexpression was sufficient to induce the 
expression of the Notch-ligand Dll1 (Fig. 3.2 B), the cell-cycle inhibitor Cdknx 
(Fig. 3.2 C) as well as of the zinc-finger transcription factor Myt1 (Fig. 3.2 D) 3 h 
after dexamethasone induction. Other neuronal differentiation genes such as 
Ebf2 (Fig. 3.2 E), Ebf3 (Appendix 6.1.1), NeuroD1 (Fig. 3.2 F) and NeuroD4 
(Appendix 6.1.1) were also strongly induced by Ptf1a-GR and Ngn2-GR mRNA 
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after 25 h of protein induction. Similarly, overexpression of Ptf1a-GR and Ngn2-
GR mRNA led to a high induction of the post-mitotic marker N-tubulin (Fig. 3.2 
G) and the cell cycle regulator Pak3 (Appendix 6.1.1) after 25 h of protein 
induction. In regard to GABAergic neuronal subtype specification, Ptf1a-GR but 
not Ngn2-GR mRNA strongly induced Gad1 (Fig. 3.2 H) expression as well as 
the expression of Pax2 (Fig. 3.2 J), Lhx5 (Fig. 3.2 I), Lbx1 (Appendix 6.1.1) and 
Lhx1 (Appendix 6.1.1) after 25 h. In contrast, Ngn2-GR mRNA robustly induced 
the marker genes for glutamatergic excitatory neurons such as Hox11L2/Tlx3 
(Fig. 3.2 L) and Vglut1 (Fig. 3.2 M). Furthermore, Ngn2-GR induced the 
expression of the PR domain containing zinc finger transcription factor Prdm14 
more than a 1000-fold (Fig. 3.2 K), however, the function of which in the 
nervous system is still unknown (Fog et al., 2012). Interestingly, Ptf1a-GR 
mRNA overexpression in animal caps also led to an increase in Lmx1b 
expression (Appendix 6.1.1), a transcription factor involved in glutamatergic 
excitatory neuron formation and normally suppressed by Ptf1a in the spinal cord 
(Fig. 3.1 G, G') (Glasgow et al., 2005).  
 In summary, both Ptf1a and Ngn2 drive early steps of general 
neurogenesis through activation of an overlapping set of downstream target 
genes in a similar temporal order. However, later in development, Ptf1a and 
Ngn2 induce unique sets of downstream genes to confer specific neuronal 
















Figure 3.2 Ptf1a and Ngn2 promote general neurogenesis via activation of the 
same gene network.  
Comparative temporal analysis of genes induced by Ptf1a-GR and Ngn2-GR mRNA in 
animal cap assays. (A) The indicated mRNAs (20 pg each) were injected into both 
blastomeres of two-cell stage embryos, animal caps excised at the blastula stage and 
treated with dexamethasone (Dex). Animal caps were cultured for 3, 6 or 25 h, which 
corresponds to stage 9, 10 and 23 of sibling embryos. Total RNA was isolated and 
marker gene expression analysed by the Nanostring nCounter system. (B-M) Shown is 
the averaged fold change over uninjected control caps (CC) of two independent 
experiments. Error bars represent the standard error of the mean (+/-SEM). Note the 




3.3 Ptf1a is able to drive both general neurogenesis and 
neuronal subtype specification when induced after neural tube 
closure  
Multiple proneural bHLH genes have been identified in vertebrates, 
including X. laevis (Lee, 1997). Analysis of the expression pattern of the X. 
laevis proneural genes reveals expression in overlapping and distinct domains 
in the CNS (Fig. 1.3) (Nieber et al., 2009; Kim et al., 1997; Kanekar et al., 1997; 
Ferreiro et al., 1993; Turner and Weintraub, 1994), suggesting that the 
proneural genes may have discrete activities in generating specific neuronal 
identities. By whole mount in situ hybridization, the earliest specific expression 
of Ptf1a is detected at stage 19 in a single longitudinal domain within the neural 
folds (Afelik et al., 2006). At late tadpole stages, Ptf1a is specifically expressed 
in the hindbrain, the spinal cord and the retina as well as in the ventral and 
dorsal pancreatic bud (Afelik et al., 2006). Previous experiments had shown that 
Ptf1a-GR, when activated at gastrula stage, is able to drive general 
neurogenesis (Dullin et al., 2007; Hedderich, 2008). To analyse, if the 
expression of Ptf1a at stage 19 may indicate an early physiological function in 
inducing general neurogenesis, Ptf1a-GR mRNA was injected into one 
blastomere of two-cell stage embryos and protein activity induced at stage 19 
(Fig. 3.3 A).  
 Gene expression analysis by in situ hybridization showed that in contrast 
to induction of Ptf1a-GR activity during early gastrula stages, induction at stage 
19, when the ectoderm has obtained an epidermal fate, did not lead to ectopic 
N-tubulin or Gad1 expression (Fig. 3.3 B and C). However, the corresponding 
sections through the hindbrain revealed increased expression of both marker 
genes on the injected side (Fig. 3.3 B' and C'). This result demonstrates that 
Ptf1a-GR, when induced at a time when endogenous Ptf1a is present, is still 
able to promote general neurogenesis and a GABAergic interneuronal identity 
within the neural tube. Moreover, Ptf1a-GR activated at stage 19 was still able 
to inhibit Hox11L2/Tlx3 expression on the injected side of the embryo (Fig. 3.3 





Figure 3.3 Ptf1a is able to drive general neurogenesis and neuronal subtype 
specification when induced after neural tube closure. (A) Ptf1a-GR mRNA (20 pg) 
was injected into one blastomere of two-cell stage embryos and induced at stage 19 
with dexamethasone (Dex). (B-D) Gene expression was analysed by whole mount in 
situ hybridization (wmish) of stage 28 X. laevis embryos using markers indicated on the 
left side. (B-D) Dorsal view of the head region with the injected side at the top and (B'-
D') the corresponding transversal sections through the hindbrain at the level of the otic 
vesicle are shown with the injected side to the right. nc, notochord; is, injected side 
 
3.4 Ptf1a is maternally expressed in X. laevis 
 The ability of Ptf1a to induce general neurogenesis before neural tube 
closure might reflect an early physiological activity. To evaluate if Ptf1a might be 
expressed earlier than detected by in situ hybridization, a semi-quantitative RT-
PCR of different developmentally staged X. laevis embryos analysed for Ptf1a 
transcripts was performed, surprisingly revealing maternal expression of Ptf1a 
(Fig. 3.4 A). Ptf1a transcripts were maintained at constant levels until late 
gastrula stage (stage 11), demonstrating that Ptf1a is actually expressed when 
the first neurons are being born. From early neurula stages (stage 13) onwards, 
the level of Ptf1a expression decreased and increased again after neural tube 
closure (stage 20). Gene expression analysis by in situ hybridization revealed 
that the maternal Ptf1a transcripts are restricted to the animal half of the embryo 
at early cleavage stages (stage 2 and stage 6) (Fig. 3.4 B and C). At early 
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gastrula stage (stage 10.5), Ptf1a transcripts were excluded from the 
blastoporus (Fig. 3.4 D). Consistent with previous reports (Afelik et al., 2006), at 
later neurula stages, weak and diffuse Ptf1a expression was detectable in a 
single longitudinal domain within the neural folds, which became stronger after 
neural tube closure (Fig. 3.4 E and F). To exclude unspecific background 
staining, particularly at the early stages, in situ hybridization with a Ptf1a sense 
RNA probe was performed (Fig. 3.4 G - K). In all stages, no specific signal was 




Figure 3.4 Spatial and temporal Ptf1a expression in X. laevis.  
(A) Temporal Ptf1a expression. Ptf1a expression was analysed by semi-quantitative 
RT-PCR. Expression levels were shown by histone 4 (H4) expression. (B-M) Spatial 
Ptf1a expression. Ptf1a expression pattern was analysed by whole mount in situ 
hybridization using (B-F) antisense RNA or (G-K) sense RNA. Shown is the lateral view 
of the embryo in B, C, D, G, H, I and the dorsal view in E, F, J and K. Dotted line in D 
and I marks the blastoporus. nf, neural folds 
3.5 Ptf1a is expressed in the inner ventricular zone of the 
hindbrain and neural tube 
 To further determine if Ptf1a endogenously might be involved in general 
neurogenesis in the developing embryo, it was evaluated, if Ptf1a is expressed 
in neural progenitor cells that do not express members of the well-characterised 
neuronal determination factor family Neurogenin (Fig. 3.5 A-C). Therefore, a 
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double in situ hybridization of stage 29 X. laevis embryos for Ptf1a and the three 
Neurogenins (Ngn1, Ngn2 and Ngn3) (Ma et al., 1996; Nieber et al., 2009) was 
performed. The gene expression analysis revealed that Ptf1a and Ngn1 (Fig. 
3.5 B, B´) and Ngn3 (Fig. 3.5 C, C´) were expressed in non-overlapping 
territories of the hindbrain. In contrast, Ptf1a and Ngn2 (Fig. 3.5 A, A´) were co-
expressed in a restricted domain of the hindbrain that will give rise to 
GABAergic interneurons, which is consistent with findings in the mouse (Henke 
et al., 2009b). However, only Ptf1a transcripts were detected in the inner 
ventricular zone where the proliferating precursor cells are located, whereas the 
expression domain of Ngn2 is found more lateral in the intermediate zone (Fig. 
3.5 A, A'), being compatible with the idea, that Ptf1a functions as a proneural 




Figure 3.5 Ptf1a is expressed in the inner ventricular zone of the hindbrain.  
(A-C) Double whole mount in situ hybridization of stage 29 X. laevis embryos for Ptf1a 
(red) and Ngn1, Ngn2 and Ngn3 (purple). (A-C) Lateral view of the head region and 
(A'-C') the corresponding transversal section through the hindbrain at the level of the 
otic vesicle. Black arrow indicates the region, where Ptf1a and Ngn2 are co-expressed. 
The ventricular zone of the hindbrain expressing Ptf1a is indicated by the white arrow 
head. nc, notochord, hb, hindbrain 
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3.6 The neuronal subtype-inducing activity of Ptf1a is dominant 
over Ngn2  
The previous result (Fig. 3.5) shows that Ptf1a and Ngn2 are co-expressed in 
the region of the hindbrain that gives rise to GABAergic inhibitory neurons. 
However, Ngn2 and Ptf1a promote distinct neuronal subtype identities in post-
mitotic neurons (Fig. 3.1) (Dullin et al., 2007; Hedderich, 2008). To analyse the 
neuronal subtype inducing-activity of Ptf1a and Ngn2 when co-expressed, 
Ptf1a-GR and Ngn2-GR mRNA were injected alone or together into both 
blastomeres of two-cell stage embryos. Animal caps were excised at blastula 
stage and the GR fusion proteins induced by dexamethasone (Fig. 3.6 A). 
When the control embryos reached stage 23, total RNA was isolated and 
marker gene expression analysed by quantitative real-time RT-PCR (Fig. 3.6 
A).  
 Overexpression of Ptf1a-GR and Ngn2-GR mRNA alone or in 
combination induced N-tubulin expression compared to uninjected control caps 
(Fig. 3.6 B). Consistent with previous results, Ptf1a-GR but not Ngn2-GR, 
strongly induced the expression of Gad1 (Fig. 3.6 C), whereas Ngn2-GR 
activated the marker expression of Hox11L2/Tlx3 (Fig. 3.6 D). Upon co-
expression of both bHLH transcription factors, Ptf1a-GR mRNA was still 
sufficient to activate Gad1 expression (Fig. 3.6 C). In fact, the induction of Gad1 
by Ptf1a-GR in combination with Ngn2-GR mRNA was even stronger than 
compared to Ptf1a-GR alone (Fig. 3.6 C). In contrast, the induction of 
Hox11L2/Tlx3 by Ngn2-GR upon co-injection of Ptf1a-GR mRNA was abolished 
(Fig. 3.6 D). These results suggest that the GABAergic neuronal subtype-












Figure 3.6 The neuronal subtype-inducing activity of Ptf1a is dominant over 
Ngn2.  
The ability of Ngn2 together with Ptf1a to induce general neurogenesis and neuronal 
subtype identity was analysed in animal cap assays. (A) The indicated mRNAs (20 pg 
each) were injected into both blastomeres of two-cell stage embryos, animal caps 
excised at the blastula stage and treated with dexamethasone (Dex) until sibling 
embryos reached stage 23. Total RNA was isolated and marker gene expression 
analysed by quantitative real-time RT-PCR. (B-D) Shown is the average of two 
independent experiments. Error bars represent the standard error of the mean (+/-
SEM). 
3.7 The bHLH domain of Ptf1a is not essential for GABAergic 
interneuronal subtype specification 
 As shown above, Ngn2 and Ptf1a drive general neurogenesis of neural 
progenitors through the same cascade of target genes, however, they confer 
distinct neuronal subtype identities in the post-mitotic neurons. In order to 
analyse if the shared and unique activities of Ptf1a and Ngn2 are regulated by 
sequences within their bHLH domains, a chimeric construct was created by 
swapping the Ptf1a bHLH domain for that of Ngn2 (chimeric Ptf1a-GR, Fig. 3.7 
B) (Hedderich, 2008). Previous analysis of a restricted set of marker genes 
implicated that the bHLH domain of Ptf1a might not be sufficient to impart 
specificity during the induction of GABAergic interneurons (Hedderich, 2008). 
To analyse the ability of the chimeric Ptf1a-GR to drive general neurogenesis 
and to specify a GABAergic interneuronal subtype in detail, quantitative digital 
multiplexed gene expression analysis using the NanoString nCounter system 
was performed (Fig. 3.7 and Appendix 6.1.2). Ptf1a-GR, Ngn2-GR or chimeric 
Ptf1a-GR mRNA were injected into both blastomeres of two-cell stage embryos. 
Animal caps were excised at blastula stage, proteins induced and cultivated 
until sibling embryos reached stage 23. Total RNA was isolated and quantitative 
Nanostring analysis performed (Fig. 3.7 and Appendix 6.1.2).  
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 To first evaluate the role of the bHLH domain in promoting general 
neurogenesis, genes involved in general neuronal differentiation were analysed. 
Similar to Ptf1a-GR and Ngn2-GR, overexpression of the chimeric Ptf1a-GR 
mRNA was sufficient to induce neuronal differentiation factors such as Ebf2 
(Fig. 3.7 C), NeuroD1 (Fig. 3.7 D), Ebf3 (Appendix 6.1.2) and NeuroD4 
(Appendix 6.1.2) as well as N-tubulin expression (Fig. 3.7 E). Furthermore, the 
chimeric Ptf1a-GR was also able to induce the expression of the cell-cycle 
inhibitor Pak3 (Appendix 6.1.2). In respect to neuronal subtype specificity, the 
chimeric Ptf1a-GR induced a robust expression of Gad1 (Fig. 3.7 F), a marker 
indicative of GABAergic neurons. However, the induction compared to wild-type 
Ptf1a-GR was reduced about 2.5-fold. Overexpression of the chimeric Ptf1a-GR 
mRNA also activated the expression of transcription factors involved in 
GABAergic interneuronal subtype specification such as Pax2 (Fig. 3.7 H), Lhx5 
(Fig. 3.7 G), Lhx1 (Appendix 6.1.2) and Lbx1 (Appendix 6.1.2), but compared to 
wild-type Ptf1a-GR the induction was strongly reduced, in particular for Pax2 
and Lbx1. However, chimeric Ptf1a-GR-mediated induction of gene expression 
was considerably stronger than background expression levels observed upon 
Ngn2-GR mRNA overexpression. Interestingly like Ngn2-GR, microinjection of 
the chimeric Ptf1a-GR mRNA was sufficient to activate the expression of 
Prdm14 (Fig. 3.7 I), Hox11L2/Tlx3 (Fig. 3.7 J) and Vglut1 (Fig. 3.7 K), albeit 
compared to Ngn2-GR the induction was also greatly reduced.  
 Taken together, the quantitative Nanostring analysis demonstrated that 
the specificity of Ptf1a to drive general neurogenesis is not based on the 
function of its individual bHLH domain. Furthermore, the bHLH domain of Ptf1a 
is not essential for the determination of a GABAergic interneuronal subtype as 
the chimeric Ptf1a was still sufficient to activate marker gene expression 
indicative of a GABAergic interneuronal identity, even though the induction was 
greatly reduced. This suggests that the specification of GABAergic interneurons 
by Ptf1a is not only conferred through the DNA binding domain via the bHLH 
domain but likely also due to flanking sequences, which may impart specificity 




Figure 3.7 The bHLH domain of Ptf1a is not essential for GABAergic interneuron 
subtype specification.  
The ability of Ngn2, Ptf1a or a chimeric construct of Ptf1a (chimeric Ptf1a) to induce 
general neurogenesis and neuronal subtype identity was analysed in animal cap 
assays. (A) The indicated mRNAs (20 pg each) were injected into both blastomeres of 
two-cell stage embryos, animal caps excised at the blastula stage and treated with 
dexamethasone (Dex) until sibling embryos reached stage 23. Total RNA was isolated 
and marker gene expression analysed by Nanostring. (B) Scheme of the chimeric 
Ptf1a construct, in which the bHLH of Ptf1a was swapped with that of Ngn2. (C-K) 
Shown is the averaged fold change over uninjected control caps (CC) of two 
independent experiments. Error bars represent the standard error of the mean (+/-
SEM). Note the different scales in each diagram. Shown are graphs of selected genes, 
for a full list see Appendix 6.1.2. 
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3.8 Interaction of Ptf1a with Su(H) is not required for the general 
neurogenesis-inducing activity of Ptf1a 
 The previous result suggested that also sequences outside the bHLH 
domain of Ptf1a are responsible for its specificity in neuronal subtype 
specification. Studies in mouse and chick demonstrated that the C-terminus of 
Ptf1a is essential for Ptf1a to promote GABAergic interneuronal subtype identity 
(Hori et al., 2008). The Ptf1a C-terminus contains a C1- and C2-domain, which 
were shown to be required for the interaction with Rbp-j (Su(H) in X. laevis) or 
its paralogue Rbp-l (Beres et al., 2006). The interaction with Rbp-j can be 
abolished through a point mutation in the C2-domain. In the mouse and chick 
neural tube, this mutant Ptf1a lost the ability to promote GABAergic inhibitory 
interneurons (Hori et al., 2008). Previous studies in X. laevis investigating the 
effect of the interaction between Ptf1a and Su(H) on Ptf1a function, revealed 
that both C-domains must be mutated by an exchange of one amino acid 
(Ptf1aW224A/W242A, Hedderich, 2008) (Fig. 3.8 B) to abolish the ability of Ptf1a to 
induce a GABAergic interneuronal identity (Hedderich, 2008). To further 
analyse the importance of these mutations on Ptf1a activity, the animal cap 
assay coupled with quantitative Nanostring analysis was utilized. Ptf1a-GR or 
Ptf1aW224A/W242A-GR mRNA were injected into both blastomeres of two-cell 
stage embryos, animal caps excised and protein activity induced at blastula 
stage (Fig. 3.8 A). The explants were collected 6 h and 32 h after 
dexamethasone induction, total mRNA was isolated and analysed by 
Nanostring (Fig. 3.8 and Appendix 6.1.3).  
 Similar to Ptf1a-GR wild-type, microinjection of Ptf1aW224A/W242A-GR 
mRNA activated genes involved in general neurogenesis. The genes Dll1 (Fig. 
3.8 C), Cdknx (Fig. 3.8 D) and Myt1 (Fig. 3.8 E) were already induced after 6 h, 
while the other neuronal differentiation factors such as NeuroD1 (Fig. 3.8 F), 
Ebf2 (Appendix 6.1.3), Ebf3 (Appendix 6.1.3), NeuroD4 (Appendix 6.1.3) as well 
as N-tubulin (Fig. 3.8 G) were activated after 32 h of protein activity initiation. 
However, in regard to neuronal subtype specificity, only the wild-type Ptf1a-GR 
but not the Ptf1aW224A/W242A-GR mRNA induced a robust activation of the 
GABAergic interneuronal marker genes Gad1 (Fig. 3.8 I), Pax2 (Fig. 3.8 J), 
Lhx1 (Appendix 6.1.3), Lhx5 (Fig. 3.8 K) and Lbx1 (Appendix 6.1.3) after 32 h of 
protein induction. In contrast, Ptf1aW224A/W242A-GR but not Ptf1a-GR wild-type 
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activated marker genes indicative of a glutamatergic excitatory phenotype such 
as Hox11L2/Tlx3 (Fig. 3.8 M) and Vglut1 (Fig. 3.8 N) as well as Prdm14 (Fig. 
3.8 L). As Ngn2, but not Ptf1a wild-type was shown in similar assays to promote 
such marker gene expression (Fig. 3.2), the expression of Ngn2 was evaluated.   
After 32 h, the wild-type Ptf1a-GR, but not Ptf1aW224A/W242A-GR induced Ngn2 
(Fig. 3.8 H) expression, which is consistent with the finding that Ngn2 is a direct 
target of the heterotrimeric Ptf1a complex in mouse (Henke et al., 2009b). In 
contrast, the other members of the Neurogenin family, Ngn1 and Ngn3, were 
differentially regulated. Both, Ptf1a-GR as well as Ptf1aW224A/W242A-GR mRNA 
was able to induce Ngn1 (Appendix 6.1.3) but not Ngn3 (Appendix 6.1.3) 
expression.  
 In summary, the experiment supports the hypothesis that Ptf1a forms two 
distinct transcription complexes during X. laevis neurogenesis: a Su(H)-
independent one to drive general neurogenesis and to specify glutamatergic 




















Figure 3.8 Interaction of Ptf1a with Su(H) is not required for the general 
neurogenesis-inducing activity of Ptf1a.  
Comparative temporal analysis of wild-type Ptf1a and a mutant Ptf1a (Ptf1aW224A/W242A), 
containing two point mutations that disrupt the association with Su(H), to induce 
markers of general neurogenesis and neuronal subtype identity was analysed in animal 
cap assays. (A) The indicated mRNAs (20 pg each) were injected into both 
blastomeres of two-cell stage embryos, animal caps excised at the blastula stage and 
treated with dexamethasone (Dex) for 6 and 32 h. Total RNA was isolated and marker 
gene expression analysed by Nanostring. (B) Scheme of the Ptf1a mutant 
(Ptf1aW224A/W242A) construct. At position 224 in the C1 domain and at position 242 in the 
C2 domain a tryptophan residue was exchanged for an alanine, which disrupts the 
interaction with Su(H). (C-N) Marker gene expression analysed by Nanostring. Shown 
is the averaged fold change over uninjected control caps (CC) of two independent 
experiments. Error bars represent the standard error of the mean (+/-SEM). Note the 
different scales in each diagram. Shown are graphs of selected genes, for a full list see 
Appendix 6.1.3. 
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3.9 Ptf1a is capable of interacting with Su(H) at early 
embryogenesis  
In mouse, the proneural gene Ngn2 was identified as a direct target gene 
that requires the heterotrimeric complex of Ptf1a (Henke et al., 2009b). It is 
likely that also in X. laevis, Ngn2 is a direct downstream target of Ptf1a. This is 
further supported by the co-expression of Ngn2 with Ptf1a in X. laevis in the 
intermediate layer of the hindbrain progenitor domain (Fig. 3.5) that gives rise to 
GABAergic interneurons. Interestingly, in the quantitative temporal expression 
analysis shown in Figure 3.8 (and Appendix 6.1.3), Ngn2 and other Ptf1a 
Su(H)-dependent genes were activated only after Su(H)-independent genes.  
This raises the question as to what prevents the activation of Ngn2 and 
other trimeric complex target genes from being activated in an immediate early 
fashion by the Ptf1a heterotrimeric complex that contains Su(H)? One possibility 
could be that the heterotrimeric Ptf1a complex only forms when cells obtain 
their neuronal subtype identity, because Su(H) is not present or is at low levels 
during the phase of general neurogenesis. Therefore, the temporal expression 
of Su(H) transcripts during X. laevis development was analysed using total RNA 
from staged embryos (Fig. 3.9 A). Semi-quantitative RT-PCR analysis revealed 
that Su(H) is maternally expressed and that Su(H) transcripts were present at 
equal levels throughout all development stages tested.  
 The ability of in vitro synthesized Ptf1a to bind Su(H) (Hedderich, 2008; 
Beres et al., 2006) suggests that the interaction is direct and not dependant on 
post-translational modification. However, post-translational modifications may 
prevent their association. Therefore, in vivo co-immunoprecipitation (Co-IP) 
experiments were done using lysates of embryos injected with Myc-tagged wild-
type (MT-Ptf1a-GR) or mutated Ptf1a (MT-Ptf1aW224A/W242A-GR) mRNA together 
with HA-tagged Su(H) mRNA (Su(H)-HA) (Fig. 3.9 B and C) to analyse if the 
heterotrimeric Ptf1a complex is capable of forming at early gastrula stages, 
when only Su(H)-independent Ptf1a target genes are activated. MT-Ptf1a-GR, 
but not MT-Ptf1aW224A/W242A-GR, which served as a negative control, was co-
immunoprecipitated with Su(H)-HA (Fig. 3.9 C). To confirm the result, the Co-IP 
was also performed in the reverse direction (Fig. 3.9 B), showing that Su(H)-HA 
was co-immunoprecipitated with MT-Ptf1a-GR, but not with MT-Ptf1aW224A/W242A-
GR. The Co-IP results demonstrated that MT-Ptf1a-GR, but not MT-
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Ptf1aW224A/W242A-GR is capable of interacting already at gastrula stages with 




Figure 3.9 Ptf1a is capable of interacting with Su(H) at early embryogenesis.  
(A) Temporal expression of Su(H). Su(H) expression levels were analysed by semi-
quantitative RT-PCR in whole X. laevis embryos. Expression levels were shown by 
histone H4. (B-C) Co-immunoprecipitation (Co-IP) of MT-Ptf1a-GR, MT-
Ptf1aW224A/W242A-GR and Su(H)-HA in X. laevis lysates. The mRNAs (250 pg each) were 
injected into both blastomeres of two-cell stage embryos. Co-IP was performed using 
embryo lysates from gastrula stage. (B-C) Co-IP experiments showing precipitation of 
Su(H)-HA via MT-Ptf1a-GR (B) and precipitation of MT-Ptf1a-GR via Su(H)-HA (C). 
  
3.10 Co-expression of Ptf1a and Su(H) influences expression 
levels of Ptf1a Su(H)-dependent target genes  
 Even though at early stages Su(H) transcripts are present and upon co-
injection of Ptf1a and Su(H) mRNAs in X. laevis embryos, Ptf1a can bind Su(H), 
Su(H)-dependent target gene activation is delayed following injection of Ptf1a-
GR mRNA. One possibility could be that Su(H) protein availability might be 
limiting. This could occur for example through a competition between Notch-ICD 
and Ptf1a for Su(H)-binding, which is mutually exclusive (Beres et al., 2006). 
The levels of Su(H) in the embryo were therefore increased by co-expression of 
Su(H)-GR mRNA together with Ptf1a-GR mRNA and the influence on marker 
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gene expression determined and compared with injection of Ptf1a-GR mRNA 
alone. Su(H)-GR and Ptf1a-GR mRNA were injected alone or in combination 
into both blastomeres of two-cell stage embryos, animal caps excised at 
blastula stage and proteins activated for 3, 6, 9 and 25 h. Total RNA was 
isolated and quantitative analysis performed with the Nanostring nCounter 
system (Fig. 3.10 A). Overexpression of Su(H)-GR mRNA alone did not 
significantly increase the expression of any of the evaluated marker genes (Fig. 
3.10 B-M). As shown previously, microinjection of Ptf1a-GR mRNA led to an 
early induction of the genes Myt1, Dll1 and Cdknx at 3 h, which was not 
significantly altered by co-injection of Su(H)-GR mRNA (Fig. 3.10 B-D). Also 
similar to the previous analysis, the expression of the late neuronal 
differentiation markers such as NeuroD1 (Fig. 3.10 E), NeuroD4 (Appendix 
6.1.4) and Ebf3 (Appendix 6.1.4) were strongly activated by Ptf1a-GR after 25 h 
of dexamethasone induction. However, co-injection of Su(H)-GR mRNA led to a 
reduction in the expression of late neuronal differentiation markers, suggesting 
that neuronal differentiation is attenuated. This was further supported by the 
reduced expression of the post-mitotic marker N-tubulin (Fig. 3.10 F) upon co-
injection of Su(H)-GR and Ptf1a-GR mRNA and an increase in the expression 
of Sox3 (Fig. 3.10 G), a marker for neural progenitor cells. Ptf1a-GR mRNA 
overexpression alone activated the genes Pax2, Lbx1, Lhx5, Lhx1 and Gad1 
(Fig. 3.10 H-K and Appendix 6.1.4), which are indicative of a GABAergic 
interneurons in higher vertebrates (Helms and Johnson, 2003; Glasgow et al., 
2005; Cheng et al., 2005), as well as Ngn2 expression (Fig. 3.10 L) after 25 h 
after dexamethasone induction. Co-injection of Su(H)-GR mRNA did not alter 
the onset of expression, however, the increase in Su(H) levels quantitatively 
influenced the induction of these genes. The induction of Gad1 (Fig. 3.10 H) 
and Pax2 (Fig. 3.10 I) was reduced upon co-injection of Su(H)-GR mRNA, while 
the expression of Lhx5 (Fig. 3.10 J) and Lmx1b (Appendix 6.1.4) was 
unaffected. In contrast, co-expression of Su(H)-GR mRNA led to a strong 
increase in expression of Lhx1 (Fig. 3.10 K), Ngn2 (Fig. 3.10 L) and Lbx1 
(Appendix 6.1.4). Moreover, the expression of the pancreatic protein disulfide 
protein isomerase (Pdia2) was analysed (Fig. 3.10 M), which is a direct Su(H)-
dependent target gene of Ptf1a in the murine pancreas. Microinjection of Ptf1a-
GR mRNA alone was not sufficient to induce the expression of Pdia2, whereas 
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together with Su(H)-GR mRNA Pdia2 expression was already activated (20-
fold) after 6 h of dexamethasone induction (Fig. 3.10), a time point at which 
Pdia2 normally is not present in the developing embryo. In summary, elevated 
Su(H) levels together with Ptf1a inhibited neuronal differentiation of progenitor 
cells, while the induction of Su(H)-dependent target genes was either increased, 
decreased or not altered.  
 
 
Figure 3.10  Co-expression of Ptf1a and Su(H) influences expression levels of  
Ptf1a Su(H)-dependent target genes.  
Comparative analysis of the activity of Ptf1a-GR alone and together with Su(H)-GR. (A) 
Ptf1a-GR (20 pg) and Su(H)-GR (40 pg) mRNAs were injected into both blastomeres of 
two-cell stage embryos, animal caps excised at the blastula stage and treated with 
dexamethasone (Dex). Animal caps were cultured for 3, 6, 9 or 25 h, which 
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corresponds to stage 9, 10, 10.5 and 23 of sibling embryos. RNA was isolated and 
gene expression analysed by Nanostring. (B-M) Shown is the averaged fold change 
over uninjected control caps (CC) of two independent experiments. Error bars 
represent the standard error of the mean (+/-SEM). Note the different scales in each 
diagram. Shown are graphs of selected genes, for a full list see Appendix 6.1.4. 
3.11 Temporal expression analysis of genes induced by Ptf1a, 
Ptf1aW224A/W242A and Ngn2 by RNA-sequencing  
 To gain insight into the genetic network downstream of Ptf1a during 
general neurogenesis and neuronal subtype specification, a comparative 
temporal expression analysis of gene induction was performed in animal caps 
using whole transcriptome RNA-sequencing. To discriminate between Su(H)-
dependent and Su(H)-independent targets, both Ptf1a-GR and Ptf1aW224A/W242A-
GR were used. Ngn2-GR was also included in this study to identify common 
proneural and unique neuronal subtype inducing activities. 
For the whole transcriptome approach, Ptf1a-GR, Ptf1aW224A/W242A-GR or 
Ngn2-GR mRNA were injected into both blastomeres of two-cell stage embryos, 
animal caps excised and treated with dexamethasone for 6 or 25 h. After total 
RNA isolation, complementary DNA was prepared and paired-end deep 
sequencing was performed using an Illumina HiSeq 2000 sequencing system 
(more than 15 million reads per sample) to evaluate the transcriptome of the 
different explants (Fig. 3.12 A). To align the sequencing reads, the transcript 
reads were first mapped to the X. tropicalis (Xt) transcriptome as the genome is 
sequenced using the Bowtie2 program allowing three mismatches. Additionally, 
the transcript reads were also aligned to selected sequences of the X. laevis 
(Xl) unigene database, representing genes that were not found in the X. 
tropicalis transcriptome. In total, 74.7% of the sequencing-reads could be 






Figure 3.11 Scheme of the alignment process of the sequencing reads to identify 
new downstream targets of Ptf1a, Ngn2 and Ptf1aW224A/W242A 
To align the sequencing reads, the transcript reads were first mapped to the X. 
tropicalis (Xt) transcriptome, which resulted in 65.0% mapped sequencing reads. 
Furthermore, the transcript reads were aligned to the X. laevis (Xl) unigene database 
allowing further mapping of 15.5% of the sequencing reads. Through this procedure, in 
total 74.7% of the sequencing reads could be mapped.The dashed arrows indicate that 
the percentages are not additive as sequences map to both transcriptome libraries.   
Applying a minimum two-fold change compared to control caps, Ptf1a-
GR, Ptf1aW224A/W242A-GR and Ngn2-GR induced 144, 155 and 88 genes, 
respectively after 6 h of protein induction (Fig. 3.12 B). Increasing this threshold 
revealed that a significant number of genes was activated more than 10-fold, 
but not over 50-fold (Fig. 3.12 B).  
As expected, after 25 h of protein induction, the number of induced 
genes was increased. Ptf1a-GR, Ptf1aW224A/W242A-GR and Ngn2-GR induced 
1636, 369 and 762 genes, respectively, by more than two-fold (Fig. 3.12 C). In 
contrast to the 6 h time point, application of different thresholds indicated that a 
high number of genes was still upregulated more than 50-fold and even more 











Figure 3.12 Temporal expression analysis of Ptf1a-GR, Ngn2-GR and 
Ptf1aW224A/W242A-GR target genes by whole transcriptome RNA-sequencing.  
(A) The indicated mRNAs (20 pg each) were injected into both blastomeres of two-cell 
stage embryos, animal caps excised at blastula stage and treated with dexamethasone 
for 6 and 25 h. Total RNA was isolated and subjected to RNA-sequencing. (B-C) 
Summary of identified target genes of Ptf1a, Ngn2 and Ptf1aW224A/W242A after 6 h (B) and 
25 h (C) after application of different fold-change categories. Given is the number of 
target genes with a two-, 10-, 50-, 100- or 1000-fold change compared to uninjected 
control caps (CC).  
3.12 Analysis of identified downstream targets of Ptf1a, Ngn2 
and Ptf1aW224A/W242A  
 The two-fold cutoff was chosen for the more detailed analysis of the 
downstream targets of Ptf1a, Ngn2 and Ptf1aW224A/W242A, to identify gene 
functions that are regulated by Ptf1a and Ptf1aW224A/W242A. The analysis 
revealed that a similar number of genes were induced by Ptf1a-GR (144 genes) 
and Ptf1aW224A/W242A-GR (155 genes) after 6 h of dexamethasone induction 
(Table 3.1), while for Ngn2-GR the number was much lower (88 genes) (Table 
3.1). A total of 48 genes were shared between Ptf1a-GR, Ngn2-GR and 
Ptf1aW224A/W242A-GR, which represents more than one third of the genes 
identified for Ptf1a-GR and Ptf1aW224A/W242A-GR (33% and 31%, respectively) 
and more than the half of the genes downstream of Ngn2-GR (55%) (Table 
3.1). 
The number of genes induced by Ptf1a-GR strongly increased over time, with 
1636 genes being identified after 25 h (Table 3.1). However, for 
Ptf1aW224A/W242A-GR, which induced at the early time point approximately the 
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same number of genes compared to the wild-type Ptf1a-GR, only 369 genes 
were activated after 25 h (Table 3.1). The number of genes for Ngn2-GR was 
also lower, with 762 genes being identified (Table 3.1). A total of 276 genes 
were shared between the three transcription factors, which comprised more 
than 70% of total genes induced by Ptf1aW224A/W242A-GR, but only 17% of the 
genes downstream of Ptf1a-GR (Table 3.1).  
 
 
Table 3.1 Comparison of the number of genes that were induced by Ptf1a-GR, 
Ngn2-GR and Ptf1aW224A/W242A-GR after 6 and 25 h.  
Represented is the number of shared and unique target genes of Ptf1a-GR, Ngn2-GR 
and Ptf1aW224A/W242A-GR (right side) and the percentage of these compared to the total 
number of genes (yellow) identified with a two-fold or more increase compared to 
uninjected control caps (CC) for each transcription factor. 
 To gain functional insight into the genes identified in the screen, gene 
ontology was performed using DAVID (Database for Annotation, Visualization 
and Integrated Discovery, http://david.abcc.ncifcrf.gov/). In a first step, the 
shared target genes between Ptf1a-GR, Ptf1aW224A/W242A-GR and Ngn2-GR 
were investigated. Most of the 48 downstream target genes shared after 6 h of 
protein induction were significantly involved in transcriptional regulation and 
regulation of RNA metabolic processes (Fig. 3.13 A). A more detailed analysis 
showed that 16 genes present in this group have been previously associated 
with general neurogenesis in X. laevis, including neuronal differentiation (Ebf2, 
MyT1), lateral inhibition (Dll1, Notch1) and cell cycle exit (Cdknx) (Dubois et al., 
1998; Coffman et al., 1990; Bellefroid et al., 1996; Chitnis et al., 1995; Vernon 
et al., 2003).  
 Gene ontology analysis of the 276 shared target genes after 25 h 
showed significant enrichment of multiple processes and several could be 
associated with general neuron development such as axogenesis, cell 
morphogenesis involved in neuron differentiation, cell motion and transmission 
of nerve impulse (Fig. 3.13 B). However, the majority of the common target 
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genes are involved in cell adhesion, neuron differentiation and neuron 
projection (Fig. 3.13 B). In summary, the group of shared target genes by Ptf1a-
GR, Ngn2-GR and Ptf1aW224A/W242A-GR is suggested to reflect the general ability 
of proneural bHLH transcription factors to drive neurogenesis.  
 
 
Figure 3.13 Overview of the biological processes enriched in the shared target 
genes by Ptf1a, Ptf1aW224A/W242A and Ngn2 after 6 h (A) and 25 h (B). 
The number of genes in each category is shown as well as the P value at false 
discovery rate.  
 To identify the downstream network specific for the two distinct Ptf1a 
transcription complexes, the sets of induced candidates by Ptf1a-GR and 
Ptf1aW224A/W242A-GR were compared. The analysis revealed that already 6 h 
after dexamethasone induction, Ptf1a-GR induced 54 target genes (38% of 
total) that were not activated by Ptf1aW224A/W242A-GR (Table 3.1), suggesting that 
some Su(H)-dependent target genes are activated early. In order to gain insight 
into the function of the early Su(H)-dependent target genes, gene ontology 
analysis was performed. This analysis associated the identified genes with 
tissue and embryonic morphogenesis as well as neural tube closure (Fig. 3.14 
A). However, the majority of the identified early Su(H)-dependent candidates 
are involved in transcription. Congruent to the Nanostring analyses (Fig. 3.2 and 
Fig. 3.8), none of the known genes involved in the later phase of GABAergic 
neuronal subtype specification such as Pax2, Lbx1 and Lhx1/5 were among the 
early Su(H)-dependent candidate genes. 
 The number of Su(H)-dependent target genes highly increased at the 25 
h time point, with Ptf1a-GR activating 1069 unique genes (65% of total) that 
were not activated by Ptf1aW224A/W242A-GR (Table 3.1). The list of the late Su(H)-
dependent Ptf1a target genes is associated with many different biological 
activities that are not only associated with the development of the nervous 
Results 68
system. The majority of the Su(H)-dependent Ptf1a target genes could be linked 
to transcriptional regulation, regulation of RNA metabolic processes and cell 
cycle regulation (Fig. 3.14 B). However, further processes were highly enriched 
in this data set such as chromosome organization, neuron differentiation, 
regulation of cell proliferation and DNA metabolic process (Fig. 3.14 B). In terms 
of molecular function, the Su(H)-dependent target genes had not only a function 
in DNA binding (161 genes, P value = 1.6E-11), but also in binding chromatin 
(27 genes, P value = 3.0E-8) and calcium ions (56 genes, P value = 7.1E-2). A 
more detailed analysis showed that consistent with the previous Nanostring 
data, the transcription factors involved in GABAergic interneuronal subtype 
specification Lbx1, Lhx1/5 and Pax2 as well as Gad1 were among the late 
Su(H)-dependent Ptf1a-GR target genes. 
 
 
Figure 3.14 Overview of the biological processes enriched in the Su(H)-
dependent  Ptf1a target genes after 6 h (A) and 25 h (B).  
The number of genes in each category is shown as well as the P value at false 
discovery rate.  
Interestingly, Ptf1aW224A/W242A-GR mRNA overexpression induced 69 
unique genes (45% of total) after 6 h and 31 (8% of total) after 25 h (Table 3.1). 
This suggests that especially early, Ptf1aW224A/W242A-GR does not simply mimic 
the activity of Ngn2 as would have been suggested by the Nanostring analysis 
using known genes involved in this process. However, gene ontology analysis 
revealed no significant enrichment of any biological processes. While most of 
the genes activated by Ptf1aW224A/W242A-GR and Ngn2-GR were also induced by 
Ptf1a-GR, in total 28 genes were not activated by wild-type Ptf1a-GR (Table 
3.1). Included in these target genes was Tlx3, which is a marker of 
glutamatergic excitatory neurons. 
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3.13 The majority of genes induced after 6 and 25 h by Ptf1a, 
Ngn2 and Ptf1aW224A/W242A are not shared  
 Comparison of the genes induced by Ngn2-GR, Ptf1a-GR and 
Ptf1aW224A/W242A-GR after 6 and 25 h, reveals that most transcripts are not 
shared between these two time points (Fig. 3.15). While many of the genes 
induced after 25 h are most likely indirect downstream targets of Ptf1a-GR, 
Ngn2-GR and Ptf1aW224A/W242A-GR, some of these genes are direct target genes 
representing the later neuronal subtype inducing-activity such as Kirrel2 for 
Ptf1a.  
 
Figure 3.15 Distinct transcripts are present after 6 and 25 h of Ptf1a-GR, Ngn2-GR 
and Ptf1aW224A/W242A-GR induction.  
Venn diagrams show unique and shared target genes at 6 and 25 h for Ptf1a-GR, 
Ngn2-GR and Ptf1aW224A/W242A-GR, respectively.  
3.14 Inhibition of protein synthesis allows earlier activation of 
Ngn2 expression 
 It is rather surprising that known murine direct Ptf1a Su(H)-dependent 
target genes such as Ngn2 and Kirrel2 are activated only after 25 h, but not 
after 6 h as it would be anticipated. In fact, as shown by Nanostring (Fig. 3.2 
and Fig. 3.8) and RNA-sequencing (Table 3.1) analyses, most of the Su(H)-
dependent genes are activated later than the Su(H)-independent genes. There 
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are many mechanisms that may explain this result. For example, the dimeric 
Ptf1a complex may activate expression of factors that repress expression of the 
Su(H)-dependent target genes. 
 To determine, if Ptf1a directly activates Ngn2, its induction by Ptf1a and 
Su(H) was analysed in the presence of the protein synthesis inhibitor 
cycloheximide (CHX). Ptf1a-GR or Su(H)-GR mRNA were injected alone or in 
combination into two-cell stage embryos, animal caps excised and treated for 1 
h with or without CHX to block translation (Fig. 3.16 A). Afterwards, the animal 
caps were cultivated for 8.5 h in the presence or absence of CHX and 
dexamethasone (Fig. 3.16 A). As a control, injected and control caps were 
treated only with CHX and did not express Ngn2. Consistent with previous 
results (Fig. 3.10), microinjection of Ptf1a-GR mRNA together with Su(H)-GR 
mRNA, but not of either one alone, led to a strong induction of Ngn2 (Fig. 3.16 
B). However, in the presence of CHX, Ptf1a-GR mRNA alone was sufficient to 
induce Ngn2 to a level similar to when Ptf1a-GR and Su(H)-GR mRNA were co-
injected in the absence of CHX (Fig. 3.16 B). The level of Ngn2 induction 
through co-expression of Ptf1a-GR and Su(H)-GR mRNAs was increased in the 
presence of CHX (Fig. 3.16 B). This finding is compatible with the idea that a 
mechanism, which is dependent on protein synthesis, prevents the early 

















Figure 3.16 Inhibition of protein synthesis allows earlier activation of Ngn2 
expression.  
Comparative analysis of the activity of Ptf1a-GR alone and together with Su(H)-GR in 
the presence of cycloheximide (CHX). (A) Ptf1a-GR and Su(H)-GR mRNA were 
injected alone or in combination into two-cell stage embryos. Animal caps were excised 
at the blastula stage and treated with our without CHX for 1 h to block protein 
synthesis. Afterwards, the animal caps were treated with or without dexamethasone 
(Dex)/CHX to induce protein activity. (B) Gene expression was analysed by semi-
quantitative RT-PCR. Expression levels were shown by H4 expression. CE, control 
embryos 
3.15 Identification of direct Ptf1a target genes 
 In the previous RNA-sequencing experiment (Fig. 3.12), Ptf1a-GR mRNA 
induced more than 100 genes (two-fold or more) after 6 h. Most likely not all of 
these early-induced genes are direct targets of Ptf1a. Moreover, it could be 
shown that Ptf1a Su(H)-dependent genes, such as Ngn2, are delayed in their 
activation, but either co-injection with Su(H) or treatment with CHX allows early 
activation (Fig. 3.16). On the basis of these findings, RNA-sequencing analysis 
was performed with the aim of identifying both, Su(H)-dependent and -
independent Ptf1a direct target genes. 
Ptf1a-GR and Su(H)-GR mRNA alone or in combination were microinjected into 
both blastomeres of two-cell stage embryos and animal caps were isolated from 
control and injected embryos (Fig. 3.18 A). After one hour of treatment with 
CHX, the animal caps were cultivated for additional 8.5 h in dexamethasone 
and CHX (Fig. 3.18 A). After total RNA isolation, the samples were subjected to 
RNA-sequencing and sequences mapped as described previously (section 




Figure 3.17 Scheme of the alignment process of the sequencing reads to identify 
new direct downstream targets of Ptf1a.  
To align the sequencing reads, the transcript reads were first mapped to the X. 
tropicalis (Xt) transcriptome, which resulted in 56.2% mapped sequencing reads. 
Furthermore, the transcript reads were aligned to the X. laevis (Xl) unigene database 
allowing further mapping of 16.3% of the sequencing reads. Through this procedure, in 
total 67.3% of the sequencing reads could be mapped. The dashed arrows indicate 
that the percentages are not additive as sequences map to both transcriptome libraries.    
 In animal caps injected with Ptf1a-GR mRNA alone or together with 
Su(H)-GR mRNA, 258 and 638 genes, respectively, were activated more than 
two-fold compared to uninjected control caps (Fig. 3.18 B). In contrast, only two 
genes were induced in animal caps by Su(H)-GR alone. Different thresholds 
were applied to investigate the strength of gene induction. By applying a 
minimum fold change of 10, Su(H)-GR alone did not induce any genes, while 
Ptf1a-GR and Ptf1a-GR together with Su(H)-GR activated 87 and 222 genes, 
respectively (Fig. 3.18 B). Increasing the cutoff to a 50 fold-activation, stronlgy 
decreased the number of candidate genes for Ptf1a-GR alone but not for Ptf1a-





Figure 3.18 Identification of direct target genes induced by Ptf1a-GR and Su(H)-
GR alone and in combination by whole transcriptome RNA-sequencing.  
(A) The indicated mRNAs were injected alone or together into both blastomeres of two-
cell stage embryos, animal caps excised at blastula stage and treated with CHX for  
1 h to block protein synthesis. Afterwards, the animal caps were treated with 
dexamethasone/CHX for 8.5 h to induce protein activity. Total RNA was isolated and 
subjected to RNA-sequencing. (B) Summary of identified direct target genes of Ptf1a 
and Su(H) alone and in combination after application of different fold-change 
categories. Given is the number of target genes with a two-, 10-, 50-, 100 or 1000-fold 
change compared to uninjected control caps (CC).  
3.16 Identification of direct target genes induced in the previous 
temporal expression analysis by RNA-sequencing 
 First, it was determined, which of the Ptf1a candidate genes induced in 
the earlier RNA-sequencing experiment analysing the temporal expression of 
Ptf1a target genes (Fig. 3.12), are indeed direct Ptf1a target genes. From the 
144 candidate genes that were activated after 6 h, 86 genes (60%) were also 
induced by Ptf1a-GR in the presence of CHX (Table 3.2). In contrast, from the 
1636 target genes that were induced after 25 h, only 63 genes (4%) were 
induced by Ptf1a-GR in the presence of CHX (Table 3.2). When Ptf1a-GR and 
Su(H)-GR mRNA were co-injected, the number of candidate genes increased 
compared to Ptf1a-GR mRNA alone. From the 144 candidate genes induced 
after 6 h, 106 genes (74%) were identified as direct targets (Table 3.2), while 
from the 1636 genes activated at the late time point, 171 genes (10%) were 
identified (Table 3.2).   
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Table 3.2 Identification of direct Ptf1a targets activated after 6 and 25 h.  
Comparison of the identified genes of the two-independent transcriptome RNA-
sequencing approaches to identify bona fide Ptf1a downstream targets during X. laevis 
neurogenesis. Represented is the number of genes that are activated by Ptf1a-GR 
after 6 and 25 h and by Ptf1a-GR and Ptf1a-GR together with Su(H) in the presence of 
CHX as well as the percentage of these compared to the total number of genes 
(yellow) identified with a two-fold or more increase compared to uninjected control caps 
(CC) for each condition alone. 
 To identify the biological processes enriched in the direct target genes of 
Ptf1a-GR during the time course, gene ontology analysis was performed using 
DAVID for genes activated by Ptf1a-GR in combination with Su(H)-GR. At the 6 
h time point, most of the 106 candidates were linked to transcriptional regulation 
and regulation of RNA metabolic processes (Fig. 3.19 A). Further biological 
processes significantly enriched in this data set were e.g. cell fate commitment, 
neuron differentiation and Notch-signalling (Fig. 3.19 A). Similar, most of the 
171 direct target genes at 25 h are involved in transcriptional regulation and 
regulation of RNA metabolic processes (Fig. 3.19 B).  However, other 
processes were also present, including cell motion, cell projection organization, 
neuronal differentiation, cell adhesion and hindbrain development (Fig. 3.19 B). 
Interestingly, eye development as well as endocrine system development were 
also enriched (Fig. 3.19 B), reflecting two known developmental functions of 
Ptf1a during development. Interestingly, none of the transcription factors known 
to be involved in GABAergic interneuronal subtype determination such as Pax2 
(Cheng et al., 2004), Lhx1/5 (Pillai et al., 2007) and Lbx1 (Cheng et al., 2005) 
were among the Ptf1a direct target genes, suggesting that their activation by 







Figure 3.19 Enrichment of biological processes in Ptf1a/Su(H) direct target 
genes, which were also present in the time course analysis analysed by RNA-
sequencing after 6 h (A) and 25 h (B).  
The number of genes in each category is shown as well as the P value at false 
discovery rate.  
3.17 Analysis of direct targets of Ptf1a and Ptf1a/Su(H) 
 The comparison of the two-independent RNA-sequencing experiments 
revealed that only a small number of the direct target genes were also present 
in the previous temporal expression analysis (Table 3.2). To analyse the total 
number of identified direct target genes, a minimal induction of two-fold was 
applied. Interestingly, Ptf1a-GR alone induced 64 genes (25% of total) that were 
not activated by Ptf1a-GR in combination with Su(H)-GR (Table 3.3). Gene 
ontology analysis revealed that translation (12 genes, P value = 3.1E-15) was 
the only biological process significantly enriched in this set of Ptf1a-GR unique 
target genes. In contrast, Ptf1a-GR together with Su(H)-GR induced 443 unique 
target genes (70% of total) (Table 3.3). The biological processes enriched in 
this data set were similar to the analysis of Ptf1a-GR/Su(H)-GR targets that 
were also present in the temporal expression analysis after 6 and 25 h (Fig. 
3.19 B). One difference was that in the set of the total identified target genes, 
eye development was not significantly enriched anymore.  
 A more detailed analysis of the identified target genes revealed that also 
pancreas specific genes were induced in the presence of CHX, however, only 
when Ptf1a-GR was overexpressed in combination with Su(H)-GR. Among 
these were Pdia2 and the digestive enzymes Cpa1 and Prss1. This is 
consistent with the finding that Ptf1a directly activates acinar digestive enzymes 




Table 3.3 Whole transcriptome RNA-sequencing to identify direct target genes of 
Ptf1a-GR and Ptf1a-GR together with Su(H)-GR.  
Summary of identified direct target genes of Ptf1a, Su(H) and both together 
represented in a table. Given is the number of shared and unique target genes of 
Ptf1a-GR and Su(H)-GR alone as well as in combination (right side) and the 
percentage of these compared to the total number of genes (yellow) identified with a 
two-fold or more increase compared to uninjected control caps (CC) for each 
transcription factor. 
3.18 Identification and validation of direct trimeric-dependent 
Ptf1a target genes  
 Comparison of the two independent RNA-sequencing approaches allows 
identification of Su(H)-dependent direct Ptf1a target genes. Genes that are 
induced by Ptf1a-GR, but not by Ptf1aW224A/W242A-GR and that are induced by 
Ptf1a-GR or Ptf1a-GR/Su(H)-GR in the presence of CHX are expected to be 
trimeric-dependent Ptf1a direct target genes. Using this comparative approach, 
111 putative direct trimeric-dependent transcripts were identified. Of these, 13 
genes (12%) were induced after 6 h, and 34 genes (31%) were induced without 
elevated Su(H)-GR expression levels. To verify selective candidate genes, eight 
(Table 3.4) of the 111 identified genes as well as the known direct target gene 
Kirrel2 (Nishida et al., 2010) were analysed using the Nanostring nCounter RNA 








Table 3.4. Summary of the fold-activation compared to control caps of the 




 In a first approach, these genes were analysed for their temporal 
activation and their dependence on Su(H) interaction for gene induction in the 
animal cap assay (Fig. 3.20 and Appendix 6.1.3). Consistent with the results of 
the RNA-sequencing experiment, Prdm13 (Fig. 3.20 B) and Esr10 (Fig. 3.20 C) 
expression were activated by Ptf1a-GR after 6 h of dexamethasone induction, 
while the expression of the known direct target gene Kirrel2 (Fig. 3.20 D) as well 
as of Mecom (Fig. 3.20 E), Hmx3 (Fig. 3.20 F), FoxD3 (Fig. 3.20 G), Sox9 (Fig. 
3.20 I) and Barhl2 (Fig. 3.20 H) were only activated after 25 h. Microinjection of 
Ptf1aW224A/W242A-GR mRNA compared to Ptf1a-GR wild-type did not 
considerably induce the expression of Kirrel2 (Fig. 3.20 D), Prdm13 (Fig. 3.20 
B), Hmx3 (Fig. 3.20 F), Mecom (Fig. 3.20 E), Barhl2 (Fig. 3.20 H) and FoxD3 
(Fig. 3.20 G), demonstrating that their induction is strongly dependent on the 
interaction of Ptf1a with Su(H). Furthermore, Ptf1aW224A/W242A-GR was not able 
to induce the early expression of Esr10 (Fig. 3.20 C), while the late expression 
of this gene was not affected. Moreover, Ptf1aW224A/W242A-GR mRNA 
overexpression was sufficient to induce the expression of Sox9 (Fig. 3.20 I), 
albeit compared to Ptf1a-GR the induction was reduced about the half. In 
summary, the interaction with Su(H) is required for strong induction of the novel 




Figure 3.20  Verification of selected direct Ptf1a Su(H)-dependent target genes.  
Comparative temporal analysis of wild-type Ptf1a and a mutant Ptf1a (Ptf1aW224A/W242A), 
containing two point mutations that disrupt the association with Su(H), to analyse, if the 
new identified Ptf1a target genes are dependent on Su(H) interaction. (A) The 
indicated mRNAs (20 pg each) were injected into both blastomeres of two-cell stage 
embryos, animal caps excised at the blastula stage and treated with dexamethasone 
(Dex) for 6 and 32 h. Total RNA was isolated and marker gene expression analysed by 
Nanostring. (B-I) Shown is the averaged fold change over uninjected control caps (CC) 
of two independent experiments. Error bars represent the standard error of the mean 
(+/-SEM). Note the different scales in each diagram. Shown are graphs of selected 
genes, for a full list see Appendix 6.1.3. 
 To further verify that these genes are trimeric Ptf1a target genes, their 
gene induction in the presence of elevated Su(H) expression levels were 
investigated in animal cap assays (Fig. 3.21 and Appendix 6.1.4). 
Corresponding with the RNA-sequencing analysis, overexpression of Su(H)-GR 
mRNA alone did not significantly increase the expression of any of the 
evaluated target genes. Ptf1a-GR activated after 3 and 6 h the expression of 
Prdm13 (Fig. 3.21 B), consistent with the previous Nanostring analysis. Also 
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congruent to the previous experiment, Ptf1a-GR activated Esr10 expression at 
the early time points (28-, 27-fold) (Fig. 3.21 C), however, the induction of Esr10 
after 25 h (Fig. 3.21 C) was so strong that the early induction is not apparent on 
the graph. The expression of Kirrel2 (Fig. 3.21 D), Mecom (Fig. 3.21 J), Hmx3 
(Fig. 3.21 E), FoxD3 (Fig. 3.21 F), Sox9 (Fig. 3.21 G) and Barhl2 (Fig. 3.21 H) 
was only activated by Ptf1a-GR after 25 h of dexamethasone induction, 
consistent with the previous analysis. Furthermore, Lhx2 (Fig. 3.21 I), a gene 
that was identified as a direct target of Ptf1a-GR and Ptf1a-GR/Su(H)-GR, but 
was surprisingly not present in the temporal gene expression analysis, was also 
only activated at the 25 h time point. Similar to what was observed for Ngn2 
(Fig. 3.10 L), co-expression of Su(H)-GR with Ptf1a-GR mRNA led to an 
increase in gene induction of Prdm13 (Fig. 3.21 B), Esr10 (Fig. 3.21 C), Kirrel2 
(Fig. 3.21 D), FoxD3 (Fig. 3.21 F) and Sox9 (Fig. 3.21 G) as well as of Barhl2 
(Fig. 3.21 H), Lhx2 (Fig. 3.21 I) and Mecom (Fig. 3.21 J). The effect on the latter 
group of genes was particularly strong. In contrast, the expression of Hmx3 
(Fig. 3.21 E) was highly reduced, if not even abolished by co-expression of 
Ptf1a-GR and Su(H)-GR mRNA. Thus, similar to the previous analysis of Su(H)-
dependent target gene activation (Fig. 3.10), also the novel identified Ptf1a 
direct target genes respond differently to the co-expression of Su(H)-GR. 
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Figure 3.21  Co-expression of Ptf1a and Su(H) influences expression of new 
identified Su(H)-dependent direct Ptf1a target genes.  
Comparative analysis of the activity of Ptf1a-GR alone and together with Su(H)-GR. (A) 
Ptf1a-GR (20 pg) and Su(H)-GR (40 pg) were injected into both blastomeres of two-cell 
stage embryos, animal caps excised at the blastula stage and treated with 
dexamethasone (Dex). Animal caps were cultured for 3, 6, 9 or 25 h, which 
corresponds to stage 9, 10, 10.5 and 23 of sibling embryos. RNA was isolated and 
gene expression analysed by Nanostring. (B-J) Shown is the averaged fold change 
over uninjected control caps (CC) of two independent experiments. Error bars 
represent the standard error of the mean (+/-SEM). Note the different scales in each 
diagram. Shown are graphs of selected genes, for a full list see Appendix 6.1.4. 
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4. Discussion 
4.1 The proneural function of Ptf1a does not require interaction 
with Su(H) 
 The bHLH transcription factor Ptf1a was shown to act as a selector gene 
for GABAergic inhibitory neurons at the expense of glutamatergic excitatory 
neurons in the retina, the dorsal horn of the spinal cord and in the cerebellum 
(Glasgow et al., 2005; Hori et al., 2008; Hoshino et al., 2005; Fujitani et al., 
2006; Nakhai et al., 2007; Pascual et al., 2007; Dullin et al., 2007; Lelievre et 
al., 2011). Consistent with this, Ptf1a overexpression in X. laevis embryos and 
animal caps promoted not only Gad1 expression, but also induced the 
expression of Pax2, Lbx1 and Lhx1/5 at the expense of markers indicative of a 
glutamatergic excitatory neuronal identity (Fig. 3.1, Fig. 3.2 and Fig. 4.1). 
Furthermore, the use of a transcriptional activator Ptf1a (Ptf1a-VP16) provides 
evidence that the repression of the molecular markers indicative of 
glutamatergic neurons is indirect, probably due to the activation of a specific 
transcriptional repressor protein (Fig. 3.1). 
 Ptf1a was identified as a component of a heterotrimeric transcription 
factor complex, consisting of a commonly expressed class A bHLH transcription 
factor and Rbp-j/-l (Su(H)) (Beres et al., 2006). Detailed Nanostring analyses 
with a chimeric form of Ptf1a, which contained the bHLH domain of Ngn2, 
showed that the bHLH domain of Ptf1a is not essential for the determination of 
a GABAergic neuronal identity, even though the induction of genes involved in 
this process is reduced compared to wild-type Ptf1a (Fig. 3.7 and Fig. 4.1). 
Furthermore, the chimeric Ptf1a was still able to induce general neurogenesis 
and also marker genes indicative of glutamatergic excitatory neurons (Fig. 3.7 
and Fig. 4.1). This suggests that the neuronal subtype inducing activity of Ngn2 
is conferred through its bHLH domain and is consistent with experiments in X. 
laevis and Drosophila that implicated a role of the bHLH domain in target gene 
specificity (Talikka et al., 2002; Chien et al., 1996).   
 In X. laevis animal cap assays, a mutant version of Ptf1a 
(Ptf1aW224A/W242A) that does not bind Su(H), is unable to promote the formation 
of GABAergic inhibitory neurons (Fig. 3.8 and Fig. 4.1); which is consistent with 
studies performed in the mouse and chick neural tube (Hori et al., 2008). 
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Surprisingly, it was found that the general neurogenesis-inducing activity of 
Ptf1aW224A/W242A was not impaired (Fig. 3.8), suggesting that the interaction with 
Su(H) is not required for the proneural function of Ptf1a. While Ptf1a was always 
considered to function in the context of a trimeric transcription factor complex, 
these findings suggest that Ptf1a forms a heterodimer with a general bHLH 
protein and only context-specifically additionally interacts with Su(H) as a co-
factor. Through the formation of different transcription complexes, Ptf1a is able 
to promote distinct activities during the development of the nervous system: one 
complex drives general neurogenesis and another promotes neuronal subtype 
specification. This would be in line with the activity of other vertebrate proneural 
bHLH transcription factors that also play a role in neuronal subtype specification 
(Lee and Pfaff, 2003; Lo et al., 1998; Hatakeyama et al., 2001; Saba et al., 
2005; Powell and Jarman, 2008; Guillemot, 2007; Brunet and Ghysen, 1999; 
Bertrand et al., 2002).  
 Through RNA-sequencing analysis, downstream target genes induced 
after 6 and 25 h by wild-type Ptf1a and Ptf1aW224A/W242A were identified. In line 
with the finding that Ptf1a forms two distinct transcription complexes during 
general neurogenesis and neuronal subtype specification, both shared and 
distinct genes were induced by the wild-type and mutant Ptf1a. As the proneural 
activity of Ptf1a was Su(H)-independent, it was anticipated that the genes 
shared by both would be involved in general neurogenesis. In contrast, those 
that were induced by the wild-type Ptf1a but not by the mutant would be 
expected to be involved in neuronal subtype specification. This, indeed, was 
what was observed in the RNA-sequencing analysis. Genes such as Pax2, 
Lbx1 and Lhx1/Lhx5, indicative of GABAergic interneuronal subtype identity 
(Helms and Johnson, 2003), were only induced by wild-type Ptf1a after 25 h. 
Additionally, the Ptf1a-trimeric complex also induced after 25 h the direct target 
genes Kirrel2 (Nishida et al., 2010) and Ngn2 (Henke et al., 2009b) as well as 
FoxD3 and Olig3, two genes with which Ptf1a promotes the formation of the 
glutamatergic climbing fiber neurons (Yamada et al., 2007; Storm et al. 2009). 
Moreover, among the genes shared between Ptf1a and the mutant Ptf1a were 
known genes involved in general neurogenesis. Correspondingly, the majority 
of the gene targets shared by the wild-type and mutant Ptf1a were also induced 
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by Ngn2. This further supports the notion that this group of genes represents 
the proneural function of these three bHLH transcription factors.  
 A defect in general neurogenesis in mice lacking Ptf1a in the CNS has 
not been reported. Furthermore, lineage tracing experiments in a viable Ptf1a 
mutant mice, in which Ptf1a expression is only absent in the cerebellum but not 
in the pancreas, indicated that the cerebellar ventricular zone can produce 
neurons even in the absence of Ptf1a expression (Hoshino et al., 2005). 
However, redundancy between Ptf1a and other proneural bHLH transcription 
factors as it has been shown for Ngn2 and Ascl1 (Mash1) (Fode et al., 2000) 
was not excluded (Hoshino, 2006). In order to investigate a putative redundancy 
between Ptf1a and other bHLH transcription factors, it should be analysed, if 
other proneural transcription factors are upregulated in the cerebellum and 
dorsal horn of the spinal cord in Ptf1a knockout and mutant mice. While no 
other member of the Neurogenin neuronal determination gene family is 
expressed in the inner ventricular zone of the hindbrain that will give rise to 
GABAergic inhibitory neurons (Fig. 3.5), the proneural bHLH transcription factor 
Ascl1 is expressed in the mouse cerebellar ventricular zone similar to Ptf1a 
(Zordan et al., 2008) and might therefore compensate for the loss of Ptf1a 
proneural function. The strong proneural activity that Ptf1a exhibits in X. laevis 
embryos and explants, coupled with its expression in the progenitor cells 
suggests that Ptf1a may promote general neurogenesis also in other 
vertebrates.  
4.2 Ptf1aW224A/W242A is a functional transcription factor  
In animal cap assays evaluated by Nanostring analysis, Ptf1aW224A/W242A 
was not only able to drive general neurogenesis, but also to induce genes 
indicative of glutamatergic excitatory neurons (Fig. 3.8 and Fig. 4.1). That Ptf1a 
bearing these mutations still promoted general neurogenesis and activated 
markers indicative of an alternative neuronal subtype was also reflected by 
RNA-sequencing. A small number of genes, including Hox11L2/Tlx3, which is 
indicative of glutamatergic excitatory neurons, was both induced by 
Ptf1aW224A/W242A and Ngn2. Thus, glutamatergic excitatory neuronal subtype 
specification might be the 'default' activity of the heterodimeric Ptf1a, similar to 
Ngn2. A dramatic increase in glutamatergic excitatory neurons in the mouse 
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neural tube is observed upon depletion of Rbp-j (Su(H)) in the presence of 
Ptf1a, demonstrating that Rbp-j, similar to Ptf1a, is required to promote 
GABAergic neurons at the expense of glutamatergic neurons (Hori et al., 2008). 
The requirement of the Ptf1a-SuH trimeric complex for GABAergic neuronal 
specification was further demonstrated using a single mutation to disrupt the 
binding of Ptf1a with Su(H) (Ptf1aW298A). Correspondingly, in homozygous 
Ptf1aW298A mice, GABAergic inhibitory interneurons were lost, while the number 
of glutamatergic excitatory neurons was increased (Hori et al., 2008). As this 
phenotype is similar to that of Ptf1a knockout mice (Glasgow et al., 2005), it 
was concluded that the Ptf1aW298A does not compensate for wild-type Ptf1a 
activity and is non-functional. However, it might be that the increase in 
glutamatergic neurons in Ptf1aW298A mice was not only due to the loss of wild-
type Ptf1a activity, but also that Ptf1aW298A actively contributed to promote this 
neuronal subtype. To investigate this possibility, lineage tracing experiments in 
the Rbp-j deficient and Ptf1aW298A mouse must be conducted to analyse the 
origin of these glutamatergic excitatory neurons. Moreover, RNA-sequencing 
identified genes induced by Ptf1aW224A/W242A after 6 and 25 h that were neither 
activated by Ptf1a nor by Ngn2, indicating that Ptf1aW224A/W242A activates a 
unique set of target genes. This group of genes might reflect an additional 
unknown function of the Ptf1a mutant, however, gene ontology analysis 
revealed no specific biological processes enriched in these candidates. Taken 
together, the experiments performed in X. laevis suggest that in absence of 
Su(H) binding, Ptf1a is still a functional proneural bHLH transcription factor, 
which specifies glutamatergic excitatory neurons in the nervous system.  
 
Figure 4.1 Distinct activities of Ptf1a, its mutated and chimeric version as well as 
of Ngn2 in regard to neuronal subtype specification. Shown are the different Ptf1a 
constructs as well as Ngn2 and their specificity in neuronal subtype specification. A 
green arrow represents specification of a neuronal subtype, while a yellow arrow 
represents no effect on the cell type. In contrast, a red arrow indicates inhibition of a 
specific neuronal subtype.   
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4.3 Regulation of gene induction of Su(H)-dependent and 
independent Ptf1a target genes 
 The context-specific cooperation with co-factors represents a common 
mechanism for how bHLH transcription factors are able to exert distinct 
activities (Bertrand et al., 2002; Powell and Jarman, 2008). However, the 
regulatory mechanism behind distinct transcriptional complex formation and 
activity often remains elusive.  
The heterodimer of Ptf1a is sufficient to activate neurogenesis, while the 
heterotrimeric complex is essential for GABAergic inhibitory neuron formation. 
In contrast to the expectations based on the Nanostring experiments using a 
limited number of known genes, the RNA-sequencing analysis revealed that 
Ptf1a also induces Su(H)-dependent target genes after 6 h of protein induction. 
However, the number of Su(H)-dependent target genes is highly increased after 
25 h. Furthermore, analysis of genes induced by Ptf1a in the presence of CHX 
through RNA-sequencing showed that, indeed, genes activated by Ptf1a after 
25 h are direct target genes of Ptf1a. Consistent with observation in the mouse, 
the proneural bHLH transcription factor Ngn2 was shown to be a direct target of 
the heterotrimeric Ptf1a transcription complex. Ngn2 and Ptf1a are co-
expressed in the region of the cerebellum that gives rise to the GABAergic 
inhibitory neurons (Fig. 3.5). In gain of function assays in X. laevis animal caps, 
the GABAergic neuronal subtype-inducing activity of Ptf1a was found to be 
dominant over the glutamatergic-inducing activity of Ngn2 (Fig. 3.6). This 
suggests that Ngn2 may act downstream of Ptf1a to participate in GABAergic 
interneuron formation. This hypothesis is supported by a slight increase in the 
number of GABAergic dI4 neurons in the chick neural tube after Ngn2 
electroporation, as well as by the absence of this neuronal cell type in 
Ascl1:Ngn2 double knockout mice, but not in the single Ascl1 knockout mice 
(Helms et al., 2005).  
 The delayed activation of direct target genes raises the question, what 
regulates the timing of activation of Ptf1a direct target genes. In a first attempt 
to answer this question, it could be shown that neither the expression of Su(H) 
transcripts alters throughout development, nor that the interaction of Ptf1a and 
Su(H) is prevented in vivo (Fig. 3.9). As Su(H) protein levels may be limiting due 
to post-transcriptional mechanisms, expression levels of Su(H) in the embryo 
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were increased by microinjection of Su(H) mRNA together with Ptf1a mRNA 
(Fig. 3.10 and Fig. 3.21). The assays were analysed by the Nanostring 
nCounter system and revealed that while co-expression of Ptf1a mRNA and 
Su(H) mRNA did not result in an earlier onset of gene expression of the Su(H)-
dependent target genes (Fig. 3.10 and Fig. 3.21), it did influence quantitatively 
the level of gene induction. This is important as it demonstrates that the injected 
Su(H) protein was functional and suggests that Su(H) protein availability is not 
the reason why direct target genes of the trimeric complex are delayed in their 
activation. As elevated Su(H) expression levels either increased or decreased 
the gene induction of Ptf1a Su(H)-dependent target genes (Fig. 3.10 and Fig. 
3.21), they may have different threshold or kinetic responses to the 
heterotrimeric complex. Similarly, Ptf1a target genes in the context of pancreas 
development respond differently to Ptf1a expression (Fukuda et al., 2008; Dong 
et al., 2008). Low levels of Ptf1a promote endocrine, while high Ptf1a levels are 
required for exocrine cell differentiation. Therefore, such a dosage-dependent 
mechanism might generally apply for the regulation of Ptf1a target gene 
induction.  
 The early function of Ptf1a during neuronal differentiation and the 
late function during neuronal subtype specification are reminiscent of Ptf1a 
activity during pancreas development. Ptf1a first promotes the commitment of 
endodermal cells into pancreatic precursors of both, endocrine and exocrine cell 
lineages (Burlison et al., 2008; Kawaguchi et al., 2002) and later, Ptf1a is 
required for acinar exocrine cell differentiation (Zecchin et al., 2004; Lin et al., 
2004; Kawaguchi et al., 2002). Notch-signalling also plays a key role during 
pancreas development. It is highly active in exocrine pancreatic precursor cells 
where it prevents their terminal differentiation (Hald et al., 2003; Murtaugh et al., 
2003; Esni et al., 2004). In this regard, it could be shown that the Notch-
pathway and its effectors of the Hes family inhibit Ptf1a activity (Esni et al., 
2004; Ghosh and Leach, 2006). In the nervous system, Notch-signalling in the 
neural progenitor cells is high and also maintains an undifferentiated cell state. 
Repression of bHLH transcription factors by the Notch-signalling effectors is a 
common regulatory mechanism in general neurogenesis (Takke et al., 1999; 
Schneider et al., 2001) and thus it is possible that also Ptf1a function in the 
nervous system is regulated by this mechanism. Furthermore, binding of Su(H) 
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by Notch-ICD and Ptf1a was shown to be mutually exclusive (Beres et al., 
2006) and therefore, a competition between Ptf1a and Notch-ICD for Su(H)-
binding may also be involved in the regulation of the expression of the distinct 
Ptf1a target genes (Henke et al., 2009b). When the Notch-signalling activity 
declines, Su(H) might be released from Notch-ICD to form the heterotrimeric 
complex with Ptf1a. To analyse if a competition between Ptf1a and Notch-ICD 
controls complex formation and thus target genes, a dominant-negative Dll1 
(Deltastu) was used to block Notch-signalling (data not shown), however, this did 
not lead to an alteration in the onset of gene expression of Su(H)-dependent 
Ptf1a target genes. However, more detailed experiments have to be conducted 
to analyse this possibility.  
 In the presence of cycloheximide (CHX), which blocks protein synthesis, 
activation of the Su(H)-dependent target gene Ngn2 was observed within 8.5 h, 
but not in the absence of CHX (Fig. 3.16). This suggests that there is a 
mechanism which prevents early activation of Su(H)-dependent target genes 
that requires protein synthesis.  
 The formation of the two distinct Ptf1a transcription complexes might be 
regulated by posttranslational modification as has been shown for other bHLH 
proteins. For example, the distinct activities of the bHLH transcription factor 
Ngn2 were shown to be regulated through posttranslational phosphorylation 
(Hindley et al., 2012; Ma et al., 2008). In this context, it was also shown that the 
transcriptional activity of Ptf1a and its cooperation with Rbp-l is dependent on 
histone acetylation mediated by the acetyltransferase cofactor p/CAF 
(Rodolosse et al., 2009).  
4.4 Identification of the genetic program regulated by Ptf1a 
during X. laevis neurogenesis 
 In contrast to the exocrine pancreas, the genetic regulatory network 
downstream of Ptf1a in the context of the nervous system is poorly understood. 
In the murine nervous system, only four direct target genes of Ptf1a have been 
identified so far, including Ptf1a itself, which undergoes positive autoregulation 
(Meredith et al., 2009), Ngn2 (Henke et al., 2009b), Kirrel2 and Nephrin 
(Nishida et al., 2010). Therefore, with the aim of identifying Ptf1a direct targets, 
genes induced in X. laevis animal caps by Ptf1a in the presence of CHX were 
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analysed by RNA-sequencing. The number of genes induced compared to 
uninjected control caps strongly increased when Ptf1a was co-expressed with 
Su(H). The identified direct target genes were compared to genes induced by 
Ptf1a after 6 or 25 h in the absence of CHX. Among the identified direct target 
genes (based on their presence in the CHX RNA-seq experiment) activated by 
Ptf1a after 25 h were Kirrel2 (Nishida et al., 2010) and Ngn2 (Henke et al., 
2009b). However, none of the known transcription factors involved in 
GABAergic interneuron formation were identified, suggesting that their 
activation by Ptf1a is indirect. Gene ontology analysis of the direct target genes 
induced by Ptf1a in combination with Su(H) revealed that Ptf1a directly induces 
many transcription factors. Several of them are involved in general 
neurogenesis, including lateral inhibition and cell-cycle regulation, 
demonstrating that Ptf1a directly controls early steps of neurogenesis. 
Additionally, the Ptf1a target genes were compared to a previous Affymetrix 
microarray analysis screen, which identified 57 direct target genes of X. laevis 
Ngn2-GR in animal caps (Seo et al., 2007). Among the 258 direct genes of 
Ptf1a-GR alone, 19 genes were also shown by Seo et al. to be direct Ngn2 
targets, while for Ptf1a-GR together with Su(H)-GR 24 out of the 638 direct 
genes were similarly identified (Appendix 6.4). The shared direct targets of 
Ptf1a-GR and Ngn2-GR included genes involved in neuronal differentiation 
(MyT1, NeuroD4) and cell migration (Snail1, Twist1). 
 Gene ontology analysis of the late target genes demonstrated that Ptf1a 
directly regulates a wide range of biological processes, including cell adhesion, 
cell motion and cell projection organisation. A similar wide program of biological 
processes was identified for the mammalian Ascl1 (Castro et al., 2011) and 
Atoh1 (Klisch et al., 2011), two proneural transcription factors with a distinct 
neuronal subtype specification in the vertebrate CNS.  
 
 Pancreas specific genes were also present in the group of genes induced 
by Ptf1a in the presence of CHX. Therefore, the direct target genes induced 
two-fold or more by Ptf1a-GR and Ptf1a/Su(H)-GR in the RNA-sequencing 
analysis were compared to published studies identifying Ptf1a targets by ChIP-
sequencing. In the pancreatic cell line 266-6, which has an expression profile 
similar to pancreatic progenitor cells, Ptf1a was found to bind regulatory 
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elements near 936 genes (Thompson et al., 2012) and near 4632 genes in the 
adult mouse pancreas (Masui et al., 2010). Of these, in our set of direct target 
genes 38 genes were identified as Ptf1a-GR/Su(H)-GR and 15 genes as Ptf1a-
GR direct targets (Appendix 6.4) (Thompson et al., 2012). In contrast, of the 
putative direct targets in the adult mouse pancreas, only seven were identified 
as Ptf1a-GR/Su(H)-GR and three as Ptf1a-GR direct target genes (Masui et al., 
2010) (Appendix 6.4). In general, the number of overlapping genes was quite 
low. However, 19 direct candidates (Appendix 6.4) induced by Ptf1a-GR/Su(H)-
GR were also found to be induced in endodermal explants of stage 32 and 36 
X. laevis embryos (Bilogan and Horb, 2012), suggesting that genes functioning 
downstream of Ptf1a during pancreatic development are present in our list of 
candidate genes.   
4.5 Identification of novel Su(H)-dependent Ptf1a direct target 
genes 
 To understand how Ptf1a induces neuronal subtype specification via the 
trimeric complex, genes were identified, which are present in both RNA-
sequencing approaches, but are not activated by Ptf1aW224A/W242A. This 
comparison identified 111 Su(H)-dependent Ptf1a target genes, among them 
Ngn2 and Kirrel2. In a first step to verify selective candidates, eight of the new 
Su(H)-dependent direct target genes were analysed with the Nanostring 
nCounter RNA profiling system (Fig. 3.20 and Fig. 3.21, Appendix 6.1.3 and 
6.1.4). The selected candidates represent different types of transcription factors 
and none of them, with the exception of barhl2, which is expressed in amacrine 
cells in the retina (Ding et al., 2009), were specifically described before as 
genes associated with GABAergic inhibitory neuronal subtype determination. 
Nanostring analyses demonstrated that all of the genes analysed were 
dependent on the interaction of Ptf1a and Su(H) as the induction by 
Ptf1aW224A/W242A was reduced at least to half or completely eliminated compared 
to wild-type Ptf1a. Similar to the known downstream targets of Ptf1a, the 
majority of the novel Su(H)-dependent genes were strongly increased when 
Ptf1a was co-expressed with Su(H). However, one gene was downregulated 
upon co-injection of Su(H). This differential gene induction by Ptf1a alone and in 
combination with Su(H) is similar to what we already observed for other Ptf1a 
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downstream targets such as Gad1 and Ngn2 (Fig. 3.10). This further supports 
the hypothesis that different Su(H)-dependent targets may have a different 
threshold response for the heterotrimeric Ptf1a complex, which regulates this 
activation. Analysis of additional Su(H)-dependent target genes will allow a 
classification of Ptf1a target genes into distinct groups and therefore may give 





In summary, this study demonstrates that Ptf1a can function as proneural 
bHLH transcription factor in X. laevis and that for this activity, Ptf1a does not 
require the interaction with Su(H). Furthermore, through two independent RNA-
sequencing approaches, the genetic network directly downstream of Ptf1a in 
the context of general neurogenesis as well as neuronal subtype specification 
could be defined. Analysis of the direct target genes will give new insight into 
the mechanism how Ptf1a activates general neurogenesis and neuronal 
subtype specification and may elucidate new mechanisms by which proneural 
transcription factors are able to confer distinct activities during the development 
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6.1 Summary of processed Nanostring data. Given is the averaged 
fold change over CC of two independent experiments for each sample and 
gene, respectively. In a second table, the calculated standard error of the 
mean (SEM) is given for each sample and gene, respectively. Data were 
processed as described in Methods and Materials. 
6.1.1 Experiment 3.2 
Table 6.1 Summary of the averaged fold change over CC of two independent 













Genes Ptf1a Ngn2 Ptf1a Ngn2 Ptf1a Ngn2 Ptf1a -Dex Ngn2 -Dex
Ascl1/Xash1 new 0,7 1,1 0,8 0,8 0,6 0,6 1,0 7,6
Cdknx (p27Xic1) 5,8 2,5 4,7 2,6 1,3 1,8 1,0 1,0
Dll1 (Delta1) 35,0 16,0 16,7 20,2 10,4 14,0 1,1 1,7
Ebf2-a/b 59,4 10,1 162,4 73,8 2857,7 2361,0 1,0 5,2
Ebf3 (Coe3) 1,0 1,0 1,0 1,0 85,5 184,2 1,1 5,4
Gad1 1,0 1,0 1,0 1,0 1069,2 10,2 1,0 1,0
H4 new 1,1 1,3 1,2 1,2 0,7 0,7 1,1 0,9
Hb9/mnx1 0,4 0,3 2,5 1,9 1,0 1,0 1,0 1,0
Hox11L2/Tlx3 1,5 1,0 0,7 0,5 1,0 1182,6 3,5 4,9
Hpx6 (Lbx1) 1,0 1,0 1,0 1,0 11,2 1,0 1,0 1,0
Islet1 (isl1) 0,8 3,0 0,4 0,7 0,2 1,9 1,1 1,1
Lhx1 (Lim1) 0,2 0,1 0,4 0,4 62,3 1,0 1,0 1,0
Lhx2 1,0 1,0 4,9 1,0 2,8 1,0 1,0 1,0
Lhx5 1,1 0,8 0,9 0,8 372,2 0,7 1,0 1,0
Lmx1b 0,4 0,6 0,5 0,8 40,8 1,0 1,0 1,0
Mxi1 4,3 3,3 4,5 4,2 0,5 1,9 0,8 1,2
MyT1 31,4 16,1 12,3 12,0 3,5 8,2 1,1 2,0
NCAMa/b 3,4 3,1 0,4 0,8 14,0 44,6 1,4 3,1
NeuroD1a/b 1,0 1,0 1,0 1,0 569,0 2342,8 1,0 1,0
NeuroD4 (Xath3) 1,0 1,0 1,0 14,5 945,9 5388,3 1,0 22,5
Ngn1 1,0 1,0 1,0 1,0 174,7 1313,4 1,0 1,0
Ngn3 0,8 0,5 0,6 0,6 1,0 8,1 1,0 1,0
Nrgn-1b (Ngn2-b) 0,7 1,1 0,7 0,7 71,4 7,8 1,0 1,0
Numbl 0,9 1,0 0,8 0,9 0,5 0,7 1,1 0,9
ODC 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0
PRDM13 67,1 3,5 41,8 1,6 1719,9 32,0 4,7 1,0
PRDM14 1,9 2,4 1,1 4,5 73,2 2256,9 1,0 1,0
Pak3 1,2 0,9 0,9 0,8 216,4 972,7 0,3 0,8
Pax2-a 1,0 1,0 1,0 1,0 183,3 0,5 1,0 1,0
Ptf1a-a/b 5'UTR 0,8 1,0 1,1 1,1 3,8 1,9 1,5 1,0
RBM38/Seb4R 1,2 1,2 1,1 1,2 0,7 1,2 0,9 1,1
RBPJ 3'UTR 1,0 1,0 0,9 0,9 0,7 0,7 1,1 1,0
Sox3 1,1 1,0 0,9 0,9 2,0 0,7 1,1 1,0
Xbra-a/b 1,4 1,0 3,8 1,1 0,1 0,9 1,3 1,2
actc1 1,4 1,0 3,5 4,2 0,3 2,2 1,5 1,0
g6pd 1,0 1,0 0,9 1,0 0,6 0,9 1,0 0,9
tubb2b (N-tubulin) 0,9 1,8 1,7 3,5 73,5 133,4 1,4 1,2








Table 6.2 Summary of the calculated standard error of the mean (SEM) of the fold 












Genes Ptf1a Ngn2 Ptf1a Ngn2 Ptf1a Ngn2 Ptf1a –Dex Ngn2 -Dex
Ascl1/Xash1 new 0,0 0,3 0,3 0,2 0,4 0,4 0,0 6,6
Cdknx (p27Xic1) 2,5 1,3 0,5 0,3 0,1 0,5 0,0 0,1
Dll1 (Delta1) 21,2 5,0 1,4 2,9 2,7 8,3 0,3 0,7
Ebf2-a/b 20,8 4,8 110,1 40,2 318,3 574,5 0,0 4,2
Ebf3 (Coe3) 0,0 0,0 0,0 0,0 33,5 137,5 0,8 5,2
Gad1 0,0 0,0 0,0 0,0 272,6 3,0 0,0 0,0
H4 new 0,1 0,1 0,4 0,4 0,2 0,1 0,0 0,0
Hb9/mnx1 0,4 0,2 2,1 1,4 0,0 0,0 0,0 0,0
Hox11L2/Tlx3 0,5 0,0 0,5 0,4 0,0 418,9 3,0 3,9
Hpx6 (Lbx1) 0,0 0,0 0,0 0,0 2,1 0,0 0,0 0,0
Islet1 (isl1) 0,2 1,1 0,1 0,5 0,0 0,6 0,1 0,2
Lhx1 (Lim1) 0,1 0,0 0,1 0,1 0,5 0,0 0,0 0,0
Lhx2 0,0 0,0 1,9 0,0 1,8 0,0 0,0 0,0
Lhx5 0,1 0,0 0,1 0,2 190,0 0,3 0,0 0,0
Lmx1b 0,3 0,2 0,4 0,6 17,0 0,0 0,0 0,0
Mxi1 0,9 0,1 0,0 0,5 0,1 0,5 0,0 0,1
MyT1 2,9 6,3 0,2 0,8 0,0 1,7 0,0 0,3
NCAMa/b 0,5 2,4 0,2 0,6 0,3 11,5 0,6 0,2
NeuroD1a/b 0,0 0,0 0,0 0,0 10,1 1228,8 0,0 0,0
NeuroD4 (Xath3) 0,0 0,0 0,0 5,8 116,6 1307,2 0,0 21,5
Ngn1 0,0 0,0 0,0 0,0 31,5 440,6 0,0 0,0
Ngn3 0,2 0,5 0,4 0,4 0,0 2,3 0,0 0,0
Nrgn-1b (Ngn2-b) 0,0 0,4 0,1 0,0 23,4 7,2 0,0 0,0
Numbl 0,1 0,2 0,0 0,0 0,0 0,0 0,1 0,1
ODC 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0
PRDM13 58,1 2,3 9,1 0,1 364,9 29,2 3,7 0,0
PRDM14 0,3 0,5 0,0 0,5 19,0 915,3 0,0 0,0
Pak3 0,3 0,3 0,1 0,0 189,5 937,6 0,2 0,5
Pax2-a 0,0 0,0 0,0 0,0 118,1 0,5 0,0 0,0
Ptf1a-a/b 5'UTR 0,1 0,2 0,2 0,2 0,2 0,5 0,3 0,0
RBM38/Seb4R 0,3 0,4 0,1 0,0 0,0 0,1 0,1 0,0
RBPJ 3'UTR 0,0 0,1 0,1 0,1 0,0 0,0 0,1 0,1
Sox3 0,0 0,1 0,1 0,1 0,5 0,1 0,2 0,0
Xbra-a/b 0,7 0,4 3,3 0,4 0,1 0,6 0,5 0,4
actc1 0,4 0,0 2,5 3,2 0,1 0,2 0,5 0,4
g6pd 0,0 0,1 0,0 0,0 0,1 0,0 0,0 0,0
tubb2b (N-tubulin) 0,0 0,6 0,3 0,4 10,1 41,3 0,3 0,2

































6.1.2 Experiment 3.7 
Table 6.3 Summary of the averaged fold change over CC of two independent 
Nanostring experiments for each sample and gene 
 Genes Ptf1a Ngn2 chimeric Ptf1a
Arx-a 0,5 0,5 0,9
Ascl1/Xash1 0,6 0,6 0,6
Cdknx (p27Xic1) 1,8 1,6 1,8
Dll1 (Delta1) 7,4 4,4 5,0
Delta2 41,4 19,9 37,3
ESR10 91,6 88,5 50,3
ESR6e (Hes3.1) 0,9 1,6 1,2
ESR9.1a 85,1 33,3 26,1
Ebf2-a/b 902,6 385,0 634,5
Ebf3 (Coe3) 159,9 149,9 131,2
Eng1-a/b 1,0 1,0 1,0
FGF8 12,1 3,6 4,7
FoxD3a (XfD6) 2,4 1,0 2,3
Gad1 685,5 1,0 273,5
H4 3,0 1,0 5,0
Hb9/mnx1 1,9 4,8 4,8
Hes1a(Hairy1) 0,8 1,3 1,7
Hes2 3,5 1,0 1,0
Hes5.1 (ESR1) 6,5 2,3 2,6
Hes6.1 1,0 0,8 1,0
Hes7 (XHR1) 0,3 0,5 0,6
Hox11L2/Tlx3 0,6 433,1 56,0
Hpx6 (Lbx1) 20,1 2,7 4,3
Insm1 14,3 17,0 10,9
Islet1 (isl1) 0,3 1,9 1,0
Jagged1 (Serrate-1) 1,9 1,7 2,0
Krox20/egr2 1,0 1,0 1,0
Lhx1 (Lim1) 95,2 2,0 10,6
Lhx2 1,0 1,0 1,0
Lhx5 83,0 1,0 19,4
Lmx1b 96,0 8,7 12,1
Mxi1 1,1 1,9 1,3
MyT1 7,4 7,5 7,9
NCAMa/b 27,4 55,4 38,9
NeuroD1a/b 21,3 30,1 30,8
NeuroD4 (Xath3) 606,1 1332,2 1125,2
NeuroD6 (Xath2) 1,0 1,0 1,0
Ngn1 178,0 317,3 289,1
Ngn3 0,3 2,9 0,6
Ngnr-1a (ngn2a) 1,7 1,0 1,0
Nkx6.1 31,4 1,0 19,1
Nkx6.2 0,7 1,0 1,3
Notch1 1,5 1,0 1,4
Nrgn-1b (Ngn2-b) 55,9 5,1 2,6
Nrp1 2,8 3,1 3,7
Numb 1,0 1,0 1,0
Numbl 0,3 0,6 0,8
ODC 1,0 1,0 1,0
Olig3 0,3 0,3 0,3
Pak3 13,2 27,3 14,8
Pax2-a 103,4 1,0 3,9
Pax3 139,1 18,4 33,0
Pax6-a 2,1 0,7 1,2
Pax6-b 23,3 0,6 0,8
PRDM14 2,4 54,2 9,5
Ptf1a-a/b 48,8 1,0 75,7
RBM38/Seb4R 0,5 1,5 1,0
RBPJ 0,6 0,8 1,0
Slug 18,9 1,0 4,5
Sox1 0,8 0,7 1,2
Sox2 18,3 3,8 6,4
Sox3 4,2 1,1 2,0
Sox9-a/b 26,0 1,4 4,4
SoxD 0,7 0,7 0,9
Twist1-a 47,8 17,3 33,7
Xbra-a/b 0,5 2,1 1,0
actb 0,6 0,8 1,1
actc1 2,1 3,4 4,8
c-myc 0,3 0,7 0,7
g6pd 1,0 1,1 1,4




runx1 (Xaml) 0,2 0,6 0,5
tubb2b (N-tubulin) 101,9 110,5 77,7
vGlut1 2,6 80,9 22,3
Table 6.4 Summary of the calculated standard error of the mean (SEM) of the fold 
change shown in table 6.3 for each sample and gene  
Genes  Ptf1a Ngn2 chimeric Ptf1a
Arx-a 0,5 0,5 0,1
Ascl1/Xash1 0,4 0,4 0,4
Cdknx (p27Xic1) 0,0 0,3 0,2
Dll1 (Delta1) 3,1 1,5 0,8
Delta2 24,7 14,6 20,0
ESR10 38,2 2,8 23,7
ESR6e (Hes3.1) 0,1 0,3 0,0
ESR9.1a 54,8 13,9 10,3
Ebf2-a/b 56,8 81,9 44,0
Ebf3 (Coe3) 22,6 70,7 40,3
Eng1-a/b 0,0 0,0 0,0
FGF8 0,3 0,6 1,4
FoxD3a (XfD6) 0,2 0,2 0,5
Gad1 101,5 0,0 9,2
H4 2,0 0,0 4,0
Hb9/mnx1 0,7 4,5 3,1
Hes1a(Hairy1) 0,1 0,2 0,0
Hes2 2,5 0,0 0,0
Hes5.1 (ESR1) 2,7 0,0 0,4
Hes6.1 0,1 0,2 0,1
Hes7 (XHR1) 0,2 0,0 0,3
Hox11L2/Tlx3 0,4 355,0 23,3
Hpx6 (Lbx1) 18,5 1,7 3,7
Insm1 2,1 6,5 0,1
Islet1 (isl1) 0,2 0,5 0,0
Jagged1 (Serrate-1) 0,3 0,2 0,1
Krox20/egr2 0,0 0,0 0,0
Lhx1 (Lim1) 39,6 1,0 9,6
Lhx2 0,0 0,0 0,0
Lhx5 43,8 0,0 5,3
Lmx1b 33,0 7,7 6,4
Mxi1 0,1 0,2 0,3
MyT1 1,2 1,6 0,2
NCAMa/b 1,2 4,7 4,4
NeuroD1a/b 5,7 16,1 9,2
NeuroD4 (Xath3) 146,5 379,5 109,1
NeuroD6 (Xath2) 0,0 0,0 0,0
Ngn1 47,9 72,6 72,7
Ngn3 0,2 1,9 0,1
Ngnr-1a (ngn2a) 0,7 0,0 0,0
Nkx6.1 13,1 0,0 18,1
Nkx6.2 0,1 0,0 0,2
Notch1 0,4 0,2 0,2
Nrgn-1b (Ngn2-b) 40,5 4,1 1,6
Nrp1 0,2 1,1 1,4
Numb 0,0 0,0 0,0
Numbl 0,2 0,1 0,1
ODC 0,0 0,0 0,0
Olig3 0,1 0,1 0,1
Pak3 2,7 13,5 5,2
Pax2-a 7,6 0,0 2,9
Pax3 44,8 17,4 24,0
Pax6-a 1,1 0,4 0,7
Pax6-b 17,4 0,4 0,6
PRDM14 1,3 16,9 1,2
Ptf1a-a/b 1,3 0,0 13,4
RBM38/Seb4R 0,1 0,3 0,0
RBPJ 0,1 0,1 0,0
Slug 11,7 0,0 1,2
Sox1 0,1 0,2 0,1
Sox2 3,0 1,3 3,6
Sox3 1,9 0,3 1,3
Sox9-a/b 13,4 0,3 2,8
SoxD 0,1 0,1 0,1
Twist1-a 9,3 12,4 30,5
Xbra-a/b 0,3 1,1 0,0
actb 0,2 0,0 0,2
actc1 1,4 0,2 1,4
c-myc 0,1 0,2 0,0
g6pd 0,4 0,1 0,4
Appendix 111
 gapdh 0,4 0,4 0,2
runx1 (Xaml) 0,0 0,0 0,0
tubb2b (N-tubulin) 9,6 28,4 4,6
vGlut1 1,2 58,7 8,0  
6.1.3 Experiment 3.8 and 3.20 
Table 6.5 Summary of the averaged fold change over CC of two independent 







Genes Ptf1a Ptf1aW224A/W242A Ptf1a Ptf1aW224A/W242A
Ascl1/Xash1 new 9,8 3,9 0,6 0,4
Barhl2 1,0 1,0 45,0 8,3
Cdknx (p27Xic1) 7,1 5,7 2,2 1,8
Cpa1 1,0 1,0 2,2 0,7
Dll1 (Delta1) 20,0 22,2 6,0 3,0
ESR10 9,5 0,9 6,1 4,7
Ebf2-a/b 234,1 51,2 2195,2 1290,9
Ebf3 (Coe3) 1,0 1,0 34,0 45,5
FoxD3a (XfD6) 0,8 1,5 126,2 15,5
Gad1 1,0 1,0 928,7 24,4
H4 new 1,0 0,9 0,6 0,4
HNF6 gene2 16,1 6,1 2261,6 1177,2
Hb9/mnx1 3,2 3,3 1,0 9,5
Hes5.1 (ESR1) 34,8 6,4 214,3 136,6
Hmx3 3,0 1,0 19,5 0,5
Hox11L2/Tlx3 5,0 12,7 17,3 219,3
Hpx6 (Lbx1) 1,0 1,0 205,8 79,2
Islet1 (isl1) 1,0 1,0 0,5 0,7
Kirrel2 3,0 0,4 51,8 1,2
Lhx1 (Lim1) 10,5 9,4 171,0 36,5
Lhx2 0,7 0,7 34,2 23,8
Lhx5 0,7 0,7 274,4 2,5
Lmx1b 4,1 0,7 66,7 51,2
Mecom 1,0 1,0 95,5 1,9
Mxi1 4,7 3,4 0,7 0,6
MyT1 27,1 14,1 4,9 4,5
NCAMa/b 1,5 1,2 16,5 19,5
NeuroD1a/b 1,0 1,0 528,4 463,3
NeuroD4 (Xath3) 4,0 1,0 776,2 1210,6
Ngn1 1,0 1,0 217,9 315,1
Ngn3 7,8 4,1 1,0 1,0
Nrgn-1b (Ngn2-b) 1,8 1,5 111,8 5,2
ODC 1,0 1,0 1,0 1,0
PRDM13 804,2 26,7 1768,6 71,7
PRDM14 1,5 2,3 135,3 761,7
Pak3 1,8 1,3 223,6 252,9
Pax2-a 6,8 0,6 20,8 1,1
Ptf1a-a/b 5'UTR 13,6 6,6 4,6 0,7
RBM38/Seb4R 1,6 1,8 0,8 0,6
RBPJ 3'UTR 1,3 1,0 0,9 0,6
Sox3 0,9 1,1 2,9 1,4
Sox9-a/b 2,3 1,3 48,8 22,6
Pdia2 (XPDip) 1,0 1,0 5,3 1,0
Xbra-a/b 2,3 2,9 0,8 0,7
actc1 6,9 1,1 3,2 1,9
g6pd 1,0 1,0 0,8 0,8
tubb2b (N-tubulin) 3,6 1,1 161,2 259,6









Table 6.6 Summary of the calculated standard error of the mean (SEM) of the fold 







Genes Ptf1a Ptf1aW224A/W242A Ptf1a Ptf1aW224A/W242A
Ascl1/Xash1 new 9,7 3,5 0,0 0,4
Barhl2 0,0 0,0 42,4 8,2
Cdknx (p27Xic1) 1,5 0,9 0,9 1,3
Cpa1 0,0 0,0 2,1 0,3
Dll1 (Delta1) 2,9 1,8 1,3 1,0
ESR10 0,3 0,2 2,4 2,8
Ebf2-a/b 94,1 26,0 457,0 673,6
Ebf3 (Coe3) 0,0 0,0 3,2 1,7
FoxD3a (XfD6) 0,3 0,5 13,9 13,6
Gad1 0,0 0,0 43,1 0,1
H4 new 0,0 0,1 0,0 0,2
HNF6 gene2 13,0 5,5 2074,7 1133,0
Hb9/mnx1 3,0 1,2 0,0 9,4
Hes5.1 (ESR1) 22,5 1,4 28,9 70,1
Hmx3 2,0 0,0 17,9 0,5
Hox11L2/Tlx3 3,2 8,4 15,8 102,4
Hpx6 (Lbx1) 0,0 0,0 7,4 72,5
Islet1 (isl1) 0,0 0,0 0,2 0,1
Kirrel2 0,6 0,1 40,0 1,1
Lhx1 (Lim1) 5,7 0,9 8,3 33,4
Lhx2 0,3 0,3 14,5 10,2
Lhx5 0,2 0,2 179,7 1,5
Lmx1b 0,7 0,3 20,6 36,0
Mecom 0,0 0,0 34,8 0,1
Mxi1 1,3 1,3 0,1 0,4
MyT1 8,4 7,5 2,9 3,0
NCAMa/b 0,4 0,3 10,2 13,5
NeuroD1a/b 0,0 0,0 504,9 445,1
NeuroD4 (Xath3) 3,0 0,0 263,4 556,6
Ngn1 0,0 0,0 180,9 283,7
Ngn3 6,8 3,1 0,0 0,0
Nrgn-1b (Ngn2-b) 1,3 0,7 23,7 4,2
ODC 0,0 0,0 0,0 0,0
PRDM13 253,0 16,1 1194,2 67,4
PRDM14 0,7 1,1 117,1 726,6
Pak3 0,4 0,0 191,9 227,5
Pax2-a 6,2 0,4 15,7 0,5
Ptf1a-a/b 5'UTR 12,3 5,0 3,2 0,5
RBM38/Seb4R 0,0 0,1 0,2 0,2
RBPJ 3'UTR 0,3 0,1 0,1 0,1
Sox3 0,2 0,0 1,3 1,2
Sox9-a/b 0,6 0,2 30,4 21,1
Pdia2 (XPDip) 0,0 0,0 4,3 0,0
Xbra-a/b 1,1 2,5 0,4 0,6
actc1 6,1 0,1 0,4 0,8
g6pd 0,0 0,0 0,0 0,2
tubb2b (N-tubulin) 1,4 0,1 106,0 172,7









6.1.4 Experiment 3.10 and 3.21 
Table 6.7 Summary of the averaged fold change over CC of two independent 








   
25 h 
 
Genes Ptf1a Ptf1a+Su(H) Su(H) Ptf1a Ptf1a+Su(H) Su(H) Ptf1a Ptf1a+Su(H) Su(H) Ptf1a Ptf1a+Su(H) Su(H)
Ascl1/Xash1 new 1,6 2,6 1,8 0,3 0,9 0,3 0,6 1,9 8,3 1,0 1,0 7,3
Barhl2 1,0 4,0 1,0 1,0 6,5 1,0 1,0 12,5 1,0 6,4 58,2 2,1
Cdknx (p27Xic1) 6,3 5,3 1,4 3,8 3,9 1,0 3,0 3,6 1,3 1,8 1,8 1,4
Cpa1 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 0,4 2,9 1,2
Dll1 (Delta1) 38,7 19,2 2,8 10,9 3,8 1,4 3,9 2,8 1,1 13,9 22,1 1,2
ESR10 28,1 58,7 1,4 16,4 26,6 2,1 40,4 58,1 3,8 446,7 1099,4 5,0
Ebf2-a/b 26,4 8,4 2,5 189,1 132,2 1,0 213,3 305,4 3,0 1071,4 947,6 2,1
Ebf3 (Coe3) 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 247,5 126,7 1,9
FoxD3a (XfD6) 1,0 2,4 2,9 0,3 0,7 0,9 0,9 7,7 2,7 123,0 279,9 2,1
Gad1 1,0 1,0 1,0 1,0 9,7 1,0 1,0 24,4 1,0 330,0 126,3 2,1
H4 new 0,7 1,1 1,5 0,9 1,2 1,0 1,1 1,3 1,2 0,8 1,1 1,6
HNF6 gene2 1,2 2,2 1,9 10,7 20,5 4,5 6,5 5,5 2,5 1090,4 1172,9 6,7
Hb9/mnx1 4,3 8,3 3,0 1,0 17,5 1,0 1,0 6,1 1,0 1,0 1,0 2,1
Hes5.1 (ESR1) 95,7 123,8 2,2 52,7 73,7 3,8 42,6 69,2 2,2 249,9 367,9 10,4
Hmx3 1,0 1,3 4,4 1,0 1,0 1,0 1,0 1,0 1,3 26,7 0,8 1,8
Hox11L2/Tlx3 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 2,1
Hpx6 (Lbx1) 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,8 14,0 6,8
Islet1 (isl1) 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 0,2 0,1 1,2
Kirrel2 0,8 0,8 1,1 1,3 1,5 1,3 1,2 1,6 1,0 927,1 1926,2 2,1
Lhx1 (Lim1) 1,0 1,0 1,5 1,0 2,7 1,0 1,0 1,0 1,0 20,8 124,4 2,1
Lhx2 1,0 1,2 1,0 1,0 1,0 1,0 3,7 9,8 1,0 2,0 207,4 2,1
Lhx5 1,3 1,4 0,8 1,2 1,1 0,9 1,1 1,2 0,6 99,2 101,6 2,1
Lmx1b 2,3 7,4 2,2 2,7 3,5 4,2 0,8 1,1 0,9 19,9 25,7 2,1
Mecom 1,0 1,0 1,0 1,0 1,0 1,0 1,0 3,5 1,0 82,8 1675,8 3,9
Mxi1 3,5 2,5 1,5 3,4 2,4 1,4 2,8 2,1 1,4 1,0 1,5 1,4
MyT1 12,8 12,8 1,2 13,9 16,0 0,9 11,1 19,7 0,9 3,5 5,8 0,7
NCAMa/b 1,3 0,8 1,4 0,9 1,1 1,4 1,8 0,9 2,0 33,5 15,6 1,8
NeuroD1a/b 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,1 1,0 290,3 73,1 2,1
NeuroD4 (Xath3) 1,0 1,0 1,0 9,9 11,5 1,0 8,8 14,7 1,0 585,2 266,9 2,1
Ngn1 1,1 1,0 1,0 0,7 0,7 0,7 1,0 1,0 1,0 177,4 375,1 2,1
Ngn3 1,1 1,9 3,7 1,0 2,8 1,0 1,0 1,5 1,0 1,0 1,0 2,1
Nrgn-1b (Ngn2-b) 0,6 1,2 0,6 0,5 0,9 0,4 1,8 3,9 1,0 58,5 264,4 2,1
ODC 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0 1,0
PRDM13 118,0 352,3 1,0 645,2 1456,8 1,0 745,7 2056,8 1,0 1549,8 3285,7 2,1
PRDM14 1,9 2,1 1,5 1,0 1,1 2,0 0,8 0,8 2,0 29,9 7,6 7,3
Pak3 1,1 0,7 0,8 1,0 1,4 0,8 1,6 1,9 1,0 49,9 108,0 1,0
Pax2-a 0,7 0,7 0,7 1,0 1,3 1,0 1,0 1,0 1,0 267,5 101,2 24,4
Ptf1a-a/b 5'UTR 2,4 16,9 3,3 1,5 6,8 0,2 10,9 115,0 7,2 1,6 11,3 3,9
RBM38/Seb4R 1,2 1,1 0,8 1,3 1,2 0,6 2,0 1,9 1,0 0,6 1,0 0,7
RBPJ 3'UTR 0,9 1,0 0,9 0,8 0,9 0,8 1,0 1,1 1,0 0,8 0,6 1,7
Sox3 0,9 1,0 1,0 0,8 0,9 0,8 1,0 1,0 0,9 2,3 39,7 1,6
Sox9-a/b 1,9 3,5 1,0 1,6 5,3 1,4 1,7 5,2 1,6 41,2 81,9 1,5
Pdia2 (XPDip) 1,0 1,3 1,0 1,0 20,1 1,0 6,4 88,5 1,0 2,4 743,6 2,1
Xbra-a/b 29,0 5,8 0,8 1,0 1,8 1,0 1,5 5,2 1,0 0,1 0,1 0,3
actc1 0,7 6,7 9,6 1,6 1,7 0,4 6,0 1,6 1,8 0,6 0,2 1,6
g6pd 0,9 1,0 0,9 0,9 1,0 0,9 0,9 1,0 1,0 0,8 0,5 0,9
tubb2b (N-tubulin) 3,4 6,6 2,4 2,2 3,0 0,2 1,3 1,6 0,8 132,3 38,0 1,0











Table 6.8 Summary of the calculated standard error of the mean (SEM) of the fold 












Genes Ptf1a Ptf1a+Su(H) Su(H) Ptf1a Ptf1a+Su(H) Su(H) Ptf1a Ptf1a+Su(H) Su(H) Ptf1a Ptf1a+Su(H) Su(H)
Ascl1/Xash1 new 1,3 0,2 0,4 0,3 0,2 0,3 0,4 0,4 6,9 0,0 0,0 4,1
Barhl2 0,0 3,0 0,0 0,0 3,5 0,0 0,0 11,5 0,0 5,4 8,1 1,1
Cdknx (p27Xic1) 0,4 0,1 0,2 0,3 0,0 0,1 0,6 0,6 0,3 0,2 0,5 0,2
Cpa1 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,3 1,0 0,4
Dll1 (Delta1) 1,7 6,5 0,6 3,8 1,0 0,3 0,8 0,8 0,1 0,8 1,8 0,2
ESR10 11,9 9,0 0,0 10,9 20,8 0,4 23,8 38,8 0,4 275,6 395,4 1,8
Ebf2-a/b 1,5 1,4 1,5 15,7 25,2 0,0 34,8 43,5 2,0 262,1 188,2 1,1
Ebf3 (Coe3) 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 70,2 39,9 1,2
FoxD3a (XfD6) 1,0 2,2 2,3 0,0 0,3 0,9 0,1 6,2 1,4 44,4 92,0 1,1
Gad1 0,0 0,0 0,0 0,0 8,7 0,0 0,0 21,5 0,0 40,3 41,5 1,1
H4 new 0,3 0,2 0,2 0,3 0,2 0,2 0,5 0,1 0,3 0,1 0,0 0,6
HNF6 gene2 0,2 0,5 1,8 5,8 1,5 3,9 1,9 1,4 1,5 720,8 800,8 6,0
Hb9/mnx1 3,3 7,3 2,0 0,0 15,0 0,0 0,0 5,1 0,0 0,0 0,0 1,1
Hes5.1 (ESR1) 58,3 58,2 0,6 17,6 14,2 1,3 0,6 9,3 0,3 70,6 58,6 7,2
Hmx3 0,0 0,3 3,2 0,0 0,0 0,0 0,0 0,0 0,3 18,8 0,2 0,4
Hox11L2/Tlx3 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 1,1
Hpx6 (Lbx1) 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,8 9,9 5,8
Islet1 (isl1) 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,2
Kirrel2 0,2 0,1 0,3 0,2 0,2 0,1 0,1 0,2 0,2 236,4 524,6 1,1
Lhx1 (Lim1) 0,0 0,0 0,5 0,0 1,7 0,0 0,0 0,0 0,0 7,8 19,4 1,1
Lhx2 0,0 0,2 0,0 0,0 0,0 0,0 0,0 1,9 0,0 1,0 49,9 1,1
Lhx5 0,0 0,1 0,1 0,4 0,2 0,3 0,1 0,0 0,1 11,2 30,2 1,1
Lmx1b 1,9 4,1 0,1 1,7 1,0 3,2 0,2 0,1 0,7 9,0 1,9 1,1
Mecom 0,0 0,0 0,0 0,0 0,0 0,0 0,0 2,3 0,0 58,9 1238,8 2,9
Mxi1 0,9 0,1 0,1 1,2 0,6 0,4 0,3 0,2 0,2 0,1 0,2 0,3
MyT1 4,5 6,3 0,6 0,8 0,2 0,2 0,1 0,9 0,0 0,9 0,8 0,2
NCAMa/b 1,1 0,2 0,6 0,8 0,6 1,1 1,6 0,7 1,7 6,4 0,7 1,0
NeuroD1a/b 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,1 0,0 125,7 15,0 1,1
NeuroD4 (Xath3) 0,0 0,0 0,0 8,9 10,5 0,0 7,8 6,0 0,0 251,1 40,6 1,1
Ngn1 0,1 0,0 0,0 0,3 0,3 0,3 0,0 0,0 0,0 79,0 84,1 1,1
Ngn3 0,1 0,9 2,7 0,0 1,2 0,0 0,0 0,5 0,0 0,0 0,0 1,1
Nrgn-1b (Ngn2-b) 0,3 0,4 0,2 0,1 0,3 0,3 0,8 1,1 0,1 19,8 38,7 1,1
ODC 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0
PRDM13 34,5 66,1 0,0 199,8 204,6 0,0 290,9 600,5 0,0 417,3 822,8 1,1
PRDM14 0,5 0,3 0,3 0,1 0,1 0,8 0,2 0,0 0,5 7,6 6,3 4,1
Pak3 0,0 0,0 0,1 0,3 0,2 0,1 0,2 0,3 0,1 22,6 42,3 0,8
Pax2-a 0,3 0,3 0,4 0,0 0,3 0,0 0,0 0,0 0,0 46,6 8,7 2,3
Ptf1a-a/b 5'UTR 2,2 14,8 2,7 1,0 4,2 0,1 8,2 93,0 6,3 0,0 1,8 3,2
RBM38/Seb4R 0,5 0,3 0,2 0,2 0,2 0,1 0,3 0,2 0,1 0,1 0,1 0,1
RBPJ 3'UTR 0,3 0,2 0,1 0,1 0,2 0,2 0,1 0,0 0,0 0,0 0,1 0,7
Sox3 0,2 0,1 0,1 0,0 0,0 0,1 0,1 0,1 0,0 0,2 3,8 0,8
Sox9-a/b 0,5 0,3 0,1 0,3 2,0 0,3 0,1 1,2 0,1 12,7 3,3 0,8
Pdia2 (XPDip) 0,0 0,3 0,0 0,0 2,6 0,0 5,4 48,2 0,0 1,4 215,4 1,1
Xbra-a/b 28,7 5,5 0,2 0,0 0,8 0,0 0,5 4,2 0,0 0,0 0,0 0,1
actc1 0,3 4,6 5,7 0,3 1,3 0,2 5,0 0,6 1,6 0,2 0,0 0,2
g6pd 0,2 0,0 0,1 0,1 0,0 0,1 0,1 0,0 0,0 0,2 0,1 0,1
tubb2b (N-tubulin) 0,0 1,0 0,9 1,3 1,5 0,0 0,7 0,1 0,3 79,2 16,7 0,1












6.2 Summary of the primary Nanostring data. Given are the primary 
data for each individual Nanostring experiment for each sample and gene.  
6.2.1 Experiment 3.2 









25 h -Dex 
 
 Genes Ptf1a Ngn2 CC Ptf1a Ngn2 CC Ptf1a Ngn2 CC Ptf1a Ngn2 CC 
Ascl1/Xash1 new 21 27 28 28 21 18 8 1 8 6 4 4 
Cdknx (p27Xic1) 1.125 415 160 1.168 799 230 1.821 951 544 476 591 589 
Dll1 (Delta1) 4.216 1.280 96 2.364 3.473 132 5.894 2.177 283 246 343 338 
Ebf2-a/b 102 16 13 345 221 15 4.732 1.351 5 2 9 3 
Ebf3 (Coe3) 2 4 5 6 16 2 2.282 1.040 21 16 15 26 
Gad1 1 3 1 2 2 1 2.012 15 2 7 4 4 
H4 new 234.325 238.913 268.862 258.756 281.627 264.463 99.148 60.339 69.450 64.557 67.722 71.375 
Hb9/mnx1 8 18 32 17 17 13 5 1 1 3 1 1 
Hox11L2/Tlx3 10 7 10 11 12 15 9 583 3 16 6 2 
Hpx6 (Lbx1) 3 2 1 4 3 2 42 1 2 3 1 1 
Islet1 (isl1) 12 13 14 15 21 14 298 774 428 508 587 617 
Lhx1 (Lim1) 15 6 24 11 8 12 114 1 1 1 1 1 
Lhx2 8 3 1 25 7 3 29 1 1 1 1 1 
Lhx5 1.513 1.088 1.781 1.450 1.088 1.505 856 5 5 3 2 3 
Lmx1b 10 14 23 12 17 17 108 1 3 1 3 1 
Mxi1 1.523 781 337 1.890 1.930 343 829 1.414 730 461 819 686 
MyT1 1.679 396 67 2.051 2.101 143 3.285 3.001 341 382 776 432 
NCAMa/b 17 9 15 18 15 15 2.665 3.117 73 65 123 41 
NeuroD1a/b 3 3 3 2 5 2 851 846 2 1 1 1 
NeuroD4 (Xath3) 6 1 1 18 39 1 1.252 3.074 1 2 6 1 
Ngn1 1 5 3 1 1 2 328 665 1 1 1 1 
Ngn3 10 3 6 2 15 7 3 14 1 1 1 1 
Nrgn-1b (Ngn2-b) 127 200 182 137 164 179 270 10 6 3 3 3 
Numbl 781 743 847 847 909 833 706 511 567 740 752 881 
ODC 23.923 19.286 26.463 25.529 24.940 20.340 31.638 16.020 11.606 14.529 17.972 17.380 
PRDM13 674 36 19 1.548 67 34 7.258 17 7 11 10 8 
PRDM14 570 610 291 368 1.304 276 159 1.017 4 5 2 3 
Pak3 249 164 189 258 252 237 826 541 16 14 19 14 
Pax2-a 2 3 8 11 4 7 1.081 8 11 3 4 4 
Ptf1a-a/b 5'UTR 23 22 26 35 32 26 143 31 16 27 22 19 
RBM38/Seb4R 1.670 1.490 1.249 1.726 2.034 1.327 337 267 173 214 329 302 
RBPJ 3'UTR 1.957 1.789 2.242 1.978 2.049 1.907 1.416 692 722 846 1.060 1.054 
Sox3 10.671 9.240 11.328 11.248 9.970 10.602 766 115 111 96 128 130 
Xbra-a/b 29 25 42 27 28 27 16 53 91 37 47 50 
actc1 14 8 7 15 10 8 84 306 114 247 204 304 
g6pd 1.633 1.401 1.764 1.652 1.702 1.457 651 407 330 427 523 508 
tubb2b (N-tubulin) 26 40 30 46 97 27 12.092 6.745 58 190 133 134 
vGlut1 9 12 11 8 15 8 30 429 2 8 6 4 
NEG_A 7 2 4 6 3 3 6 4 2 6 8 4 
NEG_B 3 4 4 9 2 9 4 3 3 3 3 2 
NEG_C 3 2 6 5 6 1 4 2 4 3 5 5 
NEG_D 2 4 1 7 7 6 7 9 5 10 6 5 
NEG_E 3 4 6 6 6 5 6 3 3 9 3 3 
NEG_F 9 11 10 11 12 5 16 13 8 17 14 11 
NEG_G 8 10 7 13 10 8 6 3 8 5 1 1 
NEG_H 7 7 5 3 4 6 9 4 2 1 1 1 
POS_A 10.882 12.610 11.204 12.750 11.576 12.511 14.805 13.681 14.149 15.447 14.521 12.036 
POS_B 5.928 6.360 5.864 6.497 5.732 6.389 7.356 6.590 6.838 7.745 8.548 6.456 
POS_C 1.653 1.790 1.611 1.807 1.630 1.721 2.058 1.870 1.894 2.181 2.356 1.780 
POS_D 412 402 347 434 366 381 478 429 420 470 494 380 
POS_E 68 79 61 95 65 86 78 84 91 89 101 81 

















25 h -Dex 
 
Genes Ptf1a Ngn2 CC Ptf1a Ngn2 CC Ptf1a Ngn2 CC Ptf1a Ngn2 CC 
Ascl1/Xash1 new 36 40 62 33 32 24 1 2 5 4 22 4 
Cdknx (p27Xic1) 690 243 253 1.733 519 184 1.188 1.767 606 512 562 489 
Dll1 (Delta1) 1.768 1.282 162 2.740 1.701 86 2.682 3.850 148 206 393 153 
Ebf2-a/b 41 22 11 372 107 4 3.273 3.190 4 3 18 6 
Ebf3 (Coe3) 1 3 2 2 6 5 1.418 3.211 18 9 19 4 
Gad1 3 1 1 2 3 3 1.038 29 5 6 4 3 
H4 new 241.378 244.122 227.724 376.957 256.086 131.144 86.171 68.804 66.216 73.555 64.327 64.809 
Hb9/mnx1 34 15 52 49 26 10 6 8 2 1 1 3 
Hox11L2/Tlx3 11 7 15 18 12 8 6 1.747 4 6 24 7 
Hpx6 (Lbx1) 2 3 1 1 1 3 28 3 1 1 1 1 
Islet1 (isl1) 8 16 17 16 6 9 205 1.960 636 519 574 437 
Lhx1 (Lim1) 16 17 72 28 20 35 97 3 1 1 1 1 
Lhx2 9 3 4 17 4 2 4 1 3 1 2 1 
Lhx5 1.074 682 1.017 1.398 872 711 546 13 12 5 9 3 
Lmx1b 25 26 40 29 26 16 47 8 2 1 1 1 
Mxi1 841 757 292 2.390 1.293 289 418 1.330 444 379 607 424 
MyT1 419 304 32 1.490 866 69 2.214 5.273 436 373 847 346 
NCAMa/b 18 22 18 24 25 15 2.172 7.437 116 43 163 54 
NeuroD1a/b 1 2 1 7 8 3 759 3.878 1 1 2 1 
NeuroD4 (Xath3) 1 3 1 11 17 1 1.379 7.257 3 3 47 1 
Ngn1 2 3 2 1 1 1 200 1.912 1 1 1 1 
Ngn3 14 11 26 11 7 10 1 26 1 1 1 1 
Nrgn-1b (Ngn2-b) 146 135 232 144 93 99 78 31 2 1 1 1 
Numbl 720 618 977 1.019 667 635 750 964 1.061 873 816 713 
ODC 15.778 14.327 18.146 25.357 16.449 13.544 24.683 20.819 16.692 14.987 16.066 15.075 
PRDM13 116 24 29 942 38 21 2.690 81 7 14 5 4 
PRDM14 183 197 140 166 456 80 86 3.446 1 3 7 1 
Pak3 69 56 99 105 62 57 537 2.081 5 9 13 14 
Pax2-a 6 4 7 5 7 6 403 3 4 2 10 2 
Ptf1a-a/b 5'UTR 43 45 69 63 40 25 80 50 22 22 23 18 
RBM38/Seb4R 1.033 970 1.439 1.579 1.028 710 201 297 191 139 176 147 
RBPJ 3'UTR 1.490 1.301 1.779 1.833 1.217 1.018 1.111 1.054 1.138 875 888 763 
Sox3 9.577 7.820 10.190 14.031 9.105 7.517 235 87 108 105 90 80 
Xbra-a/b 68 47 48 82 19 11 36 139 76 95 91 55 
actc1 4 6 7 21 16 4 112 546 189 137 101 69 
g6pd 1.106 950 1.356 1.453 977 818 373 563 485 333 323 330 
tubb2b (N-tubulin) 49 55 63 90 91 27 14.184 32.903 161 117 157 105 
vGlut1 33 42 56 63 41 26 111 3.024 2 3 1 2 
NEG_A 2 1 7 4 2 1 12 8 5 4 4 2 
NEG_B 6 6 7 7 1 2 6 6 5 5 3 4 
NEG_C 3 3 2 1 4 1 6 4 2 1 6 3 
NEG_D 3 6 9 6 2 1 8 11 9 3 5 6 
NEG_E 5 4 1 5 6 1 6 7 5 4 5 3 
NEG_F 6 15 15 6 8 4 11 13 11 10 13 6 
NEG_G 12 7 11 8 10 9 5 5 5 5 2 2 
NEG_H 4 8 4 7 6 3 5 7 3 2 1 1 
POS_A 11.995 10.430 11.453 11.338 10.769 4.119 14.514 14.988 15.429 15.767 12.424 8.790 
POS_B 5.902 5.418 5.365 5.745 5.295 2.138 6.762 7.119 7.493 7.493 6.351 4.420 
POS_C 1.631 1.518 1.529 1.566 1.476 587 1.882 2.000 2.120 1.997 1.796 1.176 
POS_D 395 326 377 340 346 144 437 411 471 482 431 277 
POS_E 64 56 66 48 68 25 92 73 97 93 69 48 










6.2.2 Experiment 3.7 
Table 6.11 Primary data of the first Nanostring experiment  
Genes Ptf1a Ngn2 chimeric Ptf1a CC 
Arx-a 17 5 29 12
Ascl1/Xash1 17 7 16 6
Cdknx (p27Xic1) 1.201 482 950 320
Dll1 (Delta1) 623 242 548 74
Delta2 591 111 547 22
ESR10 92 74 50 3
ESR6e (Hes3.1) 208 201 208 91
ESR9.1a 61 24 37 1
Ebf2-a/b 1.157 238 726 1
Ebf3 (Coe3) 1.890 615 1.123 12
Eng1-a/b 2 2 1 4
FGF8 61 17 36 7
FoxD3a (XfD6) 313 58 199 60
Gad1 1.078 7 335 3
H4 27 9 29 3
Hb9/mnx1 34 9 26 8
Hes1a(Hairy1) 668 453 1.160 361
Hes2 1 6 6 4
Hes5.1 (ESR1) 149 53 87 22
Hes6.1 155 59 140 77
Hes7 (XHR1) 39 21 53 26
Hox11L2/Tlx3 22 334 234 9
Hpx6 (Lbx1) 79 29 38 23
Insm1 390 186 307 20
Islet1 (isl1) 301 498 537 302
Jagged1 (Serrate-1) 491 193 402 107
Krox20/egr2 5 6 4 3
Lhx1 (Lim1) 95 3 9 1
Lhx2 11 4 6 2
Lhx5 73 4 35 3
Lmx1b 105 8 25 4
Mxi1 351 346 416 141
MyT1 881 467 970 72
NCAMa/b 1.001 988 1.344 22
NeuroD1a/b 621 312 759 24
NeuroD4 (Xath3) 638 728 1.498 3
NeuroD6 (Xath2) 3 3 3 1
Ngn1 195 194 452 5
Ngn3 21 17 27 12
Ngnr-1a (ngn2a) 6 2 2 2
Nkx6.1 80 5 15 1
Nkx6.2 54 33 63 26
Notch1 1.033 429 910 433
Nrgn-1b (Ngn2-b) 41 8 18 2
Nrp1 106 40 75 19
Numb 3 5 5 3
Numbl 600 389 938 575
ODC 14.005 7.860 12.492 6.763
Olig3 7 5 8 7
Pak3 404 291 331 23
Pax2-a 149 10 9 4
Pax3 147 8 29 1
Pax6-a 63 16 37 26
Pax6-b 64 6 5 9
PRDM14 78 338 168 13
Ptf1a-a/b 84 3 125 5
RBM38/Seb4R 76 79 110 53
RBPJ 404 217 531 289
Slug 30 8 25 3
Sox1 78 26 76 35
Sox2 1.023 103 182 37
Sox3 350 72 107 75
Sox9-a/b 192 23 37 12
SoxD 2.093 999 2.055 1.299
Twist1-a 97 13 22 5
Xbra-a/b 45 63 101 50
actb 309.705 177.958 419.321 178.041
actc1 1.984 1.015 3.163 280
c-myc 159 105 229 153
g6pd 470 229 507 159
gapdh 398 312 315 149
runx1 (Xaml) 52 60 92 81
tubb2b (N-tubulin) 6.434 3.213 4.552 39
Appendix 118
vGlut1 72 179 192 12
NEG_A 3 2 2 2
NEG_B 3 5 5 5
NEG_C 3 3 1 2
NEG_D 3 1 5 3
NEG_E 6 2 3 5
NEG_F 6 7 7 6
NEG_G 12 4 7 6
NEG_H 14 13 16 7
POS_A 13.666 12.441 11.328 13.077
POS_B 7.112 6.564 6.221 6.748
POS_C 2.392 2.164 2.052 2.172
POS_D 428 368 368 394
POS_E 96 86 74 80






























Table 6.12 Primary data of the second Nanostring experiment  
Genes Ptf1a Ngn2 chimeric Ptf1a CC 
Arx-a 7 13 13 4
Ascl1/Xash1 8 8 13 7
Cdknx (p27Xic1) 1.200 885 1.084 262
Dll1 (Delta1) 1.264 516 583 52
Delta2 689 263 489 9
ESR10 194 104 100 3
ESR6e (Hes3.1) 135 160 162 65
ESR9.1a 208 61 58 3
Ebf2-a/b 1.341 470 775 1
Ebf3 (Coe3) 1.414 1.207 1.079 8
Eng1-a/b 2 2 3 1
FGF8 31 18 21 2
FoxD3a (XfD6) 243 106 249 46
Gad1 822 10 333 4
H4 2 3 2 2
Hb9/mnx1 18 32 34 6
Hes1a(Hairy1) 457 718 948 277
Hes2 23 1 6 2
Hes5.1 (ESR1) 484 99 141 25
Hes6.1 192 140 160 73
Hes7 (XHR1) 17 24 26 17
Hox11L2/Tlx3 12 783 106 2
Hpx6 (Lbx1) 115 23 34 6
Insm1 431 436 243 15
Islet1 (isl1) 69 786 400 186
Jagged1 (Serrate-1) 372 315 360 94
Krox20/egr2 6 3 9 4
Lhx1 (Lim1) 201 18 40 1
Lhx2 13 5 4 2
Lhx5 190 10 45 1
Lmx1b 193 31 38 5
Mxi1 191 233 157 76
MyT1 949 709 730 48
NCAMa/b 1.212 1.950 1.288 23
NeuroD1a/b 835 1.009 1.003 17
NeuroD4 (Xath3) 1.055 1.683 1.152 4
NeuroD6 (Xath2) 8 3 3 3
Ngn1 327 395 259 2
Ngn3 14 24 16 6
Ngnr-1a (ngn2a) 18 7 4 1
Nkx6.1 40 8 59 3
Nkx6.2 48 58 92 29
Notch1 1.179 555 820 252
Nrgn-1b (Ngn2-b) 148 24 22 1
Nrp1 113 128 173 20
Numb 9 5 5 3
Numbl 214 600 636 466
ODC 14.140 9.967 11.421 5.580
Olig3 3 2 1 7
Pak3 339 600 346 13
Pax2-a 168 5 25 3
Pax3 269 50 81 1
Pax6-a 70 29 45 12
Pax6-b 71 14 19 5
PRDM14 35 907 138 12
Ptf1a-a/b 84 6 87 4
RBM38/Seb4R 44 100 73 32
RBPJ 271 342 419 215
Slug 57 7 21 1
Sox1 45 42 66 23
Sox2 1.098 197 426 25
Sox3 603 114 280 43
Sox9-a/b 317 21 62 8
SoxD 1.367 1.288 1.832 929
Twist1-a 68 44 89 1
Xbra-a/b 50 118 51 23
actb 119.965 181.584 237.167 127.128
actc1 276 1.051 1.147 164
c-myc 76 205 187 126
g6pd 252 254 306 147
gapdh 177 607 392 132
runx1 (Xaml) 38 54 50 41
tubb2b (N-tubulin) 7.652 6.724 4.566 32
vGlut1 22 520 143 7
NEG_A 3 6 1 3
NEG_B 5 5 3 1
Appendix 120
NEG_C 2 4 1 2
NEG_D 3 1 1 1
NEG_E 4 1 1 3
NEG_F 6 8 4 4
NEG_G 8 11 3 1
NEG_H 10 14 18 10
POS_A 9.701 11.659 13.983 9.955
POS_B 5.454 5.933 6.721 4.774
POS_C 1.740 1.871 2.214 1.520
POS_D 295 327 342 261
POS_E 81 64 92 64






























6.2.3 Experiment 3.8 and 3.20 







Genes Ptf1a Ptf1aW224A/W242A CC Ptf1a Ptf1aW224A/W242A CC 
Ascl1/Xash1 new 10 20 26 23 34 25
Barhl2 5 3 1 106 30 3
Cdknx (p27Xic1) 784 701 93 1.192 1.368 304
Cpa1 2 1 1 13 5 5
Dll1 (Delta1) 3.115 4.298 181 5.389 3.345 571
ESR10 624 64 66 823 828 80
Ebf2-a/b 296 90 3 2.980 2.509 1
Ebf3 (Coe3) 5 5 1 982 1.700 30
FoxD3a (XfD6) 18 59 25 134 46 1
Gad1 3 2 1 1.097 40 2
H4 new 133.016 143.976 123.942 36.571 45.747 47.895
HNF6 gene2 25 16 11 4.867 2.949 5
Hb9/mnx1 8 28 12 7 33 2
Hes5.1 (ESR1) 982 166 22 755 730 8
Hmx3 6 8 3 50 7 5
Hox11L2/Tlx3 15 33 1 17 760 10
Hpx6 (Lbx1) 3 1 4 247 202 2
Islet1 (isl1) 2 2 1 97 289 241
Kirrel2 229 67 94 1.122 41 15
Lhx1 (Lim1) 12 22 1 209 98 2
Lhx2 3 3 8 41 35 6
Lhx5 305 613 577 517 14 2
Lmx1b 20 5 8 106 120 2
Mecom 3 4 1 116 13 7
Mxi1 1.094 998 181 625 847 578
MyT1 2.229 1.574 66 2.718 2.948 274
NCAMa/b 25 28 21 2.335 3.279 73
NeuroD1a/b 3 6 2 1.166 1.165 1
NeuroD4 (Xath3) 14 11 1 1.173 2.258 2
Ngn1 1 2 4 455 771 3
Ngn3 2 19 5 1 4 1
Nrgn-1b (Ngn2-b) 26 47 43 160 21 1
ODC 11.580 13.401 11.191 14.778 16.784 11.418
PRDM13 936 55 1 3.328 186 1
PRDM14 85 398 102 291 1.903 6
Pak3 98 103 65 746 978 7
Pax2-a 10 8 9 1.065 59 28
Ptf1a-a/b 5'UTR 22 33 17 42 15 9
RBM38/Seb4R 893 1.141 542 222 203 175
RBPJ 3'UTR 728 781 731 566 512 468
Sox3 4.238 7.499 5.825 812 554 152
Sox9-a/b 108 116 63 456 290 10
XPDip 3 2 2 19 2 1
Xbra-a/b 32 21 25 103 20 166
actc1 13 21 12 734 810 205
g6pd 503 596 488 184 180 193
tubb2b (N-tubulin) 51 41 25 18.125 33.288 58
vGlut1 1 1 1 34 597 1
NEG_A 2 7 5 3 3 1
NEG_B 2 1 1 1 1 6
NEG_C 3 1 1 1 2 1
NEG_D 6 6 6 6 7 3
NEG_E 9 8 3 4 2 5
NEG_F 1 9 3 6 5 2
NEG_G 1 1 2 1 2 1
NEG_H 2 1 1 2 1 1
POS_A 5.392 6.917 6.116 6.147 7.891 7.303
POS_B 2.813 3.382 3.010 3.226 3.900 3.563
POS_C 864 1.047 892 1.010 1.192 1.069
POS_D 175 226 198 206 242 203
POS_E 24 30 30 38 45 34













Genes Ptf1a Ptf1aW224A/W242A CC Ptf1a Ptf1aW224A/W242A CC 
Ascl1/Xash1 new 16 16 21 12 36 7
Barhl2 1 1 3 16 14 3
Cdknx (p27Xic1) 277 377 146 459 1.502 141
Cpa1 1 1 3 2 51 3
Dll1 (Delta1) 688 1.113 96 615 2.060 51
ESR10 241 53 86 61 283 7
Ebf2-a/b 91 33 6 538 1.564 1
Ebf3 (Coe3) 1 1 3 206 1.962 3
FoxD3a (XfD6) 64 93 162 45 40 1
Gad1 1 1 1 275 96 1
H4 new 98.113 124.321 239.505 24.893 63.752 16.260
HNF6 gene2 22 20 11 1.028 1.981 3
Hb9/mnx1 19 26 26 7 18 3
Hes5.1 (ESR1) 174 115 55 59 200 1
Hmx3 7 3 6 15 12 4
Hox11L2/Tlx3 5 13 5 12 832 1
Hpx6 (Lbx1) 4 2 5 63 52 1
Islet1 (isl1) 1 2 2 130 897 75
Kirrel2 145 27 118 97 31 4
Lhx1 (Lim1) 14 17 17 52 43 1
Lhx2 3 4 5 7 23 10
Lhx5 290 223 826 31 10 1
Lmx1b 6 8 11 16 73 1
Mecom 2 2 4 42 40 1
Mxi1 945 871 718 207 813 145
MyT1 952 523 150 589 3.503 113
NCAMa/b 19 27 40 855 6.549 52
NeuroD1a/b 2 4 7 193 1.218 4
NeuroD4 (Xath3) 4 1 2 160 1.655 1
Ngn1 1 5 6 108 761 2
Ngn3 13 4 11 1 4 1
Nrgn-1b (Ngn2-b) 60 72 67 29 25 1
ODC 6.931 10.663 17.736 3.435 27.572 1.312
PRDM13 347 19 1 179 46 1
PRDM14 218 182 266 149 2.322 4
Pak3 49 52 72 176 1.157 3
Pax2-a 12 8 8 97 127 8
Ptf1a-a/b 5'UTR 20 20 19 21 56 6
RBM38/Seb4R 567 995 871 66 311 40
RBPJ 3'UTR 452 460 757 344 1.661 166
Sox3 5.523 7.875 11.863 242 255 58
Sox9-a/b 112 68 116 151 134 4
Pdia2 (XPDip) 4 2 3 1 4 1
Xbra-a/b 12 29 26 31 288 10
actc1 12 9 14 254 670 28
g6pd 310 479 854 65 670 31
tubb2b (N-tubulin) 7 4 14 2.905 36.739 21
vGlut1 1 1 1 9 1.485 1
NEG_A 3 6 11 2 5 6
NEG_B 4 2 7 2 3 3
NEG_C 4 3 1 2 2 1
NEG_D 3 5 6 5 16 1
NEG_E 2 7 9 3 5 6
NEG_F 6 8 6 5 5 5
NEG_G 1 2 3 1 3 1
NEG_H 2 2 3 1 2 1
POS_A 9.006 9.492 7.183 9.700 7.705 6.893
POS_B 4.727 4.675 3.742 4.913 4.638 3.554
POS_C 1.321 1.372 1.123 1.477 1.439 1.005
POS_D 291 306 242 340 325 222
POS_E 61 64 37 47 49 32





6.2.4 Experiment 3.10 and 3.21 















Genes 3 h 6 h 9 h 25 h 3 h 6 h 9 h 25 h 3 h 6 h 9 h 25 h 3 h 6 h 9 h 25 h 
Ascl1/Xash1 new 17 11 14 2 18 18 19 7 10 8 12 1 7 13 14 4
Barhl2 5 1 6 22 2 11 11 94 1 1 1 1 1 1 1 1
Cdknx (p27Xic1) 625 631 584 573 199 353 464 588 56 145 110 27 31 51 139 171
Cpa1 1 2 1 34 1 1 4 61 1 1 1 2 1 1 1 14
Dll1 (Delta1) 2.458 1.819 1.889 2.509 545 369 952 4.082 66 232 192 12 19 74 232 119
ESR10 1.108 603 1.003 337 1.175 521 1.003 1.166 33 55 35 1 21 9 18 1
Ebf2-a/b 56 282 329 1.504 10 109 319 1.257 5 2 7 1 1 3 3 1
Ebf3 (Coe3) 1 2 3 605 1 1 2 285 1 1 1 1 1 1 1 5
FoxD3a (XfD6) 13 21 14 168 10 10 27 320 16 8 10 1 21 12 7 1
Gad1 1 1 1 554 1 3 14 151 1 1 1 1 1 1 1 5
H4 new 102.500111.754127.58438.85471.73696.562151.96346.34586.761119.90075.1165.829 62.650 53.195 106.944 26.719
HNF6 gene2 31 33 66 3.336 12 17 40 3.248 3 18 18 2 6 1 13 5
Hb9/mnx1 3 6 7 7 2 6 10 1 3 4 2 1 1 1 4 1
Hes5.1 (ESR1) 1.043 1.028 1.613 352 632 643 1.484 519 17 72 37 1 10 7 30 3
Hmx3 2 6 3 58 2 5 10 14 7 7 4 1 1 1 2 8
Hox11L2/Tlx3 5 5 8 3 1 5 1 2 1 2 1 1 1 1 1 1
Hpx6 (Lbx1) 3 1 3 29 1 2 6 51 1 2 2 2 1 2 5 1
Islet1 (isl1) 1 1 2 78 3 1 3 17 1 1 2 32 2 1 1 238
Kirrel2 243 189 333 1.287 82 141 272 2.310 107 182 112 1 66 48 168 1
Lhx1 (Lim1) 10 5 2 48 4 2 7 184 4 4 1 1 2 2 2 1
Lhx2 3 7 19 8 5 4 20 270 2 4 2 1 1 2 2 1
Lhx5 460 293 336 185 158 122 265 129 83 183 81 1 99 51 183 1
Lmx1b 20 17 20 77 11 6 20 57 4 17 3 1 2 3 16 2
Mecom 3 5 8 166 1 4 12 2.344 1 1 1 1 1 1 1 9
Mxi1 1.041 1.204 1.674 267 359 496 892 335 164 433 357 22 111 154 384 136
MyT1 867 1.475 1.220 1.415 333 893 1.474 1.892 31 78 50 11 16 34 69 196
NCAMa/b 15 10 6 1.864 8 10 9 918 7 14 7 4 7 9 13 46
NeuroD1a/b 7 3 11 325 3 2 12 107 2 1 2 1 1 2 2 1
NeuroD4 (Xath3) 4 36 42 635 3 19 35 383 1 1 1 1 1 1 2 1
Ngn1 1 1 1 204 1 1 3 489 2 2 1 1 1 1 5 1
Ngn3 2 9 1 1 3 7 13 1 3 8 2 1 1 2 3 1
Nrgn-1b (Ngn2-b) 31 42 35 95 24 29 55 382 11 13 16 1 21 25 23 2
ODC 12.073 9.175 12.30912.691 4.193 4.615 8.17511.380 3.733 7.757 5.371 731 3.293 2.540 6.828 7.585
PRDM13 158 600 819 2.095 177 837 1.726 4.050 1 1 1 1 1 1 1 1
PRDM14 315 178 214 65 136 88 172 14 79 174 225 1 58 48 189 2
Pak3 78 57 72 370 18 34 61 757 18 31 23 2 18 13 28 13
Pax2-a 9 6 1 428 3 2 5 192 1 7 4 3 4 2 4 3
Ptf1a-a/b 5'UTR 18 29 34 77 33 51 130 397 10 11 10 14 13 13 14 25
RBM38/Seb4R 702 846 849 144 299 383 556 209 186 294 206 12 279 208 278 148
RBPJ 3'UTR 766 627 659 737 347 349 536 475 321 507 311 122 332 251 423 544
Sox3 7.473 5.484 6.041 235 3.140 2.854 4.181 3.311 2.925 4.034 2.765 12 2.749 1.862 3.984 56
Sox9-a/b 190 139 183 525 153 165 293 667 48 101 78 1 39 30 68 11
Pdia2 (XPDip) 2 9 14 18 4 16 58 878 2 4 1 1 1 1 3 2
Xbra-a/b 4 9 10 13 4 6 10 4 4 2 4 1 4 1 4 25
actc1 16 25 21 223 11 15 23 106 14 6 3 64 5 5 14 379
g6pd 514 458 496 214 222 227 424 105 165 339 251 15 183 131 345 186
tubb2b (N-tubulin) 44 37 61 8.515 22 26 39 3.058 7 13 12 9 5 11 23 101
vGlut1 9 8 5 19 1 3 3 4 1 4 1 1 1 1 4 1
NEG_A 1 4 3 6 2 2 3 1 5 7 5 1 2 1 6 1
NEG_B 1 3 1 10 1 3 2 3 3 1 1 2 2 6 7 2
NEG_C 2 1 1 1 1 1 1 3 1 3 1 1 1 1 2 3
NEG_D 5 6 6 7 3 1 7 7 2 2 7 3 4 5 6 4
NEG_E 5 8 5 3 7 7 8 2 4 6 7 1 5 3 7 3
NEG_F 6 4 3 11 4 3 5 5 1 4 4 7 2 7 5 4
NEG_G 1 1 2 1 1 1 2 1 2 1 1 1 1 1 1 1
NEG_H 4 2 5 1 1 1 4 1 1 3 1 1 1 1 1 1
POS_A 6.133 6.816 5.679 7.231 5.288 5.724 6.930 7.843 7.713 7.231 6.7495.695 6.402 5.512 9.721 7.005
POS_B 3.066 3.436 2.752 3.688 2.446 2.867 3.274 3.615 3.536 3.379 3.1492.612 3.308 2.870 5.089 3.714
POS_C 927 1.026 797 1.143 765 842 936 1.083 1.017 1.066 901 802 1.029 850 1.502 1.150
POS_D 188 238 199 220 166 198 180 257 236 214 198 164 233 189 344 243
POS_E 35 44 28 43 33 26 39 38 38 29 47 29 40 33 66 54



















Genes 3 h 6 h 9 h 25 h 3 h 6 h 9 h 25 h 3 h 6 h 9 h 25 h 3 h 6 h 9 h 25 h 
Ascl1/Xash1 new 28 24 12 5 25 20 25 2 19 14 13 11 18 28 15 3
Barhl2 1 2 1 25 13 8 62 70 1 1 1 1 1 3 3 2
Cdknx (p27Xic1) 605 845 624 923 462 541 1.112 575 97 153 153 363 118 214 262 388
Cpa1 1 1 5 8 1 2 7 21 1 1 1 7 1 1 1 10
Dll1 (Delta1) 2.410 1.843 1.649 3.065 825 406 1.630 3.120 126 140 327 157 89 135 774 144
ESR10 1.558 630 887 911 2.621 452 1.577 1.379 51 134 98 8 57 124 92 3
Ebf2-a/b 35 195 286 1.673 13 82 613 1.050 5 3 7 1 6 5 5 1
Ebf3 (Coe3) 6 3 7 690 1 2 5 254 1 1 1 5 1 1 1 7
FoxD3a (XfD6) 22 22 31 219 37 31 73 350 36 51 20 1 18 48 47 1
Gad1 1 1 2 472 3 19 99 163 1 1 1 4 1 3 2 1
H4 new 124.506 210.768 195.625 57.345 155.480 158.466 254.992 62.736 168.362 129.976 99.010 38.717 147.306 176.711 177.596 50.263
HNF6 gene2 8 21 60 3.640 9 31 87 2.695 10 7 10 7 6 11 31 11
Hb9/mnx1 16 9 8 1 21 29 40 1 11 3 3 1 9 9 13 3
Hes5.1 (ESR1) 1.548 1.148 1.470 410 1.821 1.310 4.196 400 30 59 51 15 22 42 66 3
Hmx3 4 4 8 67 8 6 12 8 8 3 5 5 9 3 7 4
Hox11L2/Tlx3 5 8 11 2 4 2 6 5 2 1 1 3 5 4 6 2
Hpx6 (Lbx1) 5 5 4 9 4 6 6 13 3 1 3 2 1 4 9 1
Islet1 (isl1) 1 5 4 70 2 1 4 31 2 1 1 167 1 2 3 226
Kirrel2 106 177 307 1.461 128 112 647 2.255 116 108 138 1 218 126 331 3
Lhx1 (Lim1) 8 7 6 46 6 9 14 141 6 3 3 2 3 2 3 1
Lhx2 4 7 16 14 5 5 41 245 1 6 3 1 5 2 3 2
Lhx5 353 304 350 148 398 238 507 130 208 169 101 1 321 387 404 1
Lmx1b 10 12 5 24 15 9 15 31 12 8 5 3 13 8 15 1
Mecom 5 4 3 187 2 6 31 2.680 2 3 1 8 3 1 1 5
Mxi1 734 1.506 1.887 314 408 637 2.158 338 223 376 508 204 209 333 897 230
MyT1 459 1.418 1.398 1.131 358 1.059 3.655 1.562 35 74 67 210 76 106 198 289
NCAMa/b 27 27 38 1.953 14 16 40 593 20 21 19 75 19 18 27 37
NeuroD1a/b 1 1 9 529 6 2 17 90 1 2 2 1 1 5 1 1
NeuroD4 (Xath3) 1 9 8 1.053 1 4 36 291 1 1 1 1 1 1 1 1
Ngn1 10 3 1 330 5 3 3 430 4 5 2 1 3 12 2 1
Ngn3 10 11 6 2 9 7 10 1 12 2 2 1 2 8 5 1
Nrgn-1b (Ngn2-b) 59 51 57 108 99 67 154 287 48 42 14 1 82 82 41 1
ODC 8.015 8.980 9.436 10.650 7.993 6.083 14.490 7.827 6.634 5.686 5.023 5.584 9.766 9.077 13.658 7.115
PRDM13 152 901 1.157 2.463 398 1.189 4.529 3.774 1 1 1 1 2 1 1 1
PRDM14 385 300 448 57 376 247 589 22 251 556 598 11 200 325 668 2
Pak3 82 72 89 397 57 66 155 598 46 50 31 4 92 88 96 8
Pax2-a 5 7 11 402 7 7 5 94 8 5 2 21 5 4 7 5
Ptf1a-a/b 5'UTR 17 44 33 117 63 99 374 477 16 10 12 28 12 22 13 49
RBM38/Seb4R 603 771 645 152 479 464 928 203 278 223 164 77 436 509 424 156
RBPJ 3'UTR 962 878 770 631 1.059 728 1.250 382 707 626 368 392 1.040 980 1.018 500
Sox3 6.726 6.927 5.455 289 7.008 5.108 8.027 3.583 5.502 5.078 2.291 62 7.427 8.248 7.028 95
Sox9-a/b 110 110 127 376 164 255 644 812 39 60 60 19 61 60 107 13
Pdia2 (XPDip) 5 10 25 15 8 22 253 888 1 1 1 1 2 1 4 3
Xbra-a/b 63 4 14 10 17 5 37 2 4 1 2 8 9 3 8 20
actc1 9 23 24 88 17 8 22 20 19 10 6 76 9 17 9 69
g6pd 525 489 478 233 509 373 804 115 425 366 265 128 599 566 724 158
tubb2b (N-tubulin) 15 29 24 9.367 20 20 70 1.787 12 7 17 30 12 14 46 34
vGlut1 1 1 1 13 1 1 1 3 1 2 1 1 1 1 3 1
NEG_A 4 8 5 2 2 6 5 5 6 9 3 1 5 7 9 2
NEG_B 5 7 6 1 5 3 2 1 3 2 1 2 3 5 2 5
NEG_C 1 1 1 1 1 1 4 2 3 1 1 1 5 1 4 2
NEG_D 9 7 5 3 6 5 7 6 3 4 5 5 6 3 4 4
NEG_E 6 10 5 4 4 1 13 8 5 9 6 3 5 4 6 3
NEG_F 4 6 11 9 2 7 6 8 9 6 4 4 7 7 7 2
NEG_G 3 1 3 1 1 1 2 3 1 1 1 1 1 1 2 1
NEG_H 1 3 3 2 4 1 4 1 4 1 1 1 1 1 1 1
POS_A 6.711 9.436 8.775 8.486 6.152 5.987 7.380 8.693 8.133 5.911 6.992 6.544 6.507 7.327 7.343 8.616
POS_B 3.569 4.606 4.440 4.494 3.352 3.048 3.757 4.104 4.199 3.001 3.329 3.295 3.355 3.465 3.676 4.352
POS_C 1.089 1.503 1.277 1.334 1.031 933 1.165 1.237 1.321 935 970 998 999 1.028 1.156 1.304
POS_D 221 292 272 312 222 194 245 280 293 201 226 206 221 237 252 251
POS_E 33 61 51 41 32 34 43 42 44 36 35 43 41 46 32 51




6.3 Summary of the genes analysed with the Nanostring 
Table 6.17 Summary of the genes analysed with the Nanostring. Given is the 
symbol of the gene and its accession number as well as the target region and the 
target sequence of the reporter probe. (Grey marks a non-functional H4 probe).  
Gene Accession 
Target 




















































































































































































































































Dll1 (Delta1) BC070634.1 628-728 
CTGAAGTACTCCTACCGATTTGTGTGTGATGAATACTACTATGGGGAGGGCTGCTCTGACTACTGCCGCCCCAGA
GATGATGCTTTCGGCCATTTTTCCT 


























ESR10 AJ009285.1 824-924 
TTGCTTGGGTATAAATGTATTATGGGCTCACATAGGGGAGTCAGAAGTACATGCTGTGTATTGCCACACATTGCG
GCATATTTGGGCCTCTCAGAGTCTG 




























PRDM14  650-750 
CTGACAGTGCTGGACACTTCCTATGGGACTTTGCCCAAATCTGGAGTTTTCTGCAAGAACCTCATCCCTAAAGGA
GCCAAGTTCGGTCCATTTCAAGGCA 








Numb BE189039.2 360-460 
ACCATGCAATACTGCGCGTCCATTTTCGGTAAAAGTAGAACAGAGACATTTCTCGTGGTTGTGATTGTTTAAAGCA
ATGTGCTACATACAAGGAAGGTGG 







































































































6.4 Comparison of genes identified by RNA-sequencing with 
related publications 
Table 6.18 Comparison of direct Ptf1a and Ptf1a/Su(H) target genes with Ptf1a 
target genes identified in the adult mouse pancreas by ChIP-sequencing (Masui 
et al., 2010) 
 











Table 6.19 Comparison of direct Ptf1a and Ptf1a/Su(H) target genes with direct 
Ptf1a target genes identified in the 2-666 pancreatic progenitor cells by ChIP-
sequencing (Thompson et al., 2012) 
 
symbol Ptf1a-GR vs CC Ptf1a-GR + SuH-GR vs CC
neurod4 39,7 113,5 
nr5a2 31,3 72,2 
gfi1 19,2 80,9 
zc3h12a 17,4 13,9 
hes3.3 9,2 15,9 
des.1 8,2 5,9 
cbfa2t2 7,0 10,0 
dll1 6,7 7,4 
cox4i2 6,1 5,9 
gas6 5,5 3,9 
g0s2 5,2 2,2 
arl4a 4,5 3,4 
hes3.1 3,5 4,5 
pou2f3 3,2 3,8 
cpa1 - 65,9 
atoh8 - 58,5 
slc8a2 - 25,0 
cdh15 - 24,0 
chad - 16,8 
pik3r5 - 14,6 
fat4 - 11,8 
fjx1 - 10,9 
wdr86 - 8,3 
ampd3 - 6,3 
Rpl30 2,4 - 
matn4 - 6,0 
gpx3 - 5,8 
mn1 - 5,2 
mgat3 - 4,8 
slit1 - 4,8 
nrap - 4,8 
adcy9 - 4,5 
cldn5 - 4,3 
vash2 - 3,5 
kirrel2 - 3,5 
slc16a12 - 2,7 
sh3rf1 - 2,3 
tacc1 - 2,3 
pitpnm2 - 2,2 
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Table 6.20 Comparison of direct Ptf1a target genes with direct Ngn2 target genes 
identified in animal caps by Affymetrix Microarray analysis (Seo et al., 2007) 
 













































Table 6.21 Comparison of direct Ptf1a/Su(H) target genes with identified genes 
downstream of Ptf1a in endodermal explants (Bilogan and Horb, 2012) 
  symbol Ptf1aGR + SuH-GR vs CC
NF32 Xl.72042 4,5 
  hes5.1 3,7 
  crmp1 3,4 
  des.1 2,6 
NF36 vcan 3,4 
  atp6v0d2 2,6 
  sox9 2,4 
  unknown 1,6 
  myh6 1,6 
  cebpd 1,5 
  hes4 1,0 
NF32/NF36 cpa1 6,0 
  il1b 5,2 
  thbs3 4,6 
  ebf2 4,5 
  dpysl3 3,6 
  hey1 3,5 
  hes5.2 2,3 
  cldn5 2,1 
 
6.5 Primary transcriptome sequencing data  
The primary sequencing data are provided on CD “Appendix 6.5" attached to 
the thesis. 
 
Table 6.22 Candidates_Ngn2-GR_6h_Dex_vs_Cc_6h_Dex 
 
Table 6.23 Candidates_Ngn2-GR_25h_Dex_vs_Cc_25h_Dex 
 
Table 6.24 Candidates_Ptf1a-GR_6h_Dex_vs_Cc_6h_Dex 
 
Table 6.25 Candidates_Ptf1a-GR_25h_Dex_vs_Cc_25h_Dex 
 
Table 6.26 Candidates_Ptf1aW224A_W242A-GR_25h_Dex_vs_Cc_25h_Dex 
 
Table 6.27 Candidates_Ptf1aW224A_W242A-GR_6h_Dex_vs_Cc_6h_Dex 
 
Table 6.28 VennView_Comparison of downstream targets of Ptf1a, Ngn2 and 
Ptf1aW224A_W242A after 6 and 25 h 
 
Table 6.29 Candidates_Ptf1a_vs_CC_CHX_Dex 
 
Table 6.30 Candidates_SuH_vs_CC_CHX_Dex 
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Table 6.31 Candidates_Ptf1a_SuH_vs_CC_CHX_Dex 
 
Table 6.32 VennView_Comparison of identified direct target genes for Ptf1a and 
Su(H) alone as well as in combination 
 
Table 6.33 VennView_Comparison of downstream genes of Ptf1a and 
Ptf1aW224A_W242A after 6 and 25 h and genes identified as direct targets of 
Ptf1a alone and with Su(H) in combination 
